<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Blue‐light filtering spectacle lenses for visual performance, sleep, and macular health in adults - Singh, S - 2023 | Cochrane Library</title> <meta content="Blue‐light filtering spectacle lenses for visual performance, sleep, and macular health in adults - Singh, S - 2023 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013244.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Blue‐light filtering spectacle lenses for visual performance, sleep, and macular health in adults - Singh, S - 2023 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013244.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD013244.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Blue‐light filtering spectacle lenses for visual performance, sleep, and macular health in adults" name="citation_title"/> <meta content="Sumeer Singh" name="citation_author"/> <meta content="The University of Melbourne" name="citation_author_institution"/> <meta content="Peter R Keller" name="citation_author"/> <meta content="The University of Melbourne" name="citation_author_institution"/> <meta content="Ljoudmila Busija" name="citation_author"/> <meta content="Monash University" name="citation_author_institution"/> <meta content="Patrick McMillan" name="citation_author"/> <meta content="The University of Melbourne" name="citation_author_institution"/> <meta content="Eve Makrai" name="citation_author"/> <meta content="The University of Melbourne" name="citation_author_institution"/> <meta content="John G Lawrenson" name="citation_author"/> <meta content="City University of London" name="citation_author_institution"/> <meta content="Christopher C Hull" name="citation_author"/> <meta content="City University of London" name="citation_author_institution"/> <meta content="Laura E Downie" name="citation_author"/> <meta content="The University of Melbourne" name="citation_author_institution"/> <meta content="ldownie@unimelb.edu.au" name="citation_author_email"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="8" name="citation_issue"/> <meta content="10.1002/14651858.CD013244.pub2" name="citation_doi"/> <meta content="2023" name="citation_date"/> <meta content="2023/08/18" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013244.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013244.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013244.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Asthenopia; *Drug-Related Side Effects and Adverse Reactions; Eyeglasses; Light; *Melatonin; Sleep" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013244.pub2&amp;doi=10.1002/14651858.CD013244.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013244.pub2&amp;doi=10.1002/14651858.CD013244.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013244.pub2&amp;doi=10.1002/14651858.CD013244.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013244.pub2&amp;doi=10.1002/14651858.CD013244.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013244.pub2&amp;doi=10.1002/14651858.CD013244.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013244.pub2&amp;doi=10.1002/14651858.CD013244.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013244.pub2&amp;doi=10.1002/14651858.CD013244.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013244.pub2&amp;doi=10.1002/14651858.CD013244.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013244.pub2&amp;doi=10.1002/14651858.CD013244.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013244.pub2&amp;doi=10.1002/14651858.CD013244.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013244.pub2&amp;doi=10.1002/14651858.CD013244.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013244.pub2&amp;doi=10.1002/14651858.CD013244.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013244.pub2&amp;doi=10.1002/14651858.CD013244.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013244.pub2&amp;doi=10.1002/14651858.CD013244.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013244.pub2&amp;doi=10.1002/14651858.CD013244.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013244.pub2&amp;doi=10.1002/14651858.CD013244.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013244.pub2&amp;doi=10.1002/14651858.CD013244.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013244.pub2&amp;doi=10.1002/14651858.CD013244.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013244.pub2&amp;doi=10.1002/14651858.CD013244.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013244.pub2&amp;doi=10.1002/14651858.CD013244.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013244.pub2&amp;doi=10.1002/14651858.CD013244.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013244.pub2&amp;doi=10.1002/14651858.CD013244.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013244.pub2&amp;doi=10.1002/14651858.CD013244.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774054000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774081000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="jU9oKp1Y";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD013244\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD013244\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013244\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013244\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","ru","ko","pt","ms","hr","fr","zh_HANS","zh_HANT","th","ja","fa","id","pl"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD013244.pub2",title:"Blue\\u2010light filtering spectacle lenses for visual performance, sleep, and macular health in adults",firstPublishedDate:"Aug 18, 2023 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Eyes and Vision Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738735355000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=jU9oKp1Y&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013244.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD013244.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD013244.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD013244.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013244.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD013244.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD013244.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD013244.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD013244.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD013244.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;초록&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;บทคัดย่อ&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Zusammenfassung in einfacher Sprache&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;id&quot;,&quot;title&quot;:&quot;Saripati tinjauan sistematik&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;쉬운 말 요약&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo para leigos&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;ข้้อสรุปภาษาธรรมดา&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD013244.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD013244.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD013244.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD013244.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>22472 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD013244.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013244.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013244.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013244.pub2/full#CD013244-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013244.pub2/full#CD013244-sec-0083"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013244.pub2/full#CD013244-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013244.pub2/full#CD013244-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013244.pub2/full#CD013244-sec-0014"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013244.pub2/full#CD013244-sec-0015"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013244.pub2/full#CD013244-sec-0040"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013244.pub2/full#CD013244-sec-0077"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD013244.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013244.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013244.pub2/appendices#CD013244-sec-0087"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013244.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD013244.pub2/media/CDSR/CD013244/supinfo/CD013244-dataPackage.zip?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD013244.pub2/media/CDSR/CD013244/supinfo/CD013244-dataPackage.zip?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013244.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013244.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013244.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD013244.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD013244.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD013244.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2023 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD013244.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Blue‐light filtering spectacle lenses for visual performance, sleep, and macular health in adults </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013244.pub2/information#CD013244-cr-0004">Sumeer Singh</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013244.pub2/information#CD013244-cr-0005">Peter R Keller</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013244.pub2/information#CD013244-cr-0006">Ljoudmila Busija</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013244.pub2/information#CD013244-cr-0007">Patrick McMillan</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013244.pub2/information#CD013244-cr-0008">Eve Makrai</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013244.pub2/information#CD013244-cr-0009">John G Lawrenson</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013244.pub2/information#CD013244-cr-0010">Christopher C Hull</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013244.pub2/information#CD013244-cr-0011"><i class="icon corresponding-author fa fa-envelope"></i>Laura E Downie</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD013244.pub2/information/en#CD013244-sec-0098">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 18 August 2023 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD013244.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD013244.pub2">https://doi.org/10.1002/14651858.CD013244.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD013244-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD013244-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD013244-abs-0013">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD013244-abs-0021">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD013244-abs-0011">Français</a> </li> <li class="section-language"> <a class="" href="full/ko#CD013244-abs-0005">한국어</a> </li> <li class="section-language"> <a class="" href="full/pt#CD013244-abs-0007">Português</a> </li> <li class="section-language"> <a class="" href="full/th#CD013244-abs-0018">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD013244-abs-0015">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD013244-abs-0001" lang="en"> <section id="CD013244-sec-0001"> <h3 class="title" id="CD013244-sec-0001">Background</h3> <p>'Blue‐light filtering', or 'blue‐light blocking', spectacle lenses filter ultraviolet radiation and varying portions of short‐wavelength visible light from reaching the eye. Various blue‐light filtering lenses are commercially available. Some claims exist that they can improve visual performance with digital device use, provide retinal protection, and promote sleep quality. We investigated clinical trial evidence for these suggested effects, and considered any potential adverse effects. </p> </section> <section id="CD013244-sec-0002"> <h3 class="title" id="CD013244-sec-0002">Objectives</h3> <p>To assess the effects of blue‐light filtering lenses compared with non‐blue‐light filtering lenses, for improving visual performance, providing macular protection, and improving sleep quality in adults. </p> </section> <section id="CD013244-sec-0003"> <h3 class="title" id="CD013244-sec-0003">Search methods</h3> <p>We searched the Cochrane Central Register of Controlled Trials (CENTRAL; containing the Cochrane Eyes and Vision Trials Register; 2022, Issue 3); Ovid MEDLINE; Ovid Embase; LILACS; the ISRCTN registry; ClinicalTrials.gov and WHO ICTRP, with no date or language restrictions. We last searched the electronic databases on 22 March 2022. </p> </section> <section id="CD013244-sec-0004"> <h3 class="title" id="CD013244-sec-0004">Selection criteria</h3> <p>We included randomised controlled trials (RCTs), involving adult participants, where blue‐light filtering spectacle lenses were compared with non‐blue‐light filtering spectacle lenses. </p> </section> <section id="CD013244-sec-0005"> <h3 class="title" id="CD013244-sec-0005">Data collection and analysis</h3> <p>Primary outcomes were the change in visual fatigue score and critical flicker‐fusion frequency (CFF), as continuous outcomes, between baseline and one month of follow‐up. Secondary outcomes included best‐corrected visual acuity (BCVA), contrast sensitivity, discomfort glare, proportion of eyes with a pathological macular finding, colour discrimination, proportion of participants with reduced daytime alertness, serum melatonin levels, subjective sleep quality, and patient satisfaction with their visual performance. We evaluated findings related to ocular and systemic adverse effects. </p> <p>We followed standard Cochrane methods for data extraction and assessed risk of bias using the Cochrane Risk of Bias 1 (RoB 1) tool. We used GRADE to assess the certainty of the evidence for each outcome. </p> </section> <section id="CD013244-sec-0006"> <h3 class="title" id="CD013244-sec-0006">Main results</h3> <p>We included 17 RCTs, with sample sizes ranging from five to 156 participants, and intervention follow‐up periods from less than one day to five weeks. About half of included trials used a parallel‐arm design; the rest adopted a cross‐over design. A variety of participant characteristics was represented across the studies, ranging from healthy adults to individuals with mental health and sleep disorders. </p> <p>None of the studies had a low risk of bias in all seven Cochrane RoB 1 domains. We judged 65% of studies to have a high risk of bias due to outcome assessors not being masked (detection bias) and 59% to be at high risk of bias of performance bias as participants and personnel were not masked. Thirty‐five per cent of studies were pre‐registered on a trial registry. We did not perform meta‐analyses for any of the outcome measures, due to lack of available quantitative data, heterogenous study populations, and differences in intervention follow‐up periods. </p> <p>There may be no difference in subjective visual fatigue scores with blue‐light filtering lenses compared to non‐blue‐light filtering lenses, at less than one week of follow‐up (low‐certainty evidence). One RCT reported no difference between intervention arms (mean difference (MD) 9.76 units (indicating worse symptoms), 95% confidence interval (CI) ‐33.95 to 53.47; 120 participants). Further, two studies (46 participants, combined) that measured visual fatigue scores reported no significant difference between intervention arms. </p> <p>There may be little to no difference in CFF with blue‐light filtering lenses compared to non‐blue‐light filtering lenses, measured at less than one day of follow‐up (low‐certainty evidence). One study reported no significant difference between intervention arms (MD ‐ 1.13 Hz lower (indicating poorer performance), 95% CI ‐ 3.00 to 0.74; 120 participants). Another study reported a less negative change in CFF (indicating less visual fatigue) with high‐ compared to low‐blue‐light filtering and no blue‐light filtering lenses. </p> <p>Compared to non‐blue‐light filtering lenses, there is probably little or no effect with blue‐light filtering lenses on visual performance (BCVA) (MD 0.00 logMAR units, 95% CI ‐0.02 to 0.02; 1 study, 156 participants; moderate‐certainty evidence), and unknown effects on daytime alertness (2 RCTs, 42 participants; very low‐certainty evidence); uncertainty in these effects was due to lack of available data and the small number of studies reporting these outcomes. We do not know if blue‐light filtering spectacle lenses are equivalent or superior to non‐blue‐light filtering spectacle lenses with respect to sleep quality (very low‐certainty evidence). Inconsistent findings were evident across six RCTs (148 participants); three studies reported a significant improvement in sleep scores with blue‐light filtering lenses compared to non‐blue‐light filtering lenses, and the other three studies reported no significant difference between intervention arms. We noted differences in the populations across studies and a lack of quantitative data. </p> <p>Device‐related adverse effects were not consistently reported (9 RCTs, 333 participants; low‐certainty evidence). Nine studies reported on adverse events related to study interventions; three studies described the occurrence of such events. Reported adverse events related to blue‐light filtering lenses were infrequent, but included increased depressive symptoms, headache, discomfort wearing the glasses, and lower mood. Adverse events associated with non‐blue‐light filtering lenses were occasional hyperthymia, and discomfort wearing the spectacles. </p> <p>We were unable to determine whether blue‐light filtering lenses affect contrast sensitivity, colour discrimination, discomfort glare, macular health, serum melatonin levels or overall patient visual satisfaction, compared to non‐blue‐light filtering lenses, as none of the studies evaluated these outcomes. </p> </section> <section id="CD013244-sec-0007"> <h3 class="title" id="CD013244-sec-0007">Authors' conclusions</h3> <p>This systematic review found that blue‐light filtering spectacle lenses may not attenuate symptoms of eye strain with computer use, over a short‐term follow‐up period, compared to non‐blue‐light filtering lenses. Further, this review found no clinically meaningful difference in changes to CFF with blue‐light filtering lenses compared to non‐blue‐light filtering lenses. Based on the current best available evidence, there is probably little or no effect of blue‐light filtering lenses on BCVA compared with non‐blue‐light filtering lenses. Potential effects on sleep quality were also indeterminate, with included trials reporting mixed outcomes among heterogeneous study populations. There was no evidence from RCT publications relating to the outcomes of contrast sensitivity, colour discrimination, discomfort glare, macular health, serum melatonin levels, or overall patient visual satisfaction. Future high‐quality randomised trials are required to define more clearly the effects of blue‐light filtering lenses on visual performance, macular health and sleep, in adult populations. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD013244-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD013244-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD013244-abs-0003">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD013244-abs-0014">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD013244-abs-0022">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD013244-abs-0012">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD013244-abs-0010">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/id#CD013244-abs-0023">Bahasa Indonesia</a> </li> <li class="section-language"> <a class="" href="full/ja#CD013244-abs-0020">日本語</a> </li> <li class="section-language"> <a class="" href="full/ko#CD013244-abs-0006">한국어</a> </li> <li class="section-language"> <a class="" href="full/ms#CD013244-abs-0009">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD013244-abs-0024">Polski</a> </li> <li class="section-language"> <a class="" href="full/pt#CD013244-abs-0008">Português</a> </li> <li class="section-language"> <a class="" href="full/ru#CD013244-abs-0004">Русский</a> </li> <li class="section-language"> <a class="" href="full/th#CD013244-abs-0019">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD013244-abs-0016">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD013244-abs-0017">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD013244-abs-0002" lang="en"> <h3>Blue‐light filtering spectacle lenses for visual performance, macular (back part of the eye) protection, and improving sleep quality </h3> <p><b>What is the aim of this review?</b> </p> <p>This Cochrane Review aimed to investigate the possible benefits and safety of blue‐light filtering spectacle lenses, also known as blue‐light blocking spectacle lenses, on visual performance, macular protection, and sleep quality. Cochrane Review authors collected and analysed all relevant studies to summarise the best available research evidence. </p> <p><b>Key message</b> </p> <p>Blue‐light filtering lenses may not reduce short‐term eyestrain associated with computer work, compared to non‐blue‐light filtering lenses. Potential harmful effects were temporary and generally mild, and mostly thought to be related to the glasses more generally rather than specifically the lenses themselves. </p> <p>There is a need for future research to provide evidence for the effects of blue‐light filtering lenses on multiple aspects of visual performance and sleep, including vision level (best corrected visual acuity), ability to detect differences in shading and patterns (contrast sensitivity), colour discrimination, reducing glare due to bright light (discomfort glare), the health of the retina at the back of the eye (macular health), sleep measures (including blood melatonin levels and sleep quality), and patient satisfaction. </p> <p><b>What was studied in the review?</b> </p> <p>The primary measures were the change in perceived and quantifiable assessments of eye strain, measured after at least one month of using the lenses. The other assessments considered a range of clinical measures and side effects. </p> <p><b>What are the main results of the review?</b> </p> <p>We included 17 studies that recruited 619 people and took place in six countries. This review showed the following. </p> <p>(i) There may be no short‐term advantages with using blue‐light filtering lenses to reduce visual fatigue with computer use, compared to non‐blue‐light filtering lenses. </p> <p>(ii) There is limited information about the potential effect(s) of blue‐light filtering lenses on visual acuity and the effects on sleep‐related measures are unclear. The existing evidence regarding these measures is inconclusive. </p> <p>(iii) None of the included studies investigated contrast sensitivity, colour discrimination, discomfort glare, macular health, serum melatonin levels or overall patient visual satisfaction; no conclusions could be drawn in relation to these measures. </p> <p>(iv) There is some evidence that harmful effects that may be related to using blue‐light filtering lenses include headache (1 study, 8%), increased depressive symptoms (1 study, 17%), lowered mood (1 study, 5%), and discomfort wearing the glasses (2 studies (combined), 22%), although similar adverse effects were also reported with non‐blue‐light filtering lenses and there were not enough data to accurately measure or determine possible harmful effects with certainty. </p> <p><b>How up‐to‐date is this review?</b> </p> <p>The Cochrane Review authors searched for studies that had been published up to 22 March 2022. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD013244-sec-0083" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD013244-sec-0083"></div> <h3 class="title" id="CD013244-sec-0084">Implications for practice</h3> <section id="CD013244-sec-0084"> <p>Based on the current best available research evidence, this systematic review finds that there may be no clinically meaningful difference in short‐term (less than one day) subjective visual fatigue scores or critical fusion frequency (CFF) with the use of blue‐light filtering lenses compared to non‐blue‐light filtering lenses. </p> <p>Our ability to draw conclusions about the effect of blue‐light filtering spectacle lenses on many of the prespecified secondary outcomes was limited by the available evidence, with most trials not reporting quantitative data, having shorter follow‐up periods than the period of interest defined in our systematic review protocol, or heterogeneous study populations that limited our capacity for quantitative syntheses. </p> <p>There may be no difference between blue‐light filtering and non‐blue‐light filtering spectacle lenses with respect to best‐corrected visual acuity (BCVA), based on one study with a follow‐up period of less than one day. We are highly uncertain of whether blue‐light filtering lenses affect daytime alertness relative to non‐blue‐light filtering lenses. The study follow‐up periods for daytime alertness ranged from seven days to five weeks. For subjective sleep quality, with study follow‐up periods ranging between one and five weeks, limited quantitative data were available, and individual studies investigated different study populations; the effect of blue‐light filtering spectacles on this outcome thus remains very uncertain. Overall, the main reasons for downgrading the certainty of the evidence were due to risks of bias (i.e. performance bias, detection bias and other bias). </p> <p>As none of the eligible trials evaluated outcomes related to contrast sensitivity, discomfort glare, colour discrimination, effects on macular health, serum melatonin levels or overall patient visual satisfaction, we are unable to comment on the potential effect(s) of blue‐light filtering lenses, relative to non‐blue‐light filtering lenses, on these outcomes. Further, there is no clear evidence from reports of adverse events that blue‐light filtering spectacle lenses are unsafe to wear. </p> <p>Overall, based on relatively limited clinical trial data, these findings do not support the prescription of blue‐light filtering lenses to the general population for the purpose of reducing visual fatigue or enhancing BCVA. Potential effects on sleep are indeterminate due to lack of clarity with respect to how individuals with different medical conditions might, or might not, respond differentially to the intervention. </p> </section> <h3 class="title" id="CD013244-sec-0085">Implications for research</h3> <section id="CD013244-sec-0085"> <p>Beyond the putative link between blue light and (temporary) visual fatigue from computer use, from a public health perspective a particularly concerning notion is the prospect that environmental blue‐light exposure might induce permanent retinal damage, and promote the development or progression of age‐related macular degeneration (AMD). This association remains controversial (<a href="./references#CD013244-bbs2-0091" title="DownieLE , WormaldR , EvansJ , VirgiliG , KellerPR , LawrensonJG , et al. Analysis of a systematic review about blue light–filtering intraocular lenses for retinal protection: Understanding the limitations of the evidence. JAMA Ophthalmology2019;137(6):694-7.">Downie 2019</a>). The current review did not identify any randomised controlled trial (RCT) evidence from which to draw conclusions regarding whether blue‐light filtering spectacle lenses impart macular protection. Although environmental light sources (e.g. lights and electronic devices) might irradiate the eye for an extended period, the amount of blue light emitted from these sources is significantly less than the amount of blue light from natural daylight (<a href="./references#CD013244-bbs2-0084" title="deGálvezEN , AguileraJ , SolisA , deGálvezMV , deAndrésJR , Herrera-CeballosE , et al. The potential role of UV and blue light from the sun, artificial lighting, and electronic devices in melanogenesis and oxidative stress. Journal of Photochemistry and Photobiology B: Biology2022;228:112405.">de Gálvez 2022</a>; <a href="./references#CD013244-bbs2-0132" title="O'HaganJB , KhazovaM , PriceLL . Low-energy light bulbs, computers, tablets and the blue light hazard. Eye2016;30(2):230-3.">O'Hagan 2016</a>). For longer‐term viewing, the International Commission on Non‐ionising Radiation Protection (ICNIRP) has suggested exposure limits of greater than 100 W m<sup>−2</sup> sr<sup>−1</sup> can cause ocular damage; however, the amount of blue light emitted from electronic devices has been measured to be between 0.034 to 0.380 W m<sup>−2</sup> sr<sup>−1</sup>; at least 100‐fold less than the intensity considered to have the potential to cause eye damage. Based on these data, it is unlikely that environmental sources of blue light will cause retinal damage. </p> <p>While the current epidemiological evidence suggests the risk of blue‐light‐induced retinal damage from regular environmental exposure is low (<a href="./references#CD013244-bbs2-0081" title="DarzinsP , MitchellP , HellerRF . Sun exposure and age-related macular degeneration: An australian case—control study. Ophthalmology1997;104(5):770-6.">Darzins 1997</a>; <a href="./references#CD013244-bbs2-0086" title="DelcourtC , CarriereI , Ponton-SanchezA , FourreyS , LacrouxA , PapozL , et al. Light exposure and the risk of age-related macular degeneration: the Pathologies Oculaires Liees a l'Age (POLA) study. Archives of Ophthalmology2001;119(10):1463-8.">Delcourt 2001</a>; <a href="./references#CD013244-bbs2-0125" title="McCartyCA , MukeshBN , FuCL , MitchellP , WangJJ , TaylorHR . Risk factors for age-related maculopathy: the Visual Impairment Project. Archives of Ophthalmology2001;119(10):1455-62.">McCarty 2001</a>; <a href="./references#CD013244-bbs2-0151" title="TaylorHR , WestS , MuñozB , RosenthalFS , BresslerSB , BresslerNM . The long-term effects of visible light on the eye. Archives of Ophthalmology1992;110(1):99-104.">Taylor 1992</a>), any measure that might prevent or reduce the risk of AMD, or slow its progression, has the potential to have broad public health benefit. Hence, there may be merit in future studies evaluating whether blue‐light filtering spectacle lenses confer any degree of macular protection. Such studies are, however, practically challenging, likely requiring very large sample sizes, with clinical evaluation over years (possibly decades, depending on the study population) to ascertain any potential benefit(s). </p> <p>In relation to trial follow‐up periods, most studies included in this review had follow‐up periods of less than four weeks. This limited period of evaluation restricted our ability to consider the potential longer‐term outcomes from the use of blue‐light filtering lenses. Future studies with longer follow‐up periods are warranted, as appropriate to the intended research question. As discussed above, identifying macular structural change might require a follow‐up period of several years, whereas studies evaluating sleep may optimally address questions relating to efficacy or safety over follow‐up periods of weeks to months. </p> <p>The observed inconsistency in findings related to subjective sleep outcomes likely reflects the variability in the study populations among included studies. Given the rationale that any potential effects on sleep may be population dependent, there is a need for more studies that investigate specific participant populations; this would potentially then allow for data pooling across several studies investigating the same study population, to provide more certain evidence about any effects on sleep in specific segments of the population, including healthy adults. </p> <p>Sixty‐five per cent of included trials were not registered on a clinical trial registry, resulting in an inability to assess the risk of reporting bias in these studies. This finding is surprising, given that prospective registration of clinical trials has gained high importance in the last two decades, with journals making registration of study protocols compulsory to submit the research for publication (<a href="./references#CD013244-bbs2-0083" title="De AngelisCD , DrazenJM , FrizelleFA , HaugC , HoeyJ , HortonR , et al. Is this clinical trial fully registered? A statement from the International Committee of Medical Journal Editors. Haematologica2006;91(3):293-95.">De Angelis 2006</a>). Likewise, only 47% of included trials reported a sample size calculation, indicating a lack of clarity with respect to whether these studies were appropriately powered to find a difference between the interventions. These factors should be considered in the design and reporting of future RCTs. </p> <p>The variability in the methodology and outcome measures used in the eligible RCTs highlights the potential benefit of developing a core outcome set, with an agreed set of measures to be quantified and reported in future clinical trials. The adoption, and associated reporting, of core outcome measures in RCT publications will, in the longer term, contribute to enhancing capacity to pool data across multiple studies in future meta‐analyses, and thus assist with more clearly determining the efficacy and safety of the intervention. We did not identify any RCTs that assessed contrast sensitivity, discomfort glare, colour discrimination, serum melatonin levels, or patient visual satisfaction with blue‐light filtering spectacle lenses. Given the clinical relevance of these parameters, we suggest that future studies consider their inclusion as outcome measures, and that they also be considered for potential inclusion in a relevant core outcome set. </p> <p>For risk of bias assessment, the domains most frequently judged to be at a high risk of bias among eligible trials were related to a failure to mask participants, personnel or outcome assessors, or at least one of these parties. When possible, future studies should aim for a double‐masked study design. Where masking is challenging (e.g. due to familiarity of the intervention to the participants due to the difference in colouration of blue‐light filtering vs non‐blue‐light filtering lenses), any attempts to preserve masking should be described in the body of the manuscript and if masking was not achieved this should be clearly acknowledged. An assessment of masking integrity, as was evident in one trial (<a href="./references#CD013244-bbs2-0017" title="SinghS , DownieLE , AndersonAJ . Do blue-blocking lenses reduce eye strain from extended screen time? A double-masked, randomized controlled trial. American Journal of Ophthalmology2021;226:243–51. [DOI: 10.1016/j.ajo.2021.02.010]">Singh 2021</a>), would also be beneficial. This information will help in making appropriate judgements for these risk of bias domains in future reviews. </p> <p>Overall, the results of this review indicate that future high‐quality research is required to more clearly define the potential effects of blue‐light filtering lenses on visual performance, sleep and macular health, including whether efficacy and safety outcomes are distinct in different study populations. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD013244-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD013244-sec-0008"></div> <div class="table" id="CD013244-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Summary of findings 1: blue‐light filtering lenses compared to non‐blue‐light filtering lenses</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>Blue‐light filtering lenses compared with non‐blue‐light filtering lenses</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population</b>: adults </p> <p><b>Setting</b>: any setting </p> <p><b>Intervention</b>: blue‐light filtering lenses </p> <p><b>Comparison</b>: non‐blue‐light filtering lenses </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Outcome</b> </p> </th> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Relative effect (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Number of participants</b> </p> <p><b>(Number of studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Certainty of</b> </p> <p><b>the evidence</b> </p> <p><b>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with non‐blue light‐filtering lenses</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with blue‐light filtering lenses</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Visual fatigue score, measured using a Likert scale or VAS, with follow‐up ranging from &lt; 1 to 5 days (higher values indicate a poorer outcome) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in visual fatigue score in the non‐blue‐light filtering lens group was on average 86.92 units higher (55.42 higher to 118.4 higher). </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in visual fatigue score in the blue‐light filtering lens group was on average 96.68 units higher (65.07 higher to 128.3 higher) (<a href="./references#CD013244-bbs2-0017" title="SinghS , DownieLE , AndersonAJ . Do blue-blocking lenses reduce eye strain from extended screen time? A double-masked, randomized controlled trial. American Journal of Ophthalmology2021;226:243–51. [DOI: 10.1016/j.ajo.2021.02.010]">Singh 2021</a>). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9.76 units higher (33.95 lower to 53.47 higher)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>120 (1 RCT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<sup>a</sup> </p> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quantitative data reported for this outcome derive from <a href="./references#CD013244-bbs2-0017" title="SinghS , DownieLE , AndersonAJ . Do blue-blocking lenses reduce eye strain from extended screen time? A double-masked, randomized controlled trial. American Journal of Ophthalmology2021;226:243–51. [DOI: 10.1016/j.ajo.2021.02.010]">Singh 2021</a> (120 participants). </p> <p>Symptom scores were reported only as P values or in a non‐numeric form in 1 study (<a href="./references#CD013244-bbs2-0014" title="LinJB , GerrattBW , BassiCJ , ApteRS . Short-wavelength light-blocking eyeglasses attenuate symptoms of eye fatigue. Investigative Ophthalmology and Visual Science2017;58(1):442‐7. ">Lin 2017</a>), and another study presented data as the average daily change over a 5‐day period, rather than as the change from baseline or endpoint data value (<a href="./references#CD013244-bbs2-0005" title="DabrowieckiA , VillalobosA , KrupinskiEA . Impact of blue light filtering glasses on computer vision syndrome in radiology residents: a pilot study. Journal of Medical Imaging2020;7(2):022402. ">Dabrowiecki 2020</a>). </p> <p>2 trials reported no significant difference between intervention arms (<a href="./references#CD013244-bbs2-0005" title="DabrowieckiA , VillalobosA , KrupinskiEA . Impact of blue light filtering glasses on computer vision syndrome in radiology residents: a pilot study. Journal of Medical Imaging2020;7(2):022402. ">Dabrowiecki 2020</a>; <a href="./references#CD013244-bbs2-0014" title="LinJB , GerrattBW , BassiCJ , ApteRS . Short-wavelength light-blocking eyeglasses attenuate symptoms of eye fatigue. Investigative Ophthalmology and Visual Science2017;58(1):442‐7. ">Lin 2017</a>). </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CFF, measured in Hz, with a follow‐up of 2 hours (lower values indicate a poorer outcome)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in CFF in the non‐blue‐light filtering lens group was on average 0.12 Hz lower (1.47 lower to 1.24 higher) (<a href="./references#CD013244-bbs2-0017" title="SinghS , DownieLE , AndersonAJ . Do blue-blocking lenses reduce eye strain from extended screen time? A double-masked, randomized controlled trial. American Journal of Ophthalmology2021;226:243–51. [DOI: 10.1016/j.ajo.2021.02.010]">Singh 2021</a>). </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in CFF in the blue‐light filtering lens group was on average 1.25 Hz lower (2.60 lower to 0.09 higher) (<a href="./references#CD013244-bbs2-0017" title="SinghS , DownieLE , AndersonAJ . Do blue-blocking lenses reduce eye strain from extended screen time? A double-masked, randomized controlled trial. American Journal of Ophthalmology2021;226:243–51. [DOI: 10.1016/j.ajo.2021.02.010]">Singh 2021</a>). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.13 Hz lower (3.00 lower to 0.74 higher)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>120 (1 RCT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<sup>b</sup> </p> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quantitative data reported for this outcome derive from <a href="./references#CD013244-bbs2-0017" title="SinghS , DownieLE , AndersonAJ . Do blue-blocking lenses reduce eye strain from extended screen time? A double-masked, randomized controlled trial. American Journal of Ophthalmology2021;226:243–51. [DOI: 10.1016/j.ajo.2021.02.010]">Singh 2021</a> (120 participants). </p> <p>CFF data were reported only as P values or in a non‐numeric form in one study (<a href="./references#CD013244-bbs2-0014" title="LinJB , GerrattBW , BassiCJ , ApteRS . Short-wavelength light-blocking eyeglasses attenuate symptoms of eye fatigue. Investigative Ophthalmology and Visual Science2017;58(1):442‐7. ">Lin 2017</a>). <a href="./references#CD013244-bbs2-0014" title="LinJB , GerrattBW , BassiCJ , ApteRS . Short-wavelength light-blocking eyeglasses attenuate symptoms of eye fatigue. Investigative Ophthalmology and Visual Science2017;58(1):442‐7. ">Lin 2017</a> reported a significantly less negative change in CFF (i.e. less visual fatigue) with high blue‐light filtering lenses compared to low blue‐light filtering and non‐blue‐light filtering lenses. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>BCVA, measured in log units, with follow‐up of less than 1 day (higher values indicate a poorer outcome) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean BCVA in the non‐blue‐light filtering lens group was on average 0.049 units.</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean BCVA in the blue‐light filtering lens group was on average 0.051 units.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.00 log units (0.02 lower to 0.02 higher)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>156 (1 RCT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<sup>c</sup> </p> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quantitative data reported for this outcome derive from <a href="./references#CD013244-bbs2-0009" title="Hammond, BR. Attenuating photostress and glare disability in pseudophakic patients through the addition of a short-wave absorbing filter. Journal of Ophthalmology2015;2015:Article ID 607635. [DOI: 10.1155/2015/607635]NCT01938989. Effect of blue light filtration on visual performance. clinicaltrials.gov/ct2/show/NCT01938989 (first received 11 September 2013). ">Hammond 2015</a>. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Proportion of eyes or individuals that developed macular structural changes</p> </td> <td align="center" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No relevant data were available for this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Colour discrimination, measured using the FM‐100 hue test</p> </td> <td align="center" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No relevant data were available for this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Subjective sleep scores, measured using a VAS or Likert scale, with follow‐up ranging from 4 days to 5 weeks (higher values indicate a poorer outcome) </p> </td> <td align="" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>6 studies reported subjective sleep scores (<a href="./references#CD013244-bbs2-0004" title="BurkhartK , PhelpsJR . Amber lenses to block blue light and improve sleep: a randomized trial. Chronobiology International2009;26(8):1602‐12. ">Burkhart 2009</a>; <a href="./references#CD013244-bbs2-0007" title="EsakiY , KitajimaT , TakeuchiI , TsuboiS , FurukawaO , MoriwakiM , et al. Effect of blue-blocking glasses in major depressive disorder with sleep onset insomnia: a randomized, double-blind, placebo-controlled study. Chronobiology international2017;34(6):753‐61. ">Esaki 2017</a>; <a href="./references#CD013244-bbs2-0008" title="EsakiY , TakeuchiI , TsuboiS , FujitaK , IwataN , KitajimaT . A double-blind, randomized, placebo-controlled trial of adjunctive blue-blocking glasses for the treatment of sleep and circadian rhythm in patients with bipolar disorder. Bipolar Disorders2020;22(7):739-48. ">Esaki 2020</a>; <a href="./references#CD013244-bbs2-0012" title="JankuK , SmotekM , FarkovaE , KoprivovaJ . Block the light and sleep well: Evening blue light filtration as a part of cognitive behavioral therapy for insomnia. Chronobiology International2020;37(2):248-59. JankuK , SmotekM , FarkovaE , MiletínováE , KoprivovaJ . Blue light blocking glasses and CBT-I: effect on subjective and objective sleep quality. Sleep Medicine2019;64(Suppl 1):S174. ">Janku 2020</a>; <a href="./references#CD013244-bbs2-0013" title="KnufinkeM , Fittkau-KochL , MøstEI , KompierMA , NieuwenhuysA . Restricting short-wavelength light in the evening to improve sleep in recreational athletes - A pilot study. European Journal of Sport Science2019;19(6):728‐35. ">Knufinke 2019</a>; <a href="./references#CD013244-bbs2-0016" title="ShechterA , KimEW , St-OngeMP , WestwoodAJ . Blocking nocturnal blue light for insomnia: a randomized controlled trial. Journal of Psychiatric Research2018;96:196‐202. ">Shechter 2018</a>). Of these, 3 studies reported a significant improvement in sleep scores with blue‐light filtering lenses compared to non‐blue‐light filtering lenses (<a href="./references#CD013244-bbs2-0004" title="BurkhartK , PhelpsJR . Amber lenses to block blue light and improve sleep: a randomized trial. Chronobiology International2009;26(8):1602‐12. ">Burkhart 2009</a>; <a href="./references#CD013244-bbs2-0013" title="KnufinkeM , Fittkau-KochL , MøstEI , KompierMA , NieuwenhuysA . Restricting short-wavelength light in the evening to improve sleep in recreational athletes - A pilot study. European Journal of Sport Science2019;19(6):728‐35. ">Knufinke 2019</a>; <a href="./references#CD013244-bbs2-0016" title="ShechterA , KimEW , St-OngeMP , WestwoodAJ . Blocking nocturnal blue light for insomnia: a randomized controlled trial. Journal of Psychiatric Research2018;96:196‐202. ">Shechter 2018</a>); however, the magnitude of the difference between intervention arms could not be calculated, due to a lack of complete data reporting. </p> <p>The other 3 studies reported no significant difference in subjective sleep scores between intervention arms (<a href="./references#CD013244-bbs2-0007" title="EsakiY , KitajimaT , TakeuchiI , TsuboiS , FurukawaO , MoriwakiM , et al. Effect of blue-blocking glasses in major depressive disorder with sleep onset insomnia: a randomized, double-blind, placebo-controlled study. Chronobiology international2017;34(6):753‐61. ">Esaki 2017</a>; <a href="./references#CD013244-bbs2-0008" title="EsakiY , TakeuchiI , TsuboiS , FujitaK , IwataN , KitajimaT . A double-blind, randomized, placebo-controlled trial of adjunctive blue-blocking glasses for the treatment of sleep and circadian rhythm in patients with bipolar disorder. Bipolar Disorders2020;22(7):739-48. ">Esaki 2020</a>; <a href="./references#CD013244-bbs2-0012" title="JankuK , SmotekM , FarkovaE , KoprivovaJ . Block the light and sleep well: Evening blue light filtration as a part of cognitive behavioral therapy for insomnia. Chronobiology International2020;37(2):248-59. JankuK , SmotekM , FarkovaE , MiletínováE , KoprivovaJ . Blue light blocking glasses and CBT-I: effect on subjective and objective sleep quality. Sleep Medicine2019;64(Suppl 1):S174. ">Janku 2020</a>). For these 3 studies, the difference between intervention arms ranged from 19.90 units higher (indicating poor sleep) (1.86 lower to 41.66 higher, 20 participants) to 0.03 units higher (2.53 lower to 2.59 higher, 27 participants). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>148 (6 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<sup>d</sup> </p> <p>Very low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Subjective sleep scores were reported only as P values or in a non‐numeric form in 1 study (<a href="./references#CD013244-bbs2-0004" title="BurkhartK , PhelpsJR . Amber lenses to block blue light and improve sleep: a randomized trial. Chronobiology International2009;26(8):1602‐12. ">Burkhart 2009</a>). Data were presented as the average daily change, rather than the change from baseline or endpoint data in 1 study (<a href="./references#CD013244-bbs2-0016" title="ShechterA , KimEW , St-OngeMP , WestwoodAJ . Blocking nocturnal blue light for insomnia: a randomized controlled trial. Journal of Psychiatric Research2018;96:196‐202. ">Shechter 2018</a>). </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Proportion of participants with adverse events with a probable causal linked with the study intervention </p> </td> <td align="" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>4 studies reported adverse events, consisting of increased depressive symptoms, headache, lower mood, and pain or discomfort from wearing the spectacles across the study intervention arms. In the control arms, reported adverse events were hyperthermia and discomfort from wearing the spectacles. </p> <p>1 study reported adverse events in only the active intervention (blue‐light filtering lens) group (n = 3/13 participants) (<a href="./references#CD013244-bbs2-0010" title="HenriksenTE , SkredeS , FasmerOB , SchoeyenH , LeskauskaiteI , Bjørke-BertheussenJ , et al. Blue-blocking glasses as additive treatment for mania: a randomized placebo-controlled trial. Bipolar Disorders2016;18(3):221‐32. ">Henriksen 2016</a>). </p> <p>1 study reported an identical number of adverse events across both the active intervention and control arms (n = 4/10 versus n = 4/10) (<a href="./references#CD013244-bbs2-0007" title="EsakiY , KitajimaT , TakeuchiI , TsuboiS , FurukawaO , MoriwakiM , et al. Effect of blue-blocking glasses in major depressive disorder with sleep onset insomnia: a randomized, double-blind, placebo-controlled study. Chronobiology international2017;34(6):753‐61. ">Esaki 2017</a>). </p> <p>2 studies reported more adverse events in the control arm than with the active intervention (n = 0/19 versus n = 2/16, and n = 4/44 versus n = 7/44 participants) (<a href="./references#CD013244-bbs2-0006" title="DanilenkoK , LebedinskaiaMY , GadetskaiaEV , MarkovAA , IvanovaYA , AftanasLI . Six day combined partial wake and light therapy for unipolar depression. European Neuropsychopharmacology2019;29:S410‐11. DanilenkoKV , LebedinskaiaMY , GadetskaiaEV , MarkovAA , IvanovaYA , AftanasLI . A 6-day combined wake and light therapy trial for unipolar depression. Journal of Affective Disorders2019;259:355-61. ">Danilenko 2019</a>; <a href="./references#CD013244-bbs2-0008" title="EsakiY , TakeuchiI , TsuboiS , FujitaK , IwataN , KitajimaT . A double-blind, randomized, placebo-controlled trial of adjunctive blue-blocking glasses for the treatment of sleep and circadian rhythm in patients with bipolar disorder. Bipolar Disorders2020;22(7):739-48. ">Esaki 2020</a>). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>333 (9 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<sup>e</sup> </p> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There were no adverse events reported across both intervention and control groups in 5 studies (<a href="./references#CD013244-bbs2-0004" title="BurkhartK , PhelpsJR . Amber lenses to block blue light and improve sleep: a randomized trial. Chronobiology International2009;26(8):1602‐12. ">Burkhart 2009</a>; <a href="./references#CD013244-bbs2-0012" title="JankuK , SmotekM , FarkovaE , KoprivovaJ . Block the light and sleep well: Evening blue light filtration as a part of cognitive behavioral therapy for insomnia. Chronobiology International2020;37(2):248-59. JankuK , SmotekM , FarkovaE , MiletínováE , KoprivovaJ . Blue light blocking glasses and CBT-I: effect on subjective and objective sleep quality. Sleep Medicine2019;64(Suppl 1):S174. ">Janku 2020</a>; <a href="./references#CD013244-bbs2-0015" title="Perez AlgortaG , Van MeterA , DubickaB , JonesS , YoungstromE , LobbanF . Blue blocking glasses worn at night in first year higher education students with sleep complaints: a feasibility study. Pilot and Feasibility Studies2018;4:166. ">Perez Algorta 2018</a>; <a href="./references#CD013244-bbs2-0016" title="ShechterA , KimEW , St-OngeMP , WestwoodAJ . Blocking nocturnal blue light for insomnia: a randomized controlled trial. Journal of Psychiatric Research2018;96:196‐202. ">Shechter 2018</a>; <a href="./references#CD013244-bbs2-0017" title="SinghS , DownieLE , AndersonAJ . Do blue-blocking lenses reduce eye strain from extended screen time? A double-masked, randomized controlled trial. American Journal of Ophthalmology2021;226:243–51. [DOI: 10.1016/j.ajo.2021.02.010]">Singh 2021</a>). </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI). </p> <p>BCVA: best‐corrected visual acuity; CI: confidence interval; MD: mean difference; CFF: critical flicker‐fusion frequency; Hz: hertz; VAS: visual analogue scale; FM: Farnsworth Munsell.; RCT: randomised controlled trial. </p> <p><b>GRADE Working Group grades of evidence.</b> </p> <p><b>High quality</b>: further research is very unlikely to change our confidence in the estimate of effect. </p> <p><b>Moderate quality</b>: further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. </p> <p><b>Low quality</b>: further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. </p> <p><b>Very low quality</b>: we are very uncertain about the estimate. </p> <p><sup>a</sup>Downgraded two levels for risk of bias and imprecision, because outcome assessors were not masked in one study (<a href="./references#CD013244-bbs2-0005" title="DabrowieckiA , VillalobosA , KrupinskiEA . Impact of blue light filtering glasses on computer vision syndrome in radiology residents: a pilot study. Journal of Medical Imaging2020;7(2):022402. ">Dabrowiecki 2020</a>), one study did not mask participants and study personnel (<a href="./references#CD013244-bbs2-0014" title="LinJB , GerrattBW , BassiCJ , ApteRS . Short-wavelength light-blocking eyeglasses attenuate symptoms of eye fatigue. Investigative Ophthalmology and Visual Science2017;58(1):442‐7. ">Lin 2017</a>), and one study had wide confidence intervals (<a href="./references#CD013244-bbs2-0017" title="SinghS , DownieLE , AndersonAJ . Do blue-blocking lenses reduce eye strain from extended screen time? A double-masked, randomized controlled trial. American Journal of Ophthalmology2021;226:243–51. [DOI: 10.1016/j.ajo.2021.02.010]">Singh 2021</a>).<br/><sup>b</sup>Downgraded one level each for risk of bias and inconsistency, because one study did not mask participants and study personnel (<a href="./references#CD013244-bbs2-0014" title="LinJB , GerrattBW , BassiCJ , ApteRS . Short-wavelength light-blocking eyeglasses attenuate symptoms of eye fatigue. Investigative Ophthalmology and Visual Science2017;58(1):442‐7. ">Lin 2017</a>), and one study showed no intergroup differences (<a href="./references#CD013244-bbs2-0017" title="SinghS , DownieLE , AndersonAJ . Do blue-blocking lenses reduce eye strain from extended screen time? A double-masked, randomized controlled trial. American Journal of Ophthalmology2021;226:243–51. [DOI: 10.1016/j.ajo.2021.02.010]">Singh 2021</a>) while the other reported a positive effect with the blue‐light filtering intervention (<a href="./references#CD013244-bbs2-0014" title="LinJB , GerrattBW , BassiCJ , ApteRS . Short-wavelength light-blocking eyeglasses attenuate symptoms of eye fatigue. Investigative Ophthalmology and Visual Science2017;58(1):442‐7. ">Lin 2017</a>).<br/><sup>c</sup>Downgraded one level for risk of bias, because data derived from one study, in which the outcome assessor was not masked (<a href="./references#CD013244-bbs2-0009" title="Hammond, BR. Attenuating photostress and glare disability in pseudophakic patients through the addition of a short-wave absorbing filter. Journal of Ophthalmology2015;2015:Article ID 607635. [DOI: 10.1155/2015/607635]NCT01938989. Effect of blue light filtration on visual performance. clinicaltrials.gov/ct2/show/NCT01938989 (first received 11 September 2013). ">Hammond 2015</a>).<br/><sup>d</sup>Downgraded three levels for risk of bias, imprecision and inconsistency. In four studies, participants or study personnel, or both, were not masked (<a href="./references#CD013244-bbs2-0004" title="BurkhartK , PhelpsJR . Amber lenses to block blue light and improve sleep: a randomized trial. Chronobiology International2009;26(8):1602‐12. ">Burkhart 2009</a>; <a href="./references#CD013244-bbs2-0012" title="JankuK , SmotekM , FarkovaE , KoprivovaJ . Block the light and sleep well: Evening blue light filtration as a part of cognitive behavioral therapy for insomnia. Chronobiology International2020;37(2):248-59. JankuK , SmotekM , FarkovaE , MiletínováE , KoprivovaJ . Blue light blocking glasses and CBT-I: effect on subjective and objective sleep quality. Sleep Medicine2019;64(Suppl 1):S174. ">Janku 2020</a>; <a href="./references#CD013244-bbs2-0013" title="KnufinkeM , Fittkau-KochL , MøstEI , KompierMA , NieuwenhuysA . Restricting short-wavelength light in the evening to improve sleep in recreational athletes - A pilot study. European Journal of Sport Science2019;19(6):728‐35. ">Knufinke 2019</a>; <a href="./references#CD013244-bbs2-0016" title="ShechterA , KimEW , St-OngeMP , WestwoodAJ . Blocking nocturnal blue light for insomnia: a randomized controlled trial. Journal of Psychiatric Research2018;96:196‐202. ">Shechter 2018</a>), and in three studies outcome assessors were not masked (<a href="./references#CD013244-bbs2-0004" title="BurkhartK , PhelpsJR . Amber lenses to block blue light and improve sleep: a randomized trial. Chronobiology International2009;26(8):1602‐12. ">Burkhart 2009</a>; <a href="./references#CD013244-bbs2-0013" title="KnufinkeM , Fittkau-KochL , MøstEI , KompierMA , NieuwenhuysA . Restricting short-wavelength light in the evening to improve sleep in recreational athletes - A pilot study. European Journal of Sport Science2019;19(6):728‐35. ">Knufinke 2019</a>; <a href="./references#CD013244-bbs2-0016" title="ShechterA , KimEW , St-OngeMP , WestwoodAJ . Blocking nocturnal blue light for insomnia: a randomized controlled trial. Journal of Psychiatric Research2018;96:196‐202. ">Shechter 2018</a>). Two studies were at high risk of other bias due to significant baseline imbalance (<a href="./references#CD013244-bbs2-0004" title="BurkhartK , PhelpsJR . Amber lenses to block blue light and improve sleep: a randomized trial. Chronobiology International2009;26(8):1602‐12. ">Burkhart 2009</a>; <a href="./references#CD013244-bbs2-0007" title="EsakiY , KitajimaT , TakeuchiI , TsuboiS , FurukawaO , MoriwakiM , et al. Effect of blue-blocking glasses in major depressive disorder with sleep onset insomnia: a randomized, double-blind, placebo-controlled study. Chronobiology international2017;34(6):753‐61. ">Esaki 2017</a>). Further, the included studies had small sample sizes and reported variable findings.<br/><sup>e</sup>Downgraded two levels for risk of bias and inconsistency. In four studies, participants and study personnel were not masked (<a href="./references#CD013244-bbs2-0004" title="BurkhartK , PhelpsJR . Amber lenses to block blue light and improve sleep: a randomized trial. Chronobiology International2009;26(8):1602‐12. ">Burkhart 2009</a>; <a href="./references#CD013244-bbs2-0012" title="JankuK , SmotekM , FarkovaE , KoprivovaJ . Block the light and sleep well: Evening blue light filtration as a part of cognitive behavioral therapy for insomnia. Chronobiology International2020;37(2):248-59. JankuK , SmotekM , FarkovaE , MiletínováE , KoprivovaJ . Blue light blocking glasses and CBT-I: effect on subjective and objective sleep quality. Sleep Medicine2019;64(Suppl 1):S174. ">Janku 2020</a>; <a href="./references#CD013244-bbs2-0015" title="Perez AlgortaG , Van MeterA , DubickaB , JonesS , YoungstromE , LobbanF . Blue blocking glasses worn at night in first year higher education students with sleep complaints: a feasibility study. Pilot and Feasibility Studies2018;4:166. ">Perez Algorta 2018</a>; <a href="./references#CD013244-bbs2-0016" title="ShechterA , KimEW , St-OngeMP , WestwoodAJ . Blocking nocturnal blue light for insomnia: a randomized controlled trial. Journal of Psychiatric Research2018;96:196‐202. ">Shechter 2018</a>), and in four studies outcome assessors were not masked (<a href="./references#CD013244-bbs2-0004" title="BurkhartK , PhelpsJR . Amber lenses to block blue light and improve sleep: a randomized trial. Chronobiology International2009;26(8):1602‐12. ">Burkhart 2009</a>; <a href="./references#CD013244-bbs2-0010" title="HenriksenTE , SkredeS , FasmerOB , SchoeyenH , LeskauskaiteI , Bjørke-BertheussenJ , et al. Blue-blocking glasses as additive treatment for mania: a randomized placebo-controlled trial. Bipolar Disorders2016;18(3):221‐32. ">Henriksen 2016</a>; <a href="./references#CD013244-bbs2-0015" title="Perez AlgortaG , Van MeterA , DubickaB , JonesS , YoungstromE , LobbanF . Blue blocking glasses worn at night in first year higher education students with sleep complaints: a feasibility study. Pilot and Feasibility Studies2018;4:166. ">Perez Algorta 2018</a>; <a href="./references#CD013244-bbs2-0016" title="ShechterA , KimEW , St-OngeMP , WestwoodAJ . Blocking nocturnal blue light for insomnia: a randomized controlled trial. Journal of Psychiatric Research2018;96:196‐202. ">Shechter 2018</a>). Two studies were at high risk of other bias due to significant baseline imbalance (<a href="./references#CD013244-bbs2-0004" title="BurkhartK , PhelpsJR . Amber lenses to block blue light and improve sleep: a randomized trial. Chronobiology International2009;26(8):1602‐12. ">Burkhart 2009</a>; <a href="./references#CD013244-bbs2-0007" title="EsakiY , KitajimaT , TakeuchiI , TsuboiS , FurukawaO , MoriwakiM , et al. Effect of blue-blocking glasses in major depressive disorder with sleep onset insomnia: a randomized, double-blind, placebo-controlled study. Chronobiology international2017;34(6):753‐61. ">Esaki 2017</a>). Further, the reported adverse events were observed to vary across the studies. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD013244-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD013244-sec-0009"></div> <section id="CD013244-sec-0010"> <h3 class="title" id="CD013244-sec-0010">Description of the condition</h3> <p>The ubiquitous use of technology and increasing exposure to modern lighting sources that emit relatively higher amounts of blue light than traditional light sources (e.g. light emitting diodes (LEDs) and compact fluorescent lamps (<a href="./references#CD013244-bbs2-0132" title="O'HaganJB , KhazovaM , PriceLL . Low-energy light bulbs, computers, tablets and the blue light hazard. Eye2016;30(2):230-3.">O'Hagan 2016</a>)), both in working and domestic environments, has raised questions concerning the potential adverse effects of excessive exposure to short‐wavelength visible light. In terms of digital devices, use of LED‐backlit liquid crystal displays has been associated with both symptoms of visual fatigue and changes to visual function, as quantified by a relative reduction in critical fusion frequency (CFF), the frequency at which an intermittent (flickering) light stimulus appears to be in a complete steady stage to a human observer (<a href="./references#CD013244-bbs2-0107" title="IsonoH , KumarA , KamimuraT , NoguchiY , YaguchiH . The effect of blue light on visual fatigue when reading on LED- backlit tablet LCDs. web.iiit.ac.in/~apurva.kumar/files/publications/BlueLightFatigue.pdf (accessed 6 August 2018).">Isono 2013</a>). In modern times, the range of eye‐ and vision‐related symptoms associated with prolonged computer, tablet, and e‐reader use has been collectively defined as a multifactorial condition known as "Computer Vision Syndrome" (CVS) (<a href="./references#CD013244-bbs2-0059" title="American Optometric Association. Guide to the Clinical Aspect of Computer Vision Syndrome. St Louis: American Optometric Association, 1995.">American Optometric Association 1995</a>; <a href="./references#CD013244-bbs2-0060" title="American Optometry Association. Computer vision syndrome. www.aoa.org/patients-and-public/caring-for-your-vision/protecting-your-vision/computer-vision-syndrome (accessed 19 July 2018).">American Optometry Association 2018</a>; <a href="./references#CD013244-bbs2-0144" title="SheppardAL , WolffsohnJS . Digital eye strain: prevalence, measurement and amelioration. BMJ Open Ophthalmology2018;3(1):e000146.">Sheppard 2018</a>). </p> <p>Asthenopic symptoms, such as sore eyes, eye fatigue, headaches, blurred vision, and dry eye, have been reported to affect up to 90% of computer users (<a href="./references#CD013244-bbs2-0140" title="RosenfieldM . Computer vision syndrome: a review of ocular causes and potential treatments. Ophthalmic and Physiological Optics2011;31(5):502-15.">Rosenfield 2011</a>). However, given the multifactorial nature of CVS, and that other ocular conditions (e.g. binocular vision disorders, uncorrected refractive error or presbyopia, and tear film dysfunction) can elicit similar symptomatology, the relative contribution of blue light to CVS is difficult to ascertain. Despite the absence of a clear link between blue light and CVS, claims have been made in relation to the potential adverse effects of blue light emission from digital devices. This potential association forms the rationale for a variety of commercially‐available interventions that reduce blue‐light transmission to the eye (e.g. spectacle lenses, downloadable software applications, filter attachments to digital device screens, and changing internal settings on electronic devices, such as ‘night mode' settings) (<a href="./references#CD013244-bbs2-0145" title="SinghS , DownieLE , AndersonAJ . Insights into Australian optometrists’ knowledge and attitude towards prescribing blue light‐blocking ophthalmic devices. Ophthalmic and Physiological Optics2019;39(3):194-204.">Singh 2019</a>). </p> <p>With respect to potential effects on sleep, the increasing use of digital devices that emit relatively higher levels of short‐wavelength visible light than traditional incandescent light sources (e.g. LED‐backlit computer displays) has also raised concerns about the effect(s) of blue light (particularly evening exposure) on sleep. Such effects on human chronobiology are considered to depend upon the timing, duration, intensity, and spectral composition of the light exposure (<a href="./references#CD013244-bbs2-0080" title="CzieslerCA . Perspective: casting light on sleep deficiency. Nature2013;497(7450):S13.">Czeisler 2013</a>). Some epidemiological evidence supports an association between evening use of electronic devices and adverse sleep quality, altered circadian timing and reduced daytime alertness (<a href="./references#CD013244-bbs2-0073" title="ChangAM , AeschbachD , DuffyJF , CzeislerCA . Evening use of light-emitting eReaders negatively affects sleep, circadian timing, and next-morning alertness. Proceedings of the National Academy of Sciences of the United States of America2015;112(4):1232–7.">Chang 2015</a>; <a href="./references#CD013244-bbs2-0095" title="GambleAL , D'RozarioAL , BartlettDJ , WilliamsS , BinYS , GrunsteinRR , et al. Adolescent sleep patterns and night-time technology use: results of the Australian Broadcasting Corporation's Big Sleep Survey. PLoS One2014;19(11):e111700.">Gamble 2014</a>). However, experimental investigation has also failed to demonstrate an association between short‐duration (one hour or less) screen use immediately prior to bedtime and altered sleep onset (<a href="./references#CD013244-bbs2-0103" title="HeathM , SutherlandC , BartelK , GradisarM , WilliamsonP , LovatoN , et al. Does one hour of bright or short-wavelength filtered tablet screenlight have a meaningful effect on adolescents' pre-bedtime alertness, sleep, and daytime functioning?Chronobiology International2014;31(4):496-505.">Heath 2014</a>). Some evidence suggests disruptions to biological cycles and circadian rhythm can potentially have adverse effects on a diverse range of health parameters (<a href="./references#CD013244-bbs2-0102" title="HatoriM , GronfierC , Van GelderRN , BernsteinPS , CarrerasJ , PandaS , et al. Global rise of potential health hazards caused by blue light-induced circadian disruption in modern aging societies. NPJ Aging and Mechanisms of Disease2017;16(3):9.">Hatori 2017</a>), including associations between abnormal sleeping patterns and serious conditions such as sleep disorders (<a href="./references#CD013244-bbs2-0094" title="FloE , PallesenS , ÅkerstedtT , MagerøyN , MoenBE , GrønliJ , et al. Shift-related sleep problems vary according to work schedule. Occupational and Environmental Medicine2013;70(4):238-45.">Flo 2013</a>), metabolic dysfunction (<a href="./references#CD013244-bbs2-0111" title="KarlssonB , KnutssinA , LindahlB . Is there an association between shift work and having a metabolic syndrome? Results from a population bases study of 27,485 people. Occupational and Environmental Medicine2001;58(11):745-52.">Karlsson 2001</a>), and cancer (<a href="./references#CD013244-bbs2-0118" title="KolstadHA . Nightshift work and risk of breast cancer and other cancers-a critical review of the epidemiologic evidence. Scandinavian Journal of Work, Environment and Health2008;34(1):5-22.">Kolstad 2008</a>). Understanding the role of blue‐light filters in reducing such outcomes thus has significant public health implications. </p> <p>In terms of potential effects on macular health, the maintenance of macular integrity is essential to normal visual function. In 2010, it was estimated that 2.1 million people worldwide were blind, and 6.0 million people were visually impaired, as a consequence of macular disease (<a href="./references#CD013244-bbs2-0110" title="JonasJB , BourneRR , WhiteRA , FlaxmanSR , KeeffeJ , LeasherJ , et al. Visual impairment and blindness due to macular diseases globally: a systematic review and meta-analysis. American Journal of Ophthalmology2014;158(4):808-15.">Jonas 2014</a>). A leading cause of macular disease and adult vision impairment is age‐related macular degeneration (AMD) (<a href="./references#CD013244-bbs2-0077" title="ColemanHR , ChanCC , Ferris FL 3rd, ChewEY . Age-related macular degeneration. Lancet2008;372(9652):1835-45.">Coleman 2008</a>; <a href="./references#CD013244-bbs2-0078" title="CongdonN , O'ColmainB , KlaverCC , KleinR , MuñozB , FriedmanDS , et al. Causes and prevalence of visual impairment among adults in the United States. Archives of Ophthalmology2004;122(4):477-85.">Congdon 2004</a>; <a href="./references#CD013244-bbs2-0137" title="PascoliniD , MariottiSP . Global estimates of visual impairment: 2010. British Journal of Ophthalmology2012;96(5):614-8.">Pascolini 2012</a>), a slowly progressive retinal degenerative condition that increases in prevalence with age (<a href="./references#CD013244-bbs2-0135" title="OwenCG , FletcherAE , DonoghueM , RudnickaAR . How big is the burden of visual loss caused by age related macular degeneration in the United Kingdom?British Journal of Ophthalmology2003;87(3):312-7.">Owen 2003</a>; <a href="./references#CD013244-bbs2-0162" title="WongWL , SuX , LiX , CheungCM , KleinR , ChengCY , et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Global Health2014;2(2):e106-16.">Wong 2014</a>). About one‐third of individuals aged 80 years will show some clinical signs of AMD (<a href="./references#CD013244-bbs2-0114" title="KleinR , KleinBE , LintonKL . Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology1992;99(6):933-43.">Klein 1992</a>), with approximately 6% having late‐stage AMD by this age, and 20% at age 90 (<a href="./references#CD013244-bbs2-0141" title="RudnickaAR , JarrarZ , WormaldR , CookDG , FletcherA , OwenCG . Age and gender variations in age-related macular degeneration prevalence in populations of European ancestry: a meta-analysis. Ophthalmology2012;119(3):571-80.">Rudnicka 2012</a>). Risk factors for AMD include genetic factors (<a href="./references#CD013244-bbs2-0116" title="KleinRJ , ZeissC , ChewEY , TsaiJY , SacklerRS , HaynesC , et al. Complement factor H polymorphism in age-related macular degeneration. Science2005;308(5720):358-9.">Klein 2005</a>; <a href="./references#CD013244-bbs2-0159" title="WarwickA , LoteryA . Genetics and genetic testing for age-related macular degeneration. Eye 18;32(5):849-57.">Warwick 2017</a>; <a href="./references#CD013244-bbs2-0165" title="YangZ , CampNJ , SunH , TongZ , GibbsD , CameronDJ , et al. A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration. Science2006;314(5801):992-3.">Yang 2006</a>), and tobacco smoking (<a href="./references#CD013244-bbs2-0088" title="DownieLE , KellerPR . Nutrition and age-related macular degeneration: research evidence in practice. Optometry and Vision Science2014;91(8):821-31.">Downie 2014</a>; <a href="./references#CD013244-bbs2-0152" title="ThorntonJ , EdwardsR , MitchellP , HarrisonRA , BuchanI , KellySP . Smoking and age-related macular degeneration: a review of association. Eye2005;19(9):935-44.">Thornton 2005</a>). It is currently unclear how other factors, including short‐wavelength light exposure, might contribute to the development of AMD, progression of AMD, or both (<a href="./references#CD013244-bbs2-0065" title="BeattyS , BoultonM , HensonD , KohHH , MurrayIJ . Macular pigment and age related macular degeneration. British Journal of Ophthalmology1999;83(7):867-77.">Beatty 1999</a>). Given there is currently no means for preventing AMD onset, nor a cure for the disease, there is significant interest in novel methods for preserving macular integrity through life. </p> </section> <section id="CD013244-sec-0011"> <h3 class="title" id="CD013244-sec-0011">Description of the intervention</h3> <p>Sunlight comprises electromagnetic radiation ranging from ultraviolet (UV) to infrared (IR). UV radiation encompasses wavelengths from approximately 200 nanometres (nm) to 400 nm (<a href="./references#CD013244-bbs2-0166" title="YoussefPN , SheibaniN , AlbertDM . Retinal light toxicity. Eye2011;25(1):1-14.">Youssef 2011</a>). The visible light spectrum falls approximately between 400 nm to 760 nm, with ‘short‐wavelength' visible (blue) light ranging from 400 nm to 500 nm (<a href="./references#CD013244-bbs2-0122" title="MainsterMA . Intraocular lenses should block UV radiation and violet but not blue light. Archives of Ophthalmology2005;123(4):550-5.">Mainster 2005</a>). </p> <p>Blue‐light filtering, also termed 'blue‐blocking', spectacle lenses are ophthalmic lenses (generally prescribed in prescription glasses) that are designed to selectively attenuate the transmission of UV radiation and short‐wavelength visible light (<a href="./references#CD013244-bbs2-0120" title="LeungTW , LiRW , KeeCS . Blue-light filtering spectacle lenses: optical and clinical performances. PLoS One2017;12(1):e0169114.">Leung 2013</a>; <a href="./references#CD013244-bbs2-0123" title="MainsterMA . Violet and blue light blocking intraocular lenses: photoprotection versus photoreception. British Journal of Ophthalmology2006;90(6):784-92.">Mainster 2006</a>; <a href="./references#CD013244-bbs2-0145" title="SinghS , DownieLE , AndersonAJ . Insights into Australian optometrists’ knowledge and attitude towards prescribing blue light‐blocking ophthalmic devices. Ophthalmic and Physiological Optics2019;39(3):194-204.">Singh 2019</a>). This is in contrast to standard spectacle lenses, which do not filter blue light and provide varying degrees of inherent UV protection depending on the lens material used (e.g. an uncoated polycarbonate material will inherently provide relatively greater UV attenuation than an uncoated CR‐39 material lens). </p> <p>Blue‐light filtering spectacle lenses often contain a chromophore that reduces or eliminates the amount of blue light that reaches the eye. Another approach involves coating the posterior and anterior lens surfaces with an anti‐reflection interference coating that selectively decreases transmission of a portion of the blue‐light spectrum; the target range of wavelengths is typically 415 nm to 455 nm, corresponding to the region of the spectrum considered to impart the highest risk of ocular damage (<a href="./references#CD013244-bbs2-0070" title="BoultonM , RózanowskaM , RózanowskiB . Retinal photodamage. Journal of Photochemistry and Photobiology. B, Biology2001;64(2-3):144-61.">Boulton 2001</a>). </p> <p>A range of blue‐light filtering spectacle lenses is currently commercially available; examples include blueEast (Bonastar), Blue control (Hoya), Crizal prevencia (Essilor), Dura vision/blue protect (Zeiss), Gunnar (GUNNAR Optics), Kodak Total Blue (Signet Armolite Inc), and StressFree (Swisscoat). </p> </section> <section id="CD013244-sec-0012"> <h3 class="title" id="CD013244-sec-0012">How the intervention might work</h3> <p>By reducing the intraocular transmission of short‐wavelength visible light, blue‐light filtering spectacle lenses are hypothesised to potentially impart a range of benefits, including improving visual performance with digital device use, providing retinal protection from light‐induced damage, and minimising sleep and circadian rhythm disruption associated with evening use of blue‐light emitting devices. </p> <p>Despite the existence of studies that have investigated the application of blue‐light filtering spectacle lenses for reducing the signs or symptoms of CVS, or both (<a href="./references#CD013244-bbs2-0120" title="LeungTW , LiRW , KeeCS . Blue-light filtering spectacle lenses: optical and clinical performances. PLoS One2017;12(1):e0169114.">Leung 2013</a>; <a href="./references#CD013244-bbs2-0014" title="LinJB , GerrattBW , BassiCJ , ApteRS . Short-wavelength light-blocking eyeglasses attenuate symptoms of eye fatigue. Investigative Ophthalmology and Visual Science2017;58(1):442‐7. ">Lin 2017</a>; <a href="./references#CD013244-bbs2-0017" title="SinghS , DownieLE , AndersonAJ . Do blue-blocking lenses reduce eye strain from extended screen time? A double-masked, randomized controlled trial. American Journal of Ophthalmology2021;226:243–51. [DOI: 10.1016/j.ajo.2021.02.010]">Singh 2021</a>), the specific mechanism(s) underlying how these devices might impart such benefit(s) are not known. The rationale for claims that blue‐light filtering lenses attenuate CVS is based upon the premise that modern digital devices (that emit relatively higher amounts of blue light than traditional lighting sources) are frequently being used for several hours per day and many device users experience ocular discomfort (<a href="./references#CD013244-bbs2-0144" title="SheppardAL , WolffsohnJS . Digital eye strain: prevalence, measurement and amelioration. BMJ Open Ophthalmology2018;3(1):e000146.">Sheppard 2018</a>). Given that there is a correlation between discomfort glare sensitivity and brightness sensitivity with blue LEDs (<a href="./references#CD013244-bbs2-0113" title="Kimura-MinodaT , AyamaM . Evaluation of discomfort glare from color leds and its correlation with individual variations in brightness sensitivity. Color Research and Application2011;36(4):286-94.">Kimura‐Minoda 2011</a>), a potential mechanism may involve a reduction in discomfort glare; however, there is no direct evidence to support this hypothesis. </p> <p>With respect to the potential for intraocular light transmission to pose an ocular hazard, retinal exposure to certain wavelengths of radiation is fortunately limited by the physiological absorbance characteristics of the anterior eye. Ultraviolet wavelengths below 300 nm are absorbed by the cornea (<a href="./references#CD013244-bbs2-0069" title="BoettnerEA , WalterJR . Transmission of the ocular media. Investigative Ophthalmology and Visual Science1962;1:766-83.">Boettner 1962</a>), and wavelengths between 300 nm and 400 nm are predominantly attenuated by the crystalline lens (<a href="./references#CD013244-bbs2-0069" title="BoettnerEA , WalterJR . Transmission of the ocular media. Investigative Ophthalmology and Visual Science1962;1:766-83.">Boettner 1962</a>; <a href="./references#CD013244-bbs2-0131" title="NorrenDV , VosJJ . Spectral transmission of the human ocular media. Vision Research1974;14(11):1237-44.">Norren 1974</a>). With age, the crystalline lens becomes relatively less transparent and more yellow in colour, resulting in a reduction in the degree of retinal transmission of short‐wavelength visible light (400 nm to 500 nm), effectively acting as a natural blue‐light filter (<a href="./references#CD013244-bbs2-0157" title="vanNorrenD , vande KraatsJ . Spectral transmission of intraocular lenses expressed as a virtual age. British Journal of Ophthalmology2007;91(10):1374-5.">van Norren 2007</a>). The change in lenticular absorbance of blue light occurs exponentially (<a href="./references#CD013244-bbs2-0160" title="WealeRA . Age and the transmittance of the human crystalline lens. Journal of Physiology1988;395:577-87.">Weale 1988</a>), such that by 50 years of age, only 20% of short‐wavelength visible light reaches the retina (<a href="./references#CD013244-bbs2-0087" title="DillonJ , ZhengL , MerriamJC , GaillardER . Transmission of light to the aging human retina: possible implications for age related macular degeneration. Experimental Eye Research2004;79(6):753-9.">Dillon 2004</a>). In this respect, it is unclear how blue‐light filtering spectacle lenses might provide any benefit(s) in adults with a physiologically‐yellowed lens due to age. </p> <p>A population that theoretically may be relatively advantaged by blue‐light filtering spectacle lenses is people who have undergone cataract surgery, with implantation of an intraocular lens (IOL) that enables relatively more blue‐light transmittance than the aged crystalline lens (i.e. a UV‐only filtering IOL) (<a href="./references#CD013244-bbs2-0087" title="DillonJ , ZhengL , MerriamJC , GaillardER . Transmission of light to the aging human retina: possible implications for age related macular degeneration. Experimental Eye Research2004;79(6):753-9.">Dillon 2004</a>). There is experimental evidence from animal studies (<a href="./references#CD013244-bbs2-0100" title="HamWT , MuellerHA , Ruffolo JJ Jr, GuerryD , GuerryRK . Action spectrum for retinal injury from near-ultraviolet radiation in the aphakic monkey. American Journal of Ophthalmology1982;93(3):299-306.">Ham 1982</a>; <a href="./references#CD013244-bbs2-0130" title="NoellWK , WalkerVS , KangBS , BermanS . Retinal damage by light in rats. Investigative Ophthalmology1966;5(5):450-73.">Noell 1966</a>), and cell culture experiments (<a href="./references#CD013244-bbs2-0148" title="SparrowJR , MillerAS , ZhouJ . Blue light-absorbing intraocular lens and retinal pigment epithelium protection in vitro. Journal of Cataract and Refractive Surgery2004;30(4):873-8.">Sparrow 2004</a>), which demonstrates that short‐wavelength visible light exposure can induce retinal phototoxicity. The mechanism involves retinal photochemical damage (<a href="./references#CD013244-bbs2-0166" title="YoussefPN , SheibaniN , AlbertDM . Retinal light toxicity. Eye2011;25(1):1-14.">Youssef 2011</a>), as a result of reactive oxygen species (ROS) generation, which induces protein oxidation and lipid peroxidation (<a href="./references#CD013244-bbs2-0070" title="BoultonM , RózanowskaM , RózanowskiB . Retinal photodamage. Journal of Photochemistry and Photobiology. B, Biology2001;64(2-3):144-61.">Boulton 2001</a>). Whilst the retina has several mechanisms of defence to mitigate ROS‐dependent damage, these processes become less efficient with age (<a href="./references#CD013244-bbs2-0124" title="MargrainTH , BoultonM , MarshallJ , SlineyDH . Do blue light filters confer protection against age-related macular degeneration?Progress in Retinal and Eye Research2004;23(5):523-31.">Margrain 2004</a>), thus potentially rendering the ageing retina more vulnerable to phototoxicity. As a result of their relatively high oxygen requirements, the retinal pigment epithelium and photoreceptors are considered most susceptible to blue light‐induced photochemical damage (<a href="./references#CD013244-bbs2-0099" title="Ham WT Jr, Ruffolo JJ Jr, MuellerHA , ClarkeAM , MoonME . Histologic analysis of photochemical lesions produced in rhesus retina by short-wave-length light. Investigative Ophthalmology and Visual Science1978;17(10):1029-35.">Ham 1978</a>; <a href="./references#CD013244-bbs2-0101" title="Ham WT Jr, MuellerHA , Ruffolo JJ Jr, MillenJE , ClearySF , GuerryRK , et al. Basic mechanisms underlying the production of photochemical lesions in the mammalian retina. Current Eye Research1984;3(1):165-74.">Ham 1984</a>). This experimental evidence provides the basis for a hypothesis that blue light may also induce retinal damage in humans and contribute to macular changes in AMD. In this respect, spectacle lenses that attenuate retinal blue‐light exposure have been proposed to potentially be valuable for providing macular protection, and reducing the risk of AMD development and/or progression (<a href="./references#CD013244-bbs2-0065" title="BeattyS , BoultonM , HensonD , KohHH , MurrayIJ . Macular pigment and age related macular degeneration. British Journal of Ophthalmology1999;83(7):867-77.">Beatty 1999</a>; <a href="./references#CD013244-bbs2-0067" title="BernsteinPS , DeloriFC , RicherS , vanKujikFJ , WenzelAJ . The value of measurement of macular carotenoid pigment optical densities and distributions in age-related macular degeneration and other retinal disorders. Vision Research2010;50(7):716-28.">Bernstein 2010</a>); a similar rationale applies to the implantation of blue‐light filtering IOLs, following cataract surgery, however evidence for such a benefit is currently lacking (<a href="./references#CD013244-bbs2-0090" title="DownieLE , BusijaL , KellerPR . Blue-light filtering intraocular lenses (IOLs) for protecting macular health. Cochrane Database of Systematic Reviews2018, Issue 5. Art. No: CD011977. [DOI: 10.1002/14651858.CD011977.pub2]">Downie 2018</a>). </p> <p>Blue light also has potential effects on sleep quality and circadian rhythm (<a href="./references#CD013244-bbs2-0123" title="MainsterMA . Violet and blue light blocking intraocular lenses: photoprotection versus photoreception. British Journal of Ophthalmology2006;90(6):784-92.">Mainster 2006</a>). The circadian clock is regulated by the suprachiasmatic nucleus in the hypothalamus, which controls melatonin secretion from the pineal gland (<a href="./references#CD013244-bbs2-0097" title="GoelN , BasnerN , RaoH , DingesDF . Circadian rhythms, sleep deprivation, and human performance. Progress in Molecular Biology and Translational Science2013;119:155-90.">Goel 2013</a>). Daytime blue‐light exposure can promote subjective alertness by inhibiting the secretion of melatonin (<a href="./references#CD013244-bbs2-0158" title="ViolaAU , JamesLM , SchlangenLJ , DijkDJ . Blue-enriched white light in the workplace improves self-reported alertness, performance and sleep quality. Scandinavian Journal of Work, Environment and Health2008;34(4):297-306.">Viola 2008</a>). It follows that evening light exposure, particularly to short‐wavelength light (between 465 nm and 495 nm), may disrupt the physiological circadian clock through a similar mechanism (<a href="./references#CD013244-bbs2-0112" title="KhalsaSB , JewettME , CajochenC , CzeislerCA . A phase response curve to single bright light pulses in human subjects. Journal of Physiology2003;549(Pt 3):945-52.">Khalsa 2003</a>; <a href="./references#CD013244-bbs2-0127" title="McIntyreIM , NormanTR , BurrowsGD , ArmstrongSM . Human melatonin suppression by light is intensity dependent. Journal of Pineal Research1989;6(2):149-56.">McIntyre 1989</a>; <a href="./references#CD013244-bbs2-0138" title="RahmanSA , Flynn-EvansFE , AeschbachD , BrainardGC , CzeislerCA , LockleySW . Diurnal spectral sensitivity of the acute alerting effects of light. Sleep2014;37(2):271-81.">Rahman 2014</a>; <a href="./references#CD013244-bbs2-0167" title="ZeitzerJM , DijkDJ , KronauerR , BrownE , CzeislerC . Sensitivity of the human circadian pacemaker to nocturnal light: melatonin phase resetting and suppression. Journal of Physiology2000;526(Pt 3):695-702.">Zeitzer 2000</a>). This effect has received particular attention owing to the extensive use of digital devices in the evening, close to bedtime, and the potential impacts of this exposure on disrupting sleep quantity and quality (<a href="./references#CD013244-bbs2-0075" title="ChinoyED , DuffyJF , CzeislerCA . Unrestricted evening use of light‐emitting tablet computers delays self‐selected bedtime and disrupts circadian timing and alertness. Physiology Reports2018;6(10):e13692.">Chinoy 2018</a>). Based upon this rationale, it has been proposed that limiting intraocular exposure to blue light in the evening, through measures such as blue‐light filtering spectacle filters and using ‘night mode' settings on devices that reduce blue light emissions, may be of value for mitigating these potentially negative effects on sleep. Similar rationale has been proposed for the use of these interventions in promoting sleep in people with major depression and bipolar disorders (<a href="./references#CD013244-bbs2-0007" title="EsakiY , KitajimaT , TakeuchiI , TsuboiS , FurukawaO , MoriwakiM , et al. Effect of blue-blocking glasses in major depressive disorder with sleep onset insomnia: a randomized, double-blind, placebo-controlled study. Chronobiology international2017;34(6):753‐61. ">Esaki 2017</a>; <a href="./references#CD013244-bbs2-0011" title="HenriksenTEG , GrønliJ , AssmusJ , FasmerOB , SchoeyenH , LeskauskaiteI , et al. Blue-blocking glasses as additive treatment for mania: Effects on actigraphy-derived sleep parameters. Journal of Sleep Research2020;29(5):e12984. [DOI: 10.1111/jsr.12984]">Henriksen 2020</a>). </p> </section> <section id="CD013244-sec-0013"> <h3 class="title" id="CD013244-sec-0013">Why it is important to do this review</h3> <p>There remains significant debate surrounding whether blue‐light filtering spectacle lenses have merit in ophthalmic practice (<a href="./references#CD013244-bbs2-0089" title="DownieLE . Blue-light filtering ophthalmic lenses: to prescribe, or not to prescribe?Ophthalmic and Physiological Optics2017;37(6):640-3.">Downie 2017</a>). These lenses are frequently prescribed (sometimes in preference to standard spectacles lenses) in eye care practice (<a href="./references#CD013244-bbs2-0145" title="SinghS , DownieLE , AndersonAJ . Insights into Australian optometrists’ knowledge and attitude towards prescribing blue light‐blocking ophthalmic devices. Ophthalmic and Physiological Optics2019;39(3):194-204.">Singh 2019</a>), and a range of marketing claims exist surrounding their potential benefits. In particular, it has been proposed that blue‐light filtering spectacles may alleviate eye strain associated with digital device use (<a href="./references#CD013244-bbs2-0025" title="IdeT , TodaI , Miki, E, TsubotaK . Effect of blue light-reducing eye glasses on critical flicker frequency. Asia-Pacific Journal of Ophthalmology2015;4(2):80-5. ">Ide 2015</a>; <a href="./references#CD013244-bbs2-0014" title="LinJB , GerrattBW , BassiCJ , ApteRS . Short-wavelength light-blocking eyeglasses attenuate symptoms of eye fatigue. Investigative Ophthalmology and Visual Science2017;58(1):442‐7. ">Lin 2017</a>), improve sleep quality (<a href="./references#CD013244-bbs2-0063" title="AyakiM , HattoriA , MaruyamaY , NakanoM , YoshimuraM , KitazawaM , et al. Protective effect of blue-light shield eyewear for adults against light pollution from self-luminous devices used at night. Chronobiology International2016;33(1):134-9.">Ayaki 2016</a>), and protect the retina, specifically the macula, from phototoxicity (<a href="./references#CD013244-bbs2-0068" title="Blue light exposed. www.bluelightexposed.com/ (accessed 7 July 2018).">Blue Light Exposed 2015</a>; <a href="./references#CD013244-bbs2-0150" title="SymesRJ , CuthbertsonFM . Blue-blocking intraocular implants should be used routinely during phacoemulsification surgery--yes. Eye2012;26(11):1397-9.">Symes 2012</a>). However, in 2015, the UK Advertising Standards Authority (ASA) found that an advertisement by an optical retailer promoting the use of blue‐light filtering spectacle lenses to “filter out harmful blue light” represented misleading advertising “in the absence of adequate substantiation” linking blue‐light exposure to retinal damage in clinical populations (<a href="./references#CD013244-bbs2-0126" title="McCormickE . BBCs watchdog investigates blue light. www.aop.org.uk/ot/industry/high-street/2016/11/09/bbc-watchdog-investigates-blue-light (accessed 7 July 2018).">McCormick 2016</a>; <a href="./references#CD013244-bbs2-0153" title="United Kingdom Advertising Standards Authority (ASA). ASA ruling on Boots Professional Services Ltd t/a Boots Opticians Ltd. www.asa.org.uk/rulings/boots-professional-services-ltd-a15-293200.html (accessed 7 July 2018).">UK Advertising Standards Authority 2015</a>). </p> <p>There is currently a relative paucity of clinical evidence to support many claims surrounding the deleterious effects of blue‐light exposure. Although ocular discomfort symptoms have been long‐associated with computer and video display terminal use (<a href="./references#CD013244-bbs2-0147" title="SmithMJ , CohenBG , Stammerjohn LW Jr. An investigation of health complaints and job stress in video display operations. Human Factors1981;23(4):387-400.">Smith 1981</a>; <a href="./references#CD013244-bbs2-0154" title="UstinavicieneR , JanuskeviciusV . Association between occupational asthenopia and psycho-physiological indicators of visual strain in workers using video display terminals. Medical Science Monitor2006;12(7):CR296-301.">Ustinaviciene 2006</a>), the relative contribution of blue light per se (rather than other potential causative factors, such binocular vision anomalies, postural factors and/or tear film dysfunction) remains unclear. </p> <p>In terms of potential effects on sleep, a recent systematic review and meta‐analysis (which allowed the inclusion of randomised controlled trials (RCTs), cohort, and cross‐sectional studies) reported a significant association between portable screen‐based media device (e.g. cell phone and table devices) access or use in the sleep environment and poorer sleep outcomes (including inadequate quantity, poor quality and excessive daytime sleepiness) in children (<a href="./references#CD013244-bbs2-0071" title="CarterB , ReesP , HaleL , BhattacharjeeD , ParadkarMS . Association between portable screen-based media device access or use and sleep outcomes: a systematic review and meta-analysis. JAMA Pediatrics2016;170(12):1202-8.">Carter 2016</a>). However, as acknowledged by the authors of the review, the certainty of the evidence (assessed using the GRADE approach) was judged as low due to a necessary reliance on non‐randomised studies (<a href="./references#CD013244-bbs2-0071" title="CarterB , ReesP , HaleL , BhattacharjeeD , ParadkarMS . Association between portable screen-based media device access or use and sleep outcomes: a systematic review and meta-analysis. JAMA Pediatrics2016;170(12):1202-8.">Carter 2016</a>). Thus, there is the potential for the true effect to be substantially different from the reported effect estimate. </p> <p>Concerning the potential effect(s) of blue‐light filtering spectacles in imparting macular protection, 10 out of the 12 major population‐based studies that sought to determine whether there was a relationship between light exposure and AMD did not report a positive association (<a href="./references#CD013244-bbs2-0123" title="MainsterMA . Violet and blue light blocking intraocular lenses: photoprotection versus photoreception. British Journal of Ophthalmology2006;90(6):784-92.">Mainster 2006</a>). Similarly, it is unclear whether age‐related cataract surgery, in which removal of the aged crystalline lens (which acts as a physiological blue filter) and its replacement with a non‐blue‐light filtering IOL, is a risk factor for AMD development, AMD progression, or both. Although some studies have reported a positive association between cataract surgery and AMD (<a href="./references#CD013244-bbs2-0115" title="KleinR , KleinBE , JensenSC , CruickshanksKJ . The relationship of ocular factors to the incidence and progression of age-related maculopathy. Archives of Ophthalmology1998;116(4):506-13.">Klein 1998</a>; <a href="./references#CD013244-bbs2-0121" title="LiuIY , WhiteL , LaCroixAZ . The association of age-related macular degeneration and lens opacities in the aged. American Journal of Public Health1989;79(6):765-9.">Liu 1989</a>), others have found an absence of relationship with respect to the risk of developing late‐stage AMD in individuals with earlier stages of the condition (<a href="./references#CD013244-bbs2-0064" title="BaatzH , DarawshaR , AckermannH , SchariothGB , deOrtuetaD , PavlidisM , et al. Phacoemulsification does not induce neovascular age-related macular degeneration. Investigative Ophthalmology and Visual Science2008;49(3):1079-83.">Baatz 2008</a>; <a href="./references#CD013244-bbs2-0074" title="ChewEY , SperdutoRD , MiltonRC , ClemonsTE , GenslerGR , BresslerSB , et al. Risk of advanced age-related macular degeneration after cataract surgery in the Age-Related Eye Disease Study: AREDS report 25. Ophthalmology2009;116(2):297-303.">Chew 2009</a>). Notably, observational studies have important methodological limitations, including the potential influences of bias and confounding, which limit the interpretation of these findings. </p> <p>Given the relative attenuation of short‐wavelength visible light with a blue‐light filter, any potentially undesirable effects on visual function, in particular alterations to colour discrimination, also need to be considered. In the context of blue‐light filtering IOLs, a recent systematic review by <a href="./references#CD013244-bbs2-0090" title="DownieLE , BusijaL , KellerPR . Blue-light filtering intraocular lenses (IOLs) for protecting macular health. Cochrane Database of Systematic Reviews2018, Issue 5. Art. No: CD011977. [DOI: 10.1002/14651858.CD011977.pub2]">Downie 2018</a> concluded that, due to a paucity of studies, it is currently unclear whether these devices affect colour vision relative to non‐blue‐light filtering IOLs. The status of the evidence relating to blue‐light filtering spectacle lenses also requires clarification. </p> <p>A recent systematic review investigating the potential benefits and adverse events of different interventions for treating CVS concluded that blue‐light filtering spectacles are ineffective in reducing visual fatigue associated with computer use, compared to non‐blue‐light filtering spectacles, based on findings reported from three RCTs (<a href="./references#CD013244-bbs2-0146" title="SinghS , McGuinnessMB , AndersonAJ , DownieLE . Interventions for the management of computer vision syndrome: a systematic review and meta-analysis. Ophthalmology2022;129(10):1192–1215. [DOI: 10.1016/j.ophtha.2022.05.009]">Singh 2022</a>). There is a need to clarify whether blue‐light filtering spectacles affect other parameters, such as visual performance, sleep, and macular health (<a href="./references#CD013244-bbs2-0119" title="LawrensonJG , HullCH , DownieLE . The effect of blue-light blocking spectacle lenses on visual performance, macular health and the sleep-wake cycle: a systematic review of the literature. Ophthalmic and Physiological Optics2017;37(6):644-54.">Lawrenson 2017</a>). A rigorous systematic review, considering the best‐available RCT evidence, is essential to objectively evaluate the relative appropriateness of prescribing blue‐light filtering ophthalmic lenses for these purposes. The relative benefits and potential harms of these devices also need to be considered. This knowledge has the capacity to inform clinical practice guidelines relating to the prescription of blue‐light filtering spectacle lenses, and thus is of strong relevance to clinicians, patients, researchers, and the broader ophthalmic community. We expect that this systematic review may also identify important areas for future research in the field, to fill any evidence gaps. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD013244-sec-0014" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD013244-sec-0014"></div> <p>To assess the effects of blue‐light filtering lenses compared with non‐blue‐light filtering lenses, for improving visual performance, providing macular protection, and improving sleep quality in adults. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD013244-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD013244-sec-0015"></div> <section id="CD013244-sec-0016"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD013244-sec-0017"> <h4 class="title">Types of studies</h4> <p>We only included randomised controlled trials (RCTs).</p> </section> <section id="CD013244-sec-0018"> <h4 class="title">Types of participants</h4> <p>We included trials in which participants were adults (i.e. at least 18 years of age).</p> </section> <section id="CD013244-sec-0019"> <h4 class="title">Types of interventions</h4> <p>We included RCTs that compared blue‐light filtering spectacle lenses with non‐blue‐light filtering spectacle lenses. We excluded studies that investigated blue‐light filtering spectacle lenses in combination with any other intervention, unless the same intervention was also used in the comparator group. </p> </section> <section id="CD013244-sec-0020"> <h4 class="title">Types of outcome measures</h4> <section id="CD013244-sec-0021"> <h5 class="title">Primary outcomes</h5> <p>The prespecified primary outcomes, measured at one‐month of follow‐up, were:</p> <p> <ul id="CD013244-list-0001"> <li> <p>the change in visual fatigue or discomfort, measured using a questionnaire or visual analogue scale; and </p> </li> <li> <p>the change in CFF, measured in Hertz (Hz).</p> </li> </ul> </p> <p>CFF is defined as the frequency at which a flickering light stimulus appears to be continuous to a human observer (<a href="./references#CD013244-bbs2-0108" title="IwasakiT . The significance of changes in CFF values during performance on a VDT-based visual task. Megaw, Towards Human Work: Solutions to Problems in Occupational Health and Safety1991:352-7. [URL: cir.nii.ac.jp/crid/1571417124269900288]">Iwasaki 1991</a>). It is regarded as an indicator of arousal levels (<a href="./references#CD013244-bbs2-0082" title="DavrancheK , PichonA . Critical flicker frequency threshold increment after an exhausting exercise. Journal of Sport and Exercise Psychology2005;27(4):515-20.">Davranche 2005</a>), and is also often used as an outcome measure to quantify visual fatigue in studies investigating interventions for CVS (<a href="./references#CD013244-bbs2-0014" title="LinJB , GerrattBW , BassiCJ , ApteRS . Short-wavelength light-blocking eyeglasses attenuate symptoms of eye fatigue. Investigative Ophthalmology and Visual Science2017;58(1):442‐7. ">Lin 2017</a>; <a href="./references#CD013244-bbs2-0128" title="MoritaY , JounaiK , MiyakeM , InabaM , KanauchiO . Effect of heat-killed Lactobacillus paracasei KW3110 ingestion on ocular disorders caused by visual display terminal (VDT) loads: a randomized, double-blind, placebo-controlled parallel-group study. Nutrients2018;10(8):1058.">Morita 2018</a>; <a href="./references#CD013244-bbs2-0129" title="NagakiY , HayasakaS , YamadaT , HayasakaY , SanadaM , UonomiT . Effects of astaxanthin on accommodation, critical flicker fusion, and pattern visual evoked potential in visual display terminal workers. Journal of Traditional Medicines2002;19(5):170-3.">Nagaki 2002</a>; <a href="./references#CD013244-bbs2-0133" title=" OkamotoK , MunekataM , IshiiI , NajimaM . A study for evaluating the effect of bilberry extract supplement on eye conditions and functions―a randomized, placebo—controlled, double—blind study. Japanese Pharmacology and Therapeutics2018;46(5):869-81.">Okamoto 2018</a>; <a href="./references#CD013244-bbs2-0136" title="OzawaY , KawashimaM , InoueS , InagakiE , SuzukiA , OoeE , et al. Bilberry extract supplementation for preventing eye fatigue in video display terminal workers. Journal of Nutrition, Health and Aging2015;19(5):548-54.">Ozawa 2015</a>; <a href="./references#CD013244-bbs2-0017" title="SinghS , DownieLE , AndersonAJ . Do blue-blocking lenses reduce eye strain from extended screen time? A double-masked, randomized controlled trial. American Journal of Ophthalmology2021;226:243–51. [DOI: 10.1016/j.ajo.2021.02.010]">Singh 2021</a>; <a href="./references#CD013244-bbs2-0149" title="StringhamJM , StringhamNT , O'BrienKJ . Macular carotenoid supplementation improves visual performance, sleep quality, and adverse physical symptoms in those with high screen time exposure. Foods2017;6(7):47.">Stringham 2017</a>; <a href="./references#CD013244-bbs2-0163" title="YamashitaSI , SuzukiN , YamamotoK , IioSI , YamadaT . Effects of MaquiBright® on improving eye dryness and fatigue in humans: A randomized, double-blind, placebo-controlled trial. Journal of Traditional and Complementary Medicine2019;9(3):172-8.">Yamashita 2019</a>; <a href="./references#CD013244-bbs2-0168" title="ZhangM , BiLF , AiYD , YangLP , WangHB , LiuZY , et al. Effects of taurine supplementation on VDT work induced visual stress. Amino Acids2004;26(1):59-63.">Zhang 2004</a>). Acknowledging that there remains some debate about the validity of CFF as a measure of visual fatigue (<a href="./references#CD013244-bbs2-0164" title="YanK , RosenfieldM . Digital eyestrain and the critical fusion frequency. Optometry and Vision Science2022;99(3):253-8.">Yan 2022</a>), in the absence of a gold‐standard measure for quantifying visual fatigue, we selected CFF as a co‐primary outcome measure, in addition to symptoms, for this review. </p> <p>For both of these outcomes, the acceptable follow‐up range was defined as between two weeks and three months. </p> </section> <section id="CD013244-sec-0022"> <h5 class="title">Secondary outcomes</h5> <p>We considered the following secondary outcomes:</p> <p> <ul id="CD013244-list-0002"> <li> <p>change in best‐corrected visual acuity (BCVA), with or without (disability) glare, measured in logMAR; </p> </li> <li> <p>change in contrast sensitivity, measured in log contrast sensitivity, with and without (disability) glare; </p> </li> <li> <p>change in discomfort glare, measured using a questionnaire (e.g. de Boer scale) or objectively (e.g. electromyogram); </p> </li> <li> <p>proportion of eyes, or individuals (as determined by the unit of analysis), with a finding of a pathological structural change at the macula, detected by clinical observation, optical coherence tomography (OCT) or retinal fundus photography; </p> </li> <li> <p>change in colour discrimination, considered as the standard mean difference for panel tests (e.g. Farnsworth D15 and 100‐hue) or the number of errors on plate tests (e.g. Ishihara), measured under photopic, mesopic, or scotopic conditions; </p> </li> <li> <p>daytime alertness, considered as the proportion of participants who had reduced daytime alertness, measured using a subjective scale; </p> </li> <li> <p>change in serum melatonin levels, measured in pg/mL;</p> </li> <li> <p>sleep quality, measured using questionnaires or rating scales;</p> </li> <li> <p>overall patient satisfaction with their visual performance, measured using questionnaires or rating scales. </p> </li> </ul> </p> <p>The secondary outcomes were measured at one month (with an acceptable range of two weeks to three months), except for the ‘proportion of eyes, or individuals, with a finding of a pathological structural change at the macula', which was measured at 12 months (with an acceptable range of six to 24 months). </p> </section> <section id="CD013244-sec-0023"> <h5 class="title">Adverse effects</h5> <p>We extracted data relating to both ocular and systematic adverse events from the included studies. </p> </section> </section> </section> <section id="CD013244-sec-0024"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD013244-sec-0025"> <h4 class="title">Electronic searches</h4> <p>The Cochrane Eyes and Vision Information Specialist searched the following databases for randomised controlled trials and controlled clinical trials. There were no restrictions to language or year of publication. The date of the search was 22 March 2022. </p> <p> <ul id="CD013244-list-0003"> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL) (which contains the Cochrane Eyes and Vision Trials Register) in the Cochrane Library (searched 22 March 2022) (<a href="./appendices#CD013244-sec-0088">Appendix 1</a>). </p> </li> <li> <p>MEDLINE Ovid (1946 to 22 March 2022) (<a href="./appendices#CD013244-sec-0089">Appendix 2</a>). </p> </li> <li> <p>Embase Ovid (1980 to 22 March 2022) (<a href="./appendices#CD013244-sec-0090">Appendix 3</a>). </p> </li> <li> <p>LILACS (1982 to 22 March 2022) (<a href="./appendices#CD013244-sec-0091">Appendix 4</a>). </p> </li> <li> <p>ISRCTN registry (<a href="http://www.isrctn.com/editAdvancedSearch" target="_blank">www.isrctn.com/editAdvancedSearch</a>; searched 22 March 2022) (<a href="./appendices#CD013244-sec-0092">Appendix 5</a>). </p> </li> <li> <p>US National Institutes of Health Ongoing Trials Register ClinicalTrials.gov (<a href="http://www.clinicaltrials.gov" target="_blank">www.clinicaltrials.gov</a>; searched 22 March 2022) (<a href="./appendices#CD013244-sec-0093">Appendix 6</a>). </p> </li> <li> <p>World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) (<a href="http://www.who.int/ictrp" target="_blank">www.who.int/ictrp</a>; searched 22 March 2022) (<a href="./appendices#CD013244-sec-0094">Appendix 7</a>). </p> </li> </ul> </p> </section> <section id="CD013244-sec-0026"> <h4 class="title">Searching other resources</h4> <p>We searched the bibliographies of included RCTs to identify any other potentially relevant studies. </p> </section> </section> <section id="CD013244-sec-0027"> <h3 class="title" id="CD013244-sec-0027">Data collection and analysis</h3> <section id="CD013244-sec-0028"> <h4 class="title">Selection of studies</h4> <p>We adopted a two‐stage process to identify relevant RCTs.</p> <p>First, two review authors (two of LED, SS, and PM) independently evaluated the title and abstract results from the search strategies, to identify studies potentially suitable for inclusion. We then obtained full‐text articles of records that at least one review author judged as relevant, or possibly relevant. Two review authors (two of LED, SS, and PM) then independently assessed each full‐text article and assessed its suitability for inclusion, according to the <a href="#CD013244-sec-0016">Criteria for considering studies for this review</a>. </p> <p>Any disagreements in classification were resolved by discussion and consensus between the two review authors; if required, we consulted a third review author for a final judgement with respect to eligibility. </p> <p>For records where more information was considered necessary to determine eligibility, we contacted the trial authors by email to request this information. If we did not receive a response within four weeks, we used the information provided within the full‐text article to assess eligibility. We provided details relating to the reason for excluding studies that progress to the full‐text review stage, in the <a href="./references#CD013244-sec-0105" title="">Characteristics of excluded studies</a> table. </p> </section> <section id="CD013244-sec-0029"> <h4 class="title">Data extraction and management</h4> <p>Two review authors (two of LED, SS, AL, EM, PM, JL, and CH) independently extracted key study data (detailed in <a href="./appendices#CD013244-sec-0095">Appendix 8</a>) using <a href="./references#CD013244-bbs2-0079" title="Covidence. Melbourne, Australia: Veritas Health Innovation, accessed 22 March 2022. Available at www.covidence.org.">Covidence</a>. The relevant information captured included details of the study design, country, setting, participant characteristics, number of participants, outcomes, results, and any other relevant information (e.g. funding sources, declarations of interest). Wherever possible, we extracted quantitative data for our prespecified outcomes. </p> <p>The two review authors resolved any discrepancies in data extraction by discussion to reach consensus; if necessary, they consulted a third review author. After reaching consensus in Covidence, one review author (SS) exported the collated data into Cochrane's Review Manager Web (RevMan Web) software (<a href="./references#CD013244-bbs2-0139" title="Review Manager Web (RevMan Web). Version 4.13.0. The Cochrane Collaboration, 2022. Available at revman.cochrane.org.">RevMan Web 2022</a>), and a second review author independently verified the data. </p> </section> <section id="CD013244-sec-0030"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (two of LED, SS, AL, EM, PM, JL, and CH) independently assessed the risk of bias in each of the included RCTs using the guidelines in Chapter 8 of the <i>Cochrane Handbook for Systematic Review of Interventions</i> (<a href="./references#CD013244-bbs2-0106" title="HigginsJPT , AltmanDG , SterneJAC , editor(s). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.2.0 (updated June 2017), Cochrane, 2017. Available from handbook.cochrane.org.">Higgins 2017</a>). Risk of bias was evaluated in the following domains. </p> <p> <ul id="CD013244-list-0004"> <li> <p>Selection bias (random sequence generation and allocation concealment)</p> </li> <li> <p>Performance bias (masking of participants and personnel)</p> </li> <li> <p>Detection bias (masking of outcome assessment)</p> </li> <li> <p>Attrition bias (incomplete outcome data)</p> </li> <li> <p>Reporting bias (selective reporting of outcomes)</p> </li> <li> <p>Other bias (funding source, other conflicts of interest)</p> </li> </ul> </p> <p>We performed risk of bias assessments for cross‐over studies in a similar way to parallel‐arm design studies. Carry‐over and/or washout‐period effects generally relevant to cross‐over study designs were considered unlikely to occur in studies relevant to this review, as any potential benefits or harms derived from the optical intervention would likely only occur during the acute phase of exposure, with minimal longevity to any such potential effect(s) upon cessation. </p> <p>Two review authors (two of LED, SS, AL, EM, PM, JL, and CH) judged the risk of each bias in each of the included studies as: (i) low risk, (ii) unclear risk (due to either lack of information or uncertainty over the potential for bias) or (iii) high risk. We resolved any disagreements in risk of bias assessment by consensus. </p> </section> <section id="CD013244-sec-0031"> <h4 class="title">Measures of treatment effect</h4> <p>We undertook the data analyses according to the approach described in Chapter 9 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD013244-bbs2-0085" title="DeeksJJ , HigginsJPT , Altman DG (editors) on behalf of the Cochrane Statistical Methods Group. Chapter 9: Analysing data and undertaking meta-analyses.In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Cochrane, 2017. Available from www.training.cochrane.org/handbook.">Deeks 2017</a>). </p> <p>For continuous outcomes, we extracted information on the change from baseline of the outcome measures for the intervention and comparator groups at the specified follow‐up period(s). We extracted data as means and standard deviations (SDs) of the changes. Where measures of change were not reported, we extracted the mean and SD values of the outcome for the intervention and comparator groups at the specified follow‐up period(s). </p> <p>We expressed treatment effects as the mean difference (MD), with 95% confidence intervals (CIs), between the intervention and comparator groups. For studies that had more than one intervention or control group, we had planned to combined data from the relevant study groups, as appropriate. However, there were no instances where this was required. </p> <p>For dichotomous outcomes, we had planned to extract the proportion of participants who experienced the outcome of interest in the intervention and comparator groups and to present these data as risk ratios (RRs) with 95% CIs. However, no combinable data were available for these outcomes. </p> </section> <section id="CD013244-sec-0032"> <h4 class="title">Unit of analysis issues</h4> <p>The unit of analysis was the study participant.</p> <p>When a study reported data on more than one eye per participant, we had planned to follow the guidelines for clustering or paired‐eye designs as described in Chapter 16 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD013244-bbs2-0105" title="HigginsJPT , DeeksJJ , AltmanDG , editor(s). Chapter 16: Special topics in statistics. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Higgins 2011</a>). When only one eye per person was included in the trial, we had planned to document how the eye was selected (if specified in the study report). If individual participants were randomly allocated to the intervention, but data from both eyes were included and reported, we had proposed to analyse this as clustered data, with an adjustment for within‐person correlation. </p> <p>However, as no quantitative analyses were feasible, these factors were not relevant to the current narrative synthesis. Further, cross‐over studies were treated similar to parallel‐arm design studies; no unit of analysis issues were identified. </p> </section> <section id="CD013244-sec-0033"> <h4 class="title">Dealing with missing data</h4> <p>For all reporting, we used the information available in the full‐text publications.</p> <p>We had planned to use imputed data if the trial authors reported these data, and had derived the data using a robust method. We had not planned to directly impute data ourselves. However, no imputed data were described in the included studies. </p> </section> <section id="CD013244-sec-0034"> <h4 class="title">Assessment of heterogeneity</h4> <p>If meta‐analyses had been performed, we had planned to assess heterogeneity using the recommendations outlined in Chapter 9 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD013244-bbs2-0085" title="DeeksJJ , HigginsJPT , Altman DG (editors) on behalf of the Cochrane Statistical Methods Group. Chapter 9: Analysing data and undertaking meta-analyses.In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Cochrane, 2017. Available from www.training.cochrane.org/handbook.">Deeks 2017</a>). However, this step was not required because quantitative data syntheses were not feasible. </p> </section> <section id="CD013244-sec-0035"> <h4 class="title">Assessment of reporting biases</h4> <p>For each eligible study, we assessed selective outcome reporting as part of the risk of bias assessment. </p> <p>We had intended to assess for potential publication bias using a funnel plot, if there were 10 or more studies to include in a meta‐analysis, by interpreting any asymmetries in the funnel plot in association with the trial characteristics, and by considering factors such as sample size. However, as we were unable to perform any meta‐analyses due to lack of combinable data, we could not assess for potential publication bias. </p> </section> <section id="CD013244-sec-0036"> <h4 class="title">Data synthesis</h4> <p>We had intended to perform meta‐analyses for the primary and secondary outcomes, and to use a fixed‐effect model if there were fewer than three trials or a random‐effects model if there were three or more trials with relevant data. We had planned to assess for inconsistency in the trial findings (e.g. effects in different directions, or I<sup>2</sup> statistic &gt; 60%, or a Chi<sup>2</sup> test P value &lt; 0.10). If we did not consider the pooled result to provide an appropriate summary of the findings, we had planned to describe the pattern of individual trial results. Further, if statistical heterogeneity was noted but all the effect estimates were in a consistent direction such that a pooled estimate would seem to provide an appropriate summary of the individual RCT results, we had planned to pool these data in a meta‐analysis. </p> <p>However, we did not perform meta‐analyses in this review as the study populations, outcome measures, frequency and time of spectacle wear, and intervention follow‐up periods varied substantially across the included studies. It was our view that pooled estimates would not be meaningful. Hence, we have provided descriptive summaries of individual trial findings for each outcome measure. </p> </section> <section id="CD013244-sec-0037"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>In our protocol, we had specified that if sufficient quantitative data were available, we would perform subgroup analyses to consider the potential effects of participant age (less than 40 years versus 40 years or older), degree of blue‐light attenuation imparted by the blue‐light filtering lens product (‘high' block versus ‘low' block), and extent of digital device use (less than two hours per day versus two or more hours per day). However, as meta‐analyses were not performed, we also could not undertake any subgroup analyses. </p> </section> <section id="CD013244-sec-0038"> <h4 class="title">Sensitivity analysis</h4> <p>We had planned to perform a sensitivity analysis on the primary outcome measures, to assess for the effects of excluding trials that: (i) we judged to have a high risk of bias due in the domains of allocation concealment or lack of masking (participants and personnel, or outcome assessors), (ii) were unpublished, and (iii) were funded by industry. However, there was an insufficient number of studies to perform this analysis. </p> </section> <section id="CD013244-sec-0039"> <h4 class="title">Summary of findings and assessment of the certainty of the evidence</h4> <p>We created a summary of findings table summarising the results of the analyses, using the approach described in Chapter 11 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD013244-bbs2-0142" title="SchünemannHJ , OxmanAD , HigginsJPT , VistGE , GlasziouP , AklE , Guyatt GH on behalf of the Cochrane GRADEing Methods Group and the Cochrane Statistical Methods Group. Chapter 11: In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.2.0 (updated June 2017), Cochrane, 2017. Available from training.cochrane.org/handbook.">Schünemann 2017</a>). </p> <p>We adopted the GRADE Working Group approach to grade the certainty of evidence (<a href="./references#CD013244-bbs2-0098" title="GRADEpro GDT. Version accessed 30 January 2022. Hamilton (ON): McMaster University (developed by Evidence Prime). Available at gradepro.org.">GRADEpro GDT</a>). </p> <p>Outcomes, measured between the intervention and control groups, included:</p> <p> <ul id="CD013244-list-0005"> <li> <p>change in subjective visual fatigue or discomfort;</p> </li> <li> <p>change in CFF;</p> </li> <li> <p>change in BCVA, with or without (disability) glare;</p> </li> <li> <p>proportion of eyes, or individuals, with a finding of pathological structural change at the macula; </p> </li> <li> <p>change in colour discrimination;</p> </li> <li> <p>sleep quality;</p> </li> <li> <p>proportion of participants with adverse events with a probable causal link with the study intervention. </p> </li> </ul> </p> <p>For continuous outcomes, we extracted information on the change from baseline to one month of follow‐up (with an acceptable range of two weeks to three months). For dichotomous outcomes, we extracted the proportion of participants in the intervention and comparator groups who experienced the outcome of interest at the follow‐up period(s) reported by the trial authors. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD013244-sec-0040" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD013244-sec-0040"></div> <section id="CD013244-sec-0041"> <h3 class="title">Description of studies</h3> <section id="CD013244-sec-0042"> <h4 class="title">Results of the search</h4> <p>The electronic database searches performed on 22 March 2022 identified a total of 259 records (<a href="#CD013244-fig-0001">Figure 1</a>). The Cochrane Information Specialist removed 74 duplicate records, and two review authors independently screened titles/abstracts of a total of 185 records. Of these, 60 records were judged to be relevant, or potentially relevant, and proceeded to the full‐text review stage. </p> <div class="figure" id="CD013244-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram" data-id="CD013244-fig-0001" src="/cdsr/doi/10.1002/14651858.CD013244.pub2/media/CDSR/CD013244/image_n/nCD013244-FIG-01.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram</p> </div> </div> </div> <p>Two review authors independently screened the full‐text articles. We included 20 reports of 17 studies and excluded 32 studies (see <a href="./references#CD013244-sec-0105" title="">Characteristics of excluded studies</a>). Three trials were published as conference abstracts, and we could not identify full‐text publications. Hence, these three conference abstracts are awaiting classification (<a href="./references#CD013244-bbs2-0050" title="SmoldersKC , De KortYA . Turn down the light at night? investigating the effect of blocking blue light exposure in the evening on sleepiness and sleep. Neuropsychobiology2016;74(4):250-1. ">Smolders 2016</a>; <a href="./references#CD013244-bbs2-0051" title="WolffsohnJS , GibsonGA , DaviesLN . Violet- vs blue-blocking intraocular lenses: a tint matched spectacle lens-based study. Investigative Ophthalmology and Visual Science2007;48(13):ARVO E‐Abstract 3117. ">Wolffsohn 2007</a>; <a href="./references#CD013244-bbs2-0052" title="Youngstrom, E. Preliminary test of amber glasses as a way of resetting circadian melatonin release: Randomized trial during travel from Asia. Neuropsychopharmacology2014;39:S562. ">Youngstrom 2014</a>) (see <a href="./references#CD013244-sec-0106" title="">Characteristics of studies awaiting classification</a>). We classified five listings in clinical trial registries as 'potentially relevant' ongoing studies (see <a href="./references#CD013244-sec-0107" title="">Characteristics of ongoing studies</a>); two of these trials were marked as not yet recruiting (<a href="./references#CD013244-bbs2-0056" title="NCT04904328. A proof of concept alleviating the symptoms of photosensitive migraine [A proof of concept clinical investigation designed to evaluate the performance of Lumishade® lens with frame in alleviating the symptoms of photosensitive migraine]. clinicaltrials.gov/ct2/show/NCT04904328 (first received 27 May 2021). ">NCT04904328</a>; <a href="./references#CD013244-bbs2-0057" title="NCT05206747. Ottawa sunglasses at night for mania study (OSAN) [A randomized control trial of the effectiveness of blue-blocking glasses for mania in inpatients with bipolar disorder]. clinicaltrials.gov/show/NCT05206747 (first received 25 January 2022). ">NCT05206747</a>), one study was marked as active but not recruiting (<a href="./references#CD013244-bbs2-0054" title="NCT03114072. Blocking blue light in pregnancy, effects on melatonin profile and sleep [Nightly light exposure in pregnancy: blue-blocking glasses as an intervention to ease sleep disturbances and to improve mood]. clinicaltrials.gov/ct2/show/NCT03114072 (first received14 April 2017). ">NCT03114072</a>), one trial was marked as recruiting (<a href="./references#CD013244-bbs2-0055" title="NCT04578249. Effects of blocking blue light at night on patient outcomes after elective CABG surgery [Effects of blocking blue light at night on patient outcomes after elective CABG, AVR, MVR, CABG AVR, or CABG MVR surgery]. clinicaltrials.gov/show/NCT04578249 (first received 8 October 2020). ">NCT04578249</a>), and one study was marked as having completed study participant recruitment but had not published their study results (<a href="./references#CD013244-bbs2-0053" title="ChiCTR1800020191. Evaluation of effect of blue-light filtering spectacles on objective detection and visual quality [Evaluation of effect of blue-light filtering spectacles on visual quality in adults ]. chictr.org.cn/showprojen.aspx?proj=34119 (first received 19 December 2018). ">ChiCTR1800020191</a>). </p> </section> <section id="CD013244-sec-0043"> <h4 class="title">Included studies</h4> <p>We included 17 unique trials that had published full texts. <a href="#CD013244-tbl-0002">Table 1</a> presents the key characteristics of these studies, including their designs, participant population(s), comparator(s), recruited sample size, and intervention duration. Further study‐specific details are provided in the <a href="./references#CD013244-sec-0104" title="">Characteristics of included studies</a> table. </p> <div class="table" id="CD013244-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Summary of study design, participants, interventions, and follow‐up periods for the included studies</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study design</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Recruited sample size</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Participant population</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Blue‐light filtering lens name(s) (manufacturer)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Non‐blue‐light filtering lens name(s) (manufacturer)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Intervention follow‐up duration</b> </p> </th> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013244-bbs2-0002" title="AlzahranHS , RoyM , HonsonV , KhuuSK . Effect of blue-blocking lenses on colour contrast sensitivity. Clinical and Experimental Optometry2021;104(2):207-14. ">Alzahrani 2021</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Randomised,</p> <p>cross‐over, controlled</p> <p>trial</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Healthy volunteers</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Crizal Prevencia (Essilor), Blue Guardian (Opticare), and Blu‐OLP (GenOp) lenses.</p> <p>Spectral transmittance data presented in figure 1 of the publication.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> <p>Spectral transmittance data presented in figure 1 of the publication.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013244-bbs2-0001" title="AlzahraniHS , KhuuSK , AliA , RoyM . The effect of blue-blocking lenses on photostress recovery times. Optometry and Vision Science2020;97(11):995-1004. ">Alzahrani 2020</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Randomised,</p> <p>cross‐over, controlled</p> <p>trial</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Individuals with no history of ocular disease or abnormal vision</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>UV++Blue Control (JuzVision, Bulli, NSW, Australia), Crizal Prevencia (Essilor, Silverwater, NSW, Australia), BlueGuardian (Opticare, Sydney, NSW, Australia), and Blu‐OLP (GenOp, Rosebery, NSW, Australia) lenses </p> <p>Spectral transmittance data presented in figure 1 of the publication.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> <p>Spectral transmittance data presented in figure 1 of the publication.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013244-bbs2-0003" title="BigalkeJA , GreenlundIM , NicevskiJR , CarterJR . Effect of evening blue light blocking glasses on subjective and objective sleep in healthy adults: a randomized control trial. Sleep Health2021;7(4):485–90. ">Bigalke 2021</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Randomised,</p> <p>cross‐over, controlled</p> <p>trial</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Healthy volunteers</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported (LowBlueLights. com, University Heights, OH, USA)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported (Ultra‐Spec 2001 OTG, Uvex, Honeywell Safety, USA)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 week</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013244-bbs2-0004" title="BurkhartK , PhelpsJR . Amber lenses to block blue light and improve sleep: a randomized trial. Chronobiology International2009;26(8):1602‐12. ">Burkhart 2009</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Randomised,</p> <p>parallel‐group,</p> <p>controlled trial</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sleep difficulty</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported (NoIR Polycarbonate Eyewear)</p> <p>“blocked wavelengths &lt; 550nm (blue‐green or longer wavelengths being transmitted)”</p> <p>Spectral transmittance data presented in figure 1 of the publication.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported (NoIR Polycarbonate Eyewear)</p> <p>Spectral transmittance data presented in figure 1 of the publication.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 weeks</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013244-bbs2-0005" title="DabrowieckiA , VillalobosA , KrupinskiEA . Impact of blue light filtering glasses on computer vision syndrome in radiology residents: a pilot study. Journal of Medical Imaging2020;7(2):022402. ">Dabrowiecki 2020</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Randomised,</p> <p>cross‐over, controlled</p> <p>trial</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Radiology residents</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported (Felix Gray, Inc., NewYork, New York)</p> <p>“The BLFL filter 50% of 380‐ to 500‐nm blue light, nearly 90% of 400‐ to 440‐nm blue light, and reduced glare by 99%” </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported (Felix Gray, Inc., NewYork, New York)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 days</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013244-bbs2-0006" title="DanilenkoK , LebedinskaiaMY , GadetskaiaEV , MarkovAA , IvanovaYA , AftanasLI . Six day combined partial wake and light therapy for unipolar depression. European Neuropsychopharmacology2019;29:S410‐11. DanilenkoKV , LebedinskaiaMY , GadetskaiaEV , MarkovAA , IvanovaYA , AftanasLI . A 6-day combined wake and light therapy trial for unipolar depression. Journal of Affective Disorders2019;259:355-61. ">Danilenko 2019</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Randomised,</p> <p>parallel‐group,</p> <p>controlled trial</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>35</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Major depressive disorder or persistent depressive disorder (dysthymia)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported (Chron‐optic, Québec, Canada)</p> <p>"Orange glasses completely cut the wavelengths below 540 nm (Sasseville et al., 2015; Fig. 1S) and diminished the light intensity by ∼70%” </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported (Chron‐optic, Québec, Canada)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 days</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013244-bbs2-0008" title="EsakiY , TakeuchiI , TsuboiS , FujitaK , IwataN , KitajimaT . A double-blind, randomized, placebo-controlled trial of adjunctive blue-blocking glasses for the treatment of sleep and circadian rhythm in patients with bipolar disorder. Bipolar Disorders2020;22(7):739-48. ">Esaki 2020</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Randomised,</p> <p>parallel‐group,</p> <p>controlled trial</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>43</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bipolar disorder</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported (Yamamoto Kogaku, No. 360S UV Orange, Osaka, Japan)</p> <p>Spectral transmittance data presented in supplementary figure 1 of the publication.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported (Yamamoto Kogaku, No. 331, Osaka, Japan)</p> <p>Spectral transmittance data presented in supplementary figure 1 of the publication.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 weeks</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013244-bbs2-0007" title="EsakiY , KitajimaT , TakeuchiI , TsuboiS , FurukawaO , MoriwakiM , et al. Effect of blue-blocking glasses in major depressive disorder with sleep onset insomnia: a randomized, double-blind, placebo-controlled study. Chronobiology international2017;34(6):753‐61. ">Esaki 2017</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Randomised,</p> <p>parallel‐group,</p> <p>controlled trial</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Major depressive disorder with sleep onset insomnia</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported (Yamamoto Kogaku, No. 360S UV Orange, Osaka, Japan)</p> <p>Spectral transmittance data presented in figure 1 of the publication.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported (Yamamoto Kogaku, No. 331, Osaka, Japan)</p> <p>Spectral transmittance data presented in figure 1 of the publication.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 weeks</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013244-bbs2-0009" title="Hammond, BR. Attenuating photostress and glare disability in pseudophakic patients through the addition of a short-wave absorbing filter. Journal of Ophthalmology2015;2015:Article ID 607635. [DOI: 10.1155/2015/607635]NCT01938989. Effect of blue light filtration on visual performance. clinicaltrials.gov/ct2/show/NCT01938989 (first received 11 September 2013). ">Hammond 2015</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Randomised,</p> <p>cross‐over, controlled</p> <p>trial</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>156</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bilateral pseudophakia</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013244-bbs2-0011" title="HenriksenTEG , GrønliJ , AssmusJ , FasmerOB , SchoeyenH , LeskauskaiteI , et al. Blue-blocking glasses as additive treatment for mania: Effects on actigraphy-derived sleep parameters. Journal of Sleep Research2020;29(5):e12984. [DOI: 10.1111/jsr.12984]">Henriksen 2020</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Randomised,</p> <p>parallel‐group,</p> <p>controlled trial</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bipolar disorder</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported (LowBlueLights.com, University Heights, OH, USA)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported (Uvex, Furth, Germany, and 3M, Austin, TX, USA)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7 days</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013244-bbs2-0010" title="HenriksenTE , SkredeS , FasmerOB , SchoeyenH , LeskauskaiteI , Bjørke-BertheussenJ , et al. Blue-blocking glasses as additive treatment for mania: a randomized placebo-controlled trial. Bipolar Disorders2016;18(3):221‐32. ">Henriksen 2016</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Randomised,</p> <p>parallel‐group,</p> <p>controlled trial</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bipolar disorder</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported (LowBlueLights.com, University Heights, OH,USA)</p> <p>Spectral transmittance data presented in supplementary figure 1 of the publication.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported (Uvex, Furth, Germany and 3M, Austin,TX, USA)</p> <p>Spectral transmittance data presented in supplementary figure 1 of the publication.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7 days</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013244-bbs2-0012" title="JankuK , SmotekM , FarkovaE , KoprivovaJ . Block the light and sleep well: Evening blue light filtration as a part of cognitive behavioral therapy for insomnia. Chronobiology International2020;37(2):248-59. JankuK , SmotekM , FarkovaE , MiletínováE , KoprivovaJ . Blue light blocking glasses and CBT-I: effect on subjective and objective sleep quality. Sleep Medicine2019;64(Suppl 1):S174. ">Janku 2020</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Randomised,</p> <p>parallel‐group,</p> <p>controlled trial</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>35</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Insomnia</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>UVEX S1933X (not reported)</p> <p>“Based on the used spectrum control technology they were supposed to reduce up to 98% of the lights of blue wavelength.” </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>UVEX S1900 (not reported)</p> <p>“clear glasses with no ability to filtrate blue light were used.”</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 weeks</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013244-bbs2-0013" title="KnufinkeM , Fittkau-KochL , MøstEI , KompierMA , NieuwenhuysA . Restricting short-wavelength light in the evening to improve sleep in recreational athletes - A pilot study. European Journal of Sport Science2019;19(6):728‐35. ">Knufinke 2019</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Randomised,</p> <p>cross‐over, controlled</p> <p>trial</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Recreational athletes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported (Eye shield soft red Safety Glasses, Königswinter, Germany)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported (Oramics)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9 nights</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013244-bbs2-0014" title="LinJB , GerrattBW , BassiCJ , ApteRS . Short-wavelength light-blocking eyeglasses attenuate symptoms of eye fatigue. Investigative Ophthalmology and Visual Science2017;58(1):442‐7. ">Lin 2017</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Randomised,</p> <p>parallel‐group,</p> <p>controlled trial</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>36</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Healthy volunteers</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD013244-list-0006"> <li> <p>High blue light blocking lenses (JINS CO., LTD)</p> </li> <li> <p>Low blue light blocking lenses (JINS CO., LTD)</p> </li> </ul> </p> <p>Spectral transmittance data presented in figure 1 of the publication.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported (JINS CO., LTD)</p> <p>Spectral transmittance data presented in figure 1 of the publication.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 hours</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013244-bbs2-0015" title="Perez AlgortaG , Van MeterA , DubickaB , JonesS , YoungstromE , LobbanF . Blue blocking glasses worn at night in first year higher education students with sleep complaints: a feasibility study. Pilot and Feasibility Studies2018;4:166. ">Perez Algorta 2018</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Randomised,</p> <p>cross‐over, controlled</p> <p>trial</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sleep complaints/disorders</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Uvex S1933X (not reported)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Uvex S1932X (not reported)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 days</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013244-bbs2-0016" title="ShechterA , KimEW , St-OngeMP , WestwoodAJ . Blocking nocturnal blue light for insomnia: a randomized controlled trial. Journal of Psychiatric Research2018;96:196‐202. ">Shechter 2018</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Randomised,</p> <p>cross‐over, controlled</p> <p>trial</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Chronic insomnia</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported (Bandit style frames, Uvex, Honeywell Safety, Smithfield, USA)</p> <p>“The amber lenses filter out blue‐wavelength light, while allowing the other visible spectrum light to pass, resulting in a blue‐light absorption (BLA) of 65% and a visible light transmission (VLT) of 90%” </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> <p>“The clear lenses have a VLT of 92%, while allowing for the almost complete transmission of blue‐wavelength light (∼90%) based on manufacturer specifications” </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 week</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013244-bbs2-0017" title="SinghS , DownieLE , AndersonAJ . Do blue-blocking lenses reduce eye strain from extended screen time? A double-masked, randomized controlled trial. American Journal of Ophthalmology2021;226:243–51. [DOI: 10.1016/j.ajo.2021.02.010]">Singh 2021</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Randomised,</p> <p>parallel‐group,</p> <p>controlled trial</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>120</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Symptomatic computer users</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prevencia (Essilor, Dallas, Texas, USA)</p> <p>"The “active” intervention group received blue‐blocking lenses (Prevencia; Essilor, Dallas, Texas, USA) that filtered blue light by front surface coating between 10% and 30% in the range of 400‐500 nm. These lenses almost completely blocked transmission below 400 nm and had approximately 95% transmission between 500 and 700 nm.” </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Crizal UV coated lenses (Essilor)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 hours</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>Abbreviations: BLFL, blue light filtering lens; nm, nanometres</p> </div> </div> <section id="CD013244-sec-0044"> <h5 class="title">Types of studies</h5> <p>The 17 trials were published between 2009 and 2021. Of these, nine had a parallel‐arm trial design (<a href="./references#CD013244-bbs2-0004" title="BurkhartK , PhelpsJR . Amber lenses to block blue light and improve sleep: a randomized trial. Chronobiology International2009;26(8):1602‐12. ">Burkhart 2009</a>; <a href="./references#CD013244-bbs2-0006" title="DanilenkoK , LebedinskaiaMY , GadetskaiaEV , MarkovAA , IvanovaYA , AftanasLI . Six day combined partial wake and light therapy for unipolar depression. European Neuropsychopharmacology2019;29:S410‐11. DanilenkoKV , LebedinskaiaMY , GadetskaiaEV , MarkovAA , IvanovaYA , AftanasLI . A 6-day combined wake and light therapy trial for unipolar depression. Journal of Affective Disorders2019;259:355-61. ">Danilenko 2019</a>; <a href="./references#CD013244-bbs2-0007" title="EsakiY , KitajimaT , TakeuchiI , TsuboiS , FurukawaO , MoriwakiM , et al. Effect of blue-blocking glasses in major depressive disorder with sleep onset insomnia: a randomized, double-blind, placebo-controlled study. Chronobiology international2017;34(6):753‐61. ">Esaki 2017</a>; <a href="./references#CD013244-bbs2-0008" title="EsakiY , TakeuchiI , TsuboiS , FujitaK , IwataN , KitajimaT . A double-blind, randomized, placebo-controlled trial of adjunctive blue-blocking glasses for the treatment of sleep and circadian rhythm in patients with bipolar disorder. Bipolar Disorders2020;22(7):739-48. ">Esaki 2020</a>; <a href="./references#CD013244-bbs2-0010" title="HenriksenTE , SkredeS , FasmerOB , SchoeyenH , LeskauskaiteI , Bjørke-BertheussenJ , et al. Blue-blocking glasses as additive treatment for mania: a randomized placebo-controlled trial. Bipolar Disorders2016;18(3):221‐32. ">Henriksen 2016</a>; <a href="./references#CD013244-bbs2-0011" title="HenriksenTEG , GrønliJ , AssmusJ , FasmerOB , SchoeyenH , LeskauskaiteI , et al. Blue-blocking glasses as additive treatment for mania: Effects on actigraphy-derived sleep parameters. Journal of Sleep Research2020;29(5):e12984. [DOI: 10.1111/jsr.12984]">Henriksen 2020</a>; <a href="./references#CD013244-bbs2-0109" title="JankuK , SmotekM , FarkovaE , KoprivovaJ . Block the light and sleep well: Evening blue light filtration as a part of cognitive behavioral therapy for insomnia. Chronobiology International2020;37(2):248-59.">Janku 2020</a>; <a href="./references#CD013244-bbs2-0014" title="LinJB , GerrattBW , BassiCJ , ApteRS . Short-wavelength light-blocking eyeglasses attenuate symptoms of eye fatigue. Investigative Ophthalmology and Visual Science2017;58(1):442‐7. ">Lin 2017</a>; <a href="./references#CD013244-bbs2-0017" title="SinghS , DownieLE , AndersonAJ . Do blue-blocking lenses reduce eye strain from extended screen time? A double-masked, randomized controlled trial. American Journal of Ophthalmology2021;226:243–51. [DOI: 10.1016/j.ajo.2021.02.010]">Singh 2021</a>), and the remaining eight trials were cross‐over studies. </p> <p>The unit of randomisation was the participant in all studies, and the unit of analysis was also the participant in most studies (<a href="./references#CD013244-bbs2-0002" title="AlzahranHS , RoyM , HonsonV , KhuuSK . Effect of blue-blocking lenses on colour contrast sensitivity. Clinical and Experimental Optometry2021;104(2):207-14. ">Alzahrani 2021</a>; <a href="./references#CD013244-bbs2-0001" title="AlzahraniHS , KhuuSK , AliA , RoyM . The effect of blue-blocking lenses on photostress recovery times. Optometry and Vision Science2020;97(11):995-1004. ">Alzahrani 2020</a>; <a href="./references#CD013244-bbs2-0003" title="BigalkeJA , GreenlundIM , NicevskiJR , CarterJR . Effect of evening blue light blocking glasses on subjective and objective sleep in healthy adults: a randomized control trial. Sleep Health2021;7(4):485–90. ">Bigalke 2021</a>; <a href="./references#CD013244-bbs2-0004" title="BurkhartK , PhelpsJR . Amber lenses to block blue light and improve sleep: a randomized trial. Chronobiology International2009;26(8):1602‐12. ">Burkhart 2009</a>; <a href="./references#CD013244-bbs2-0005" title="DabrowieckiA , VillalobosA , KrupinskiEA . Impact of blue light filtering glasses on computer vision syndrome in radiology residents: a pilot study. Journal of Medical Imaging2020;7(2):022402. ">Dabrowiecki 2020</a>; <a href="./references#CD013244-bbs2-0006" title="DanilenkoK , LebedinskaiaMY , GadetskaiaEV , MarkovAA , IvanovaYA , AftanasLI . Six day combined partial wake and light therapy for unipolar depression. European Neuropsychopharmacology2019;29:S410‐11. DanilenkoKV , LebedinskaiaMY , GadetskaiaEV , MarkovAA , IvanovaYA , AftanasLI . A 6-day combined wake and light therapy trial for unipolar depression. Journal of Affective Disorders2019;259:355-61. ">Danilenko 2019</a>; <a href="./references#CD013244-bbs2-0007" title="EsakiY , KitajimaT , TakeuchiI , TsuboiS , FurukawaO , MoriwakiM , et al. Effect of blue-blocking glasses in major depressive disorder with sleep onset insomnia: a randomized, double-blind, placebo-controlled study. Chronobiology international2017;34(6):753‐61. ">Esaki 2017</a>; <a href="./references#CD013244-bbs2-0008" title="EsakiY , TakeuchiI , TsuboiS , FujitaK , IwataN , KitajimaT . A double-blind, randomized, placebo-controlled trial of adjunctive blue-blocking glasses for the treatment of sleep and circadian rhythm in patients with bipolar disorder. Bipolar Disorders2020;22(7):739-48. ">Esaki 2020</a>; <a href="./references#CD013244-bbs2-0010" title="HenriksenTE , SkredeS , FasmerOB , SchoeyenH , LeskauskaiteI , Bjørke-BertheussenJ , et al. Blue-blocking glasses as additive treatment for mania: a randomized placebo-controlled trial. Bipolar Disorders2016;18(3):221‐32. ">Henriksen 2016</a>; <a href="./references#CD013244-bbs2-0011" title="HenriksenTEG , GrønliJ , AssmusJ , FasmerOB , SchoeyenH , LeskauskaiteI , et al. Blue-blocking glasses as additive treatment for mania: Effects on actigraphy-derived sleep parameters. Journal of Sleep Research2020;29(5):e12984. [DOI: 10.1111/jsr.12984]">Henriksen 2020</a>; <a href="./references#CD013244-bbs2-0109" title="JankuK , SmotekM , FarkovaE , KoprivovaJ . Block the light and sleep well: Evening blue light filtration as a part of cognitive behavioral therapy for insomnia. Chronobiology International2020;37(2):248-59.">Janku 2020</a>; <a href="./references#CD013244-bbs2-0013" title="KnufinkeM , Fittkau-KochL , MøstEI , KompierMA , NieuwenhuysA . Restricting short-wavelength light in the evening to improve sleep in recreational athletes - A pilot study. European Journal of Sport Science2019;19(6):728‐35. ">Knufinke 2019</a>; <a href="./references#CD013244-bbs2-0014" title="LinJB , GerrattBW , BassiCJ , ApteRS . Short-wavelength light-blocking eyeglasses attenuate symptoms of eye fatigue. Investigative Ophthalmology and Visual Science2017;58(1):442‐7. ">Lin 2017</a>; <a href="./references#CD013244-bbs2-0015" title="Perez AlgortaG , Van MeterA , DubickaB , JonesS , YoungstromE , LobbanF . Blue blocking glasses worn at night in first year higher education students with sleep complaints: a feasibility study. Pilot and Feasibility Studies2018;4:166. ">Perez Algorta 2018</a>; <a href="./references#CD013244-bbs2-0016" title="ShechterA , KimEW , St-OngeMP , WestwoodAJ . Blocking nocturnal blue light for insomnia: a randomized controlled trial. Journal of Psychiatric Research2018;96:196‐202. ">Shechter 2018</a>; <a href="./references#CD013244-bbs2-0017" title="SinghS , DownieLE , AndersonAJ . Do blue-blocking lenses reduce eye strain from extended screen time? A double-masked, randomized controlled trial. American Journal of Ophthalmology2021;226:243–51. [DOI: 10.1016/j.ajo.2021.02.010]">Singh 2021</a>). In one study, the unit of analysis was a randomly selected eye (<a href="./references#CD013244-bbs2-0009" title="Hammond, BR. Attenuating photostress and glare disability in pseudophakic patients through the addition of a short-wave absorbing filter. Journal of Ophthalmology2015;2015:Article ID 607635. [DOI: 10.1155/2015/607635]NCT01938989. Effect of blue light filtration on visual performance. clinicaltrials.gov/ct2/show/NCT01938989 (first received 11 September 2013). ">Hammond 2015</a>). </p> </section> <section id="CD013244-sec-0045"> <h5 class="title">Types of participants</h5> <p>In total the 17 included studies recruited 619 participants, with individual sample sizes ranging from five to 156 participants. The intervention duration ranged from less than one day to five weeks, but was not reported in three studies (<a href="./references#CD013244-bbs2-0002" title="AlzahranHS , RoyM , HonsonV , KhuuSK . Effect of blue-blocking lenses on colour contrast sensitivity. Clinical and Experimental Optometry2021;104(2):207-14. ">Alzahrani 2021</a>; <a href="./references#CD013244-bbs2-0001" title="AlzahraniHS , KhuuSK , AliA , RoyM . The effect of blue-blocking lenses on photostress recovery times. Optometry and Vision Science2020;97(11):995-1004. ">Alzahrani 2020</a>; <a href="./references#CD013244-bbs2-0009" title="Hammond, BR. Attenuating photostress and glare disability in pseudophakic patients through the addition of a short-wave absorbing filter. Journal of Ophthalmology2015;2015:Article ID 607635. [DOI: 10.1155/2015/607635]NCT01938989. Effect of blue light filtration on visual performance. clinicaltrials.gov/ct2/show/NCT01938989 (first received 11 September 2013). ">Hammond 2015</a>). </p> <p>The studies were conducted across six countries: five in the USA (<a href="./references#CD013244-bbs2-0003" title="BigalkeJA , GreenlundIM , NicevskiJR , CarterJR . Effect of evening blue light blocking glasses on subjective and objective sleep in healthy adults: a randomized control trial. Sleep Health2021;7(4):485–90. ">Bigalke 2021</a>; <a href="./references#CD013244-bbs2-0004" title="BurkhartK , PhelpsJR . Amber lenses to block blue light and improve sleep: a randomized trial. Chronobiology International2009;26(8):1602‐12. ">Burkhart 2009</a>; <a href="./references#CD013244-bbs2-0009" title="Hammond, BR. Attenuating photostress and glare disability in pseudophakic patients through the addition of a short-wave absorbing filter. Journal of Ophthalmology2015;2015:Article ID 607635. [DOI: 10.1155/2015/607635]NCT01938989. Effect of blue light filtration on visual performance. clinicaltrials.gov/ct2/show/NCT01938989 (first received 11 September 2013). ">Hammond 2015</a>; <a href="./references#CD013244-bbs2-0014" title="LinJB , GerrattBW , BassiCJ , ApteRS . Short-wavelength light-blocking eyeglasses attenuate symptoms of eye fatigue. Investigative Ophthalmology and Visual Science2017;58(1):442‐7. ">Lin 2017</a>; <a href="./references#CD013244-bbs2-0016" title="ShechterA , KimEW , St-OngeMP , WestwoodAJ . Blocking nocturnal blue light for insomnia: a randomized controlled trial. Journal of Psychiatric Research2018;96:196‐202. ">Shechter 2018</a>), two in Norway (<a href="./references#CD013244-bbs2-0010" title="HenriksenTE , SkredeS , FasmerOB , SchoeyenH , LeskauskaiteI , Bjørke-BertheussenJ , et al. Blue-blocking glasses as additive treatment for mania: a randomized placebo-controlled trial. Bipolar Disorders2016;18(3):221‐32. ">Henriksen 2016</a>; <a href="./references#CD013244-bbs2-0011" title="HenriksenTEG , GrønliJ , AssmusJ , FasmerOB , SchoeyenH , LeskauskaiteI , et al. Blue-blocking glasses as additive treatment for mania: Effects on actigraphy-derived sleep parameters. Journal of Sleep Research2020;29(5):e12984. [DOI: 10.1111/jsr.12984]">Henriksen 2020</a>), two in Japan (<a href="./references#CD013244-bbs2-0007" title="EsakiY , KitajimaT , TakeuchiI , TsuboiS , FurukawaO , MoriwakiM , et al. Effect of blue-blocking glasses in major depressive disorder with sleep onset insomnia: a randomized, double-blind, placebo-controlled study. Chronobiology international2017;34(6):753‐61. ">Esaki 2017</a>; <a href="./references#CD013244-bbs2-0008" title="EsakiY , TakeuchiI , TsuboiS , FujitaK , IwataN , KitajimaT . A double-blind, randomized, placebo-controlled trial of adjunctive blue-blocking glasses for the treatment of sleep and circadian rhythm in patients with bipolar disorder. Bipolar Disorders2020;22(7):739-48. ">Esaki 2020</a>), one in the UK (<a href="./references#CD013244-bbs2-0015" title="Perez AlgortaG , Van MeterA , DubickaB , JonesS , YoungstromE , LobbanF . Blue blocking glasses worn at night in first year higher education students with sleep complaints: a feasibility study. Pilot and Feasibility Studies2018;4:166. ">Perez Algorta 2018</a>), one in Australia (<a href="./references#CD013244-bbs2-0017" title="SinghS , DownieLE , AndersonAJ . Do blue-blocking lenses reduce eye strain from extended screen time? A double-masked, randomized controlled trial. American Journal of Ophthalmology2021;226:243–51. [DOI: 10.1016/j.ajo.2021.02.010]">Singh 2021</a>), and one in the Czech Republic (<a href="./references#CD013244-bbs2-0109" title="JankuK , SmotekM , FarkovaE , KoprivovaJ . Block the light and sleep well: Evening blue light filtration as a part of cognitive behavioral therapy for insomnia. Chronobiology International2020;37(2):248-59.">Janku 2020</a>). Five studies did not report the country in which the trial was conducted (<a href="./references#CD013244-bbs2-0002" title="AlzahranHS , RoyM , HonsonV , KhuuSK . Effect of blue-blocking lenses on colour contrast sensitivity. Clinical and Experimental Optometry2021;104(2):207-14. ">Alzahrani 2021</a>; <a href="./references#CD013244-bbs2-0001" title="AlzahraniHS , KhuuSK , AliA , RoyM . The effect of blue-blocking lenses on photostress recovery times. Optometry and Vision Science2020;97(11):995-1004. ">Alzahrani 2020</a>; <a href="./references#CD013244-bbs2-0005" title="DabrowieckiA , VillalobosA , KrupinskiEA . Impact of blue light filtering glasses on computer vision syndrome in radiology residents: a pilot study. Journal of Medical Imaging2020;7(2):022402. ">Dabrowiecki 2020</a>; <a href="./references#CD013244-bbs2-0006" title="DanilenkoK , LebedinskaiaMY , GadetskaiaEV , MarkovAA , IvanovaYA , AftanasLI . Six day combined partial wake and light therapy for unipolar depression. European Neuropsychopharmacology2019;29:S410‐11. DanilenkoKV , LebedinskaiaMY , GadetskaiaEV , MarkovAA , IvanovaYA , AftanasLI . A 6-day combined wake and light therapy trial for unipolar depression. Journal of Affective Disorders2019;259:355-61. ">Danilenko 2019</a>; <a href="./references#CD013244-bbs2-0013" title="KnufinkeM , Fittkau-KochL , MøstEI , KompierMA , NieuwenhuysA . Restricting short-wavelength light in the evening to improve sleep in recreational athletes - A pilot study. European Journal of Sport Science2019;19(6):728‐35. ">Knufinke 2019</a>). </p> <p>The participant inclusion criteria varied across the included studies, as follows.</p> <p> <ul id="CD013244-list-0007"> <li> <p>Healthy volunteers with uncorrected vision or contact lens–corrected vision of 20/30 or better with both eyes (<a href="./references#CD013244-bbs2-0014" title="LinJB , GerrattBW , BassiCJ , ApteRS . Short-wavelength light-blocking eyeglasses attenuate symptoms of eye fatigue. Investigative Ophthalmology and Visual Science2017;58(1):442‐7. ">Lin 2017</a>) </p> </li> <li> <p>Symptomatic computer users (<a href="./references#CD013244-bbs2-0017" title="SinghS , DownieLE , AndersonAJ . Do blue-blocking lenses reduce eye strain from extended screen time? A double-masked, randomized controlled trial. American Journal of Ophthalmology2021;226:243–51. [DOI: 10.1016/j.ajo.2021.02.010]">Singh 2021</a>) </p> </li> <li> <p>Participants with no history of ocular disease or abnormal vision (<a href="./references#CD013244-bbs2-0001" title="AlzahraniHS , KhuuSK , AliA , RoyM . The effect of blue-blocking lenses on photostress recovery times. Optometry and Vision Science2020;97(11):995-1004. ">Alzahrani 2020</a>) </p> </li> <li> <p>Recreational athletes (<a href="./references#CD013244-bbs2-0013" title="KnufinkeM , Fittkau-KochL , MøstEI , KompierMA , NieuwenhuysA . Restricting short-wavelength light in the evening to improve sleep in recreational athletes - A pilot study. European Journal of Sport Science2019;19(6):728‐35. ">Knufinke 2019</a>) </p> </li> <li> <p>Radiology residents (<a href="./references#CD013244-bbs2-0005" title="DabrowieckiA , VillalobosA , KrupinskiEA . Impact of blue light filtering glasses on computer vision syndrome in radiology residents: a pilot study. Journal of Medical Imaging2020;7(2):022402. ">Dabrowiecki 2020</a>) </p> </li> <li> <p>Participants with bilateral pseudophakia and ≥3 months post‐implantation with clear IOLs (<a href="./references#CD013244-bbs2-0009" title="Hammond, BR. Attenuating photostress and glare disability in pseudophakic patients through the addition of a short-wave absorbing filter. Journal of Ophthalmology2015;2015:Article ID 607635. [DOI: 10.1155/2015/607635]NCT01938989. Effect of blue light filtration on visual performance. clinicaltrials.gov/ct2/show/NCT01938989 (first received 11 September 2013). ">Hammond 2015</a>) </p> </li> <li> <p>Undergraduate students with sleep complaints/disorders (<a href="./references#CD013244-bbs2-0015" title="Perez AlgortaG , Van MeterA , DubickaB , JonesS , YoungstromE , LobbanF . Blue blocking glasses worn at night in first year higher education students with sleep complaints: a feasibility study. Pilot and Feasibility Studies2018;4:166. ">Perez Algorta 2018</a>) </p> </li> <li> <p>Participants with chronic insomnia symptoms (<a href="./references#CD013244-bbs2-0016" title="ShechterA , KimEW , St-OngeMP , WestwoodAJ . Blocking nocturnal blue light for insomnia: a randomized controlled trial. Journal of Psychiatric Research2018;96:196‐202. ">Shechter 2018</a>) </p> </li> <li> <p>Participants with sleep difficulty (sleep onset insomnia, mid‐sleep insomnia, and terminal insomnia) (<a href="./references#CD013244-bbs2-0004" title="BurkhartK , PhelpsJR . Amber lenses to block blue light and improve sleep: a randomized trial. Chronobiology International2009;26(8):1602‐12. ">Burkhart 2009</a>) </p> </li> <li> <p>Participants with bipolar disorder diagnosis (<a href="./references#CD013244-bbs2-0008" title="EsakiY , TakeuchiI , TsuboiS , FujitaK , IwataN , KitajimaT . A double-blind, randomized, placebo-controlled trial of adjunctive blue-blocking glasses for the treatment of sleep and circadian rhythm in patients with bipolar disorder. Bipolar Disorders2020;22(7):739-48. ">Esaki 2020</a>; <a href="./references#CD013244-bbs2-0010" title="HenriksenTE , SkredeS , FasmerOB , SchoeyenH , LeskauskaiteI , Bjørke-BertheussenJ , et al. Blue-blocking glasses as additive treatment for mania: a randomized placebo-controlled trial. Bipolar Disorders2016;18(3):221‐32. ">Henriksen 2016</a>; <a href="./references#CD013244-bbs2-0011" title="HenriksenTEG , GrønliJ , AssmusJ , FasmerOB , SchoeyenH , LeskauskaiteI , et al. Blue-blocking glasses as additive treatment for mania: Effects on actigraphy-derived sleep parameters. Journal of Sleep Research2020;29(5):e12984. [DOI: 10.1111/jsr.12984]">Henriksen 2020</a>) </p> </li> <li> <p>Participants with an insomnia diagnosis (<a href="./references#CD013244-bbs2-0109" title="JankuK , SmotekM , FarkovaE , KoprivovaJ . Block the light and sleep well: Evening blue light filtration as a part of cognitive behavioral therapy for insomnia. Chronobiology International2020;37(2):248-59.">Janku 2020</a>) </p> </li> <li> <p>Participants with major depressive disorder with sleep onset insomnia (<a href="./references#CD013244-bbs2-0007" title="EsakiY , KitajimaT , TakeuchiI , TsuboiS , FurukawaO , MoriwakiM , et al. Effect of blue-blocking glasses in major depressive disorder with sleep onset insomnia: a randomized, double-blind, placebo-controlled study. Chronobiology international2017;34(6):753‐61. ">Esaki 2017</a>) </p> </li> <li> <p>Participants with major depressive disorder or persistent depressive disorder (dysthymia) (<a href="./references#CD013244-bbs2-0006" title="DanilenkoK , LebedinskaiaMY , GadetskaiaEV , MarkovAA , IvanovaYA , AftanasLI . Six day combined partial wake and light therapy for unipolar depression. European Neuropsychopharmacology2019;29:S410‐11. DanilenkoKV , LebedinskaiaMY , GadetskaiaEV , MarkovAA , IvanovaYA , AftanasLI . A 6-day combined wake and light therapy trial for unipolar depression. Journal of Affective Disorders2019;259:355-61. ">Danilenko 2019</a>) </p> </li> <li> <p>Healthy participants with no information relating to the inclusion criteria (<a href="./references#CD013244-bbs2-0002" title="AlzahranHS , RoyM , HonsonV , KhuuSK . Effect of blue-blocking lenses on colour contrast sensitivity. Clinical and Experimental Optometry2021;104(2):207-14. ">Alzahrani 2021</a>; <a href="./references#CD013244-bbs2-0003" title="BigalkeJA , GreenlundIM , NicevskiJR , CarterJR . Effect of evening blue light blocking glasses on subjective and objective sleep in healthy adults: a randomized control trial. Sleep Health2021;7(4):485–90. ">Bigalke 2021</a>) </p> </li> </ul> </p> </section> <section id="CD013244-sec-0046"> <h5 class="title">Types of interventions</h5> <p>All trials compared blue‐light filtering spectacle lenses with non‐blue‐light filtering spectacle lenses. </p> <p><a href="#CD013244-tbl-0002">Table 1</a> provides details of the type of blue‐light filtering spectacle lenses used in the included trials. Although most studies investigated and compared one type of blue‐light filtering spectacle lens with a non‐blue‐light filtering spectacle lens, two studies compared different brands of blue‐light filtering spectacle lenses with non‐blue‐light filtering lenses (<a href="./references#CD013244-bbs2-0002" title="AlzahranHS , RoyM , HonsonV , KhuuSK . Effect of blue-blocking lenses on colour contrast sensitivity. Clinical and Experimental Optometry2021;104(2):207-14. ">Alzahrani 2021</a>; <a href="./references#CD013244-bbs2-0001" title="AlzahraniHS , KhuuSK , AliA , RoyM . The effect of blue-blocking lenses on photostress recovery times. Optometry and Vision Science2020;97(11):995-1004. ">Alzahrani 2020</a>), and one study compared blue‐light filtering spectacle lenses that attenuated a relatively high or low percentage of blue light, with non‐blue‐light filtering spectacle lenses (<a href="./references#CD013244-bbs2-0014" title="LinJB , GerrattBW , BassiCJ , ApteRS . Short-wavelength light-blocking eyeglasses attenuate symptoms of eye fatigue. Investigative Ophthalmology and Visual Science2017;58(1):442‐7. ">Lin 2017</a>). </p> </section> <section id="CD013244-sec-0047"> <h5 class="title">Outcomes</h5> <p>Most of the studies included in this review reported the outcome(s) at a shorter follow‐up period of two weeks or less. The time point of interest defined in our protocol involved outcomes measured at one month of follow‐up, with an acceptable follow‐up range of between two weeks and three months (<a href="./references#CD013244-bbs2-0169" title="DownieLE , KellerPR , BusijaL , LawrensonJG , HullCC . Blue‐light filtering spectacle lenses for visual performance, sleep, and macular health in adults. Cochrane Database of Systematic Reviews2019, Issue 1. Art. No: CD013244. [DOI: 10.1002/14651858.CD013244]">Downie 2019b</a>). The exception to this was the measure of the proportion of eyes, or individuals, with a finding of a pathological structural change at the macula, measured at 12 months (with an acceptable follow‐up range of six to 24 months). </p> <p>To ensure maximum representation of the available evidence, we have descriptively reported the outcomes from studies with reported follow‐up times that are different to those defined a priori in our protocol. </p> <section id="CD013244-sec-0048"> <h6 class="title">Primary outcomes ‐ visual fatigue</h6> <p>Three trials reported change in subjective visual fatigue or discomfort scores (<a href="./references#CD013244-bbs2-0005" title="DabrowieckiA , VillalobosA , KrupinskiEA . Impact of blue light filtering glasses on computer vision syndrome in radiology residents: a pilot study. Journal of Medical Imaging2020;7(2):022402. ">Dabrowiecki 2020</a>; <a href="./references#CD013244-bbs2-0014" title="LinJB , GerrattBW , BassiCJ , ApteRS . Short-wavelength light-blocking eyeglasses attenuate symptoms of eye fatigue. Investigative Ophthalmology and Visual Science2017;58(1):442‐7. ">Lin 2017</a>; <a href="./references#CD013244-bbs2-0017" title="SinghS , DownieLE , AndersonAJ . Do blue-blocking lenses reduce eye strain from extended screen time? A double-masked, randomized controlled trial. American Journal of Ophthalmology2021;226:243–51. [DOI: 10.1016/j.ajo.2021.02.010]">Singh 2021</a>). One study measured this outcome using a visual analogue scale (<a href="./references#CD013244-bbs2-0017" title="SinghS , DownieLE , AndersonAJ . Do blue-blocking lenses reduce eye strain from extended screen time? A double-masked, randomized controlled trial. American Journal of Ophthalmology2021;226:243–51. [DOI: 10.1016/j.ajo.2021.02.010]">Singh 2021</a>), and the other two studies used Likert scales (<a href="./references#CD013244-bbs2-0005" title="DabrowieckiA , VillalobosA , KrupinskiEA . Impact of blue light filtering glasses on computer vision syndrome in radiology residents: a pilot study. Journal of Medical Imaging2020;7(2):022402. ">Dabrowiecki 2020</a>; <a href="./references#CD013244-bbs2-0014" title="LinJB , GerrattBW , BassiCJ , ApteRS . Short-wavelength light-blocking eyeglasses attenuate symptoms of eye fatigue. Investigative Ophthalmology and Visual Science2017;58(1):442‐7. ">Lin 2017</a>). One trial reported change from baseline data (<a href="./references#CD013244-bbs2-0017" title="SinghS , DownieLE , AndersonAJ . Do blue-blocking lenses reduce eye strain from extended screen time? A double-masked, randomized controlled trial. American Journal of Ophthalmology2021;226:243–51. [DOI: 10.1016/j.ajo.2021.02.010]">Singh 2021</a>), one trial presented change from baseline scores and reported data in the form of figures (<a href="./references#CD013244-bbs2-0014" title="LinJB , GerrattBW , BassiCJ , ApteRS . Short-wavelength light-blocking eyeglasses attenuate symptoms of eye fatigue. Investigative Ophthalmology and Visual Science2017;58(1):442‐7. ">Lin 2017</a>), and one study reported average daily change in visual fatigue scores over a five‐day period, compared to change from baseline or endpoint outcomes (<a href="./references#CD013244-bbs2-0005" title="DabrowieckiA , VillalobosA , KrupinskiEA . Impact of blue light filtering glasses on computer vision syndrome in radiology residents: a pilot study. Journal of Medical Imaging2020;7(2):022402. ">Dabrowiecki 2020</a>). </p> <p>Two studies reported CFF data (<a href="./references#CD013244-bbs2-0014" title="LinJB , GerrattBW , BassiCJ , ApteRS . Short-wavelength light-blocking eyeglasses attenuate symptoms of eye fatigue. Investigative Ophthalmology and Visual Science2017;58(1):442‐7. ">Lin 2017</a>; <a href="./references#CD013244-bbs2-0017" title="SinghS , DownieLE , AndersonAJ . Do blue-blocking lenses reduce eye strain from extended screen time? A double-masked, randomized controlled trial. American Journal of Ophthalmology2021;226:243–51. [DOI: 10.1016/j.ajo.2021.02.010]">Singh 2021</a>), with one study reporting change from baseline (<a href="./references#CD013244-bbs2-0017" title="SinghS , DownieLE , AndersonAJ . Do blue-blocking lenses reduce eye strain from extended screen time? A double-masked, randomized controlled trial. American Journal of Ophthalmology2021;226:243–51. [DOI: 10.1016/j.ajo.2021.02.010]">Singh 2021</a>), and the other study presenting data in the form of figures without reporting quantitative data (<a href="./references#CD013244-bbs2-0014" title="LinJB , GerrattBW , BassiCJ , ApteRS . Short-wavelength light-blocking eyeglasses attenuate symptoms of eye fatigue. Investigative Ophthalmology and Visual Science2017;58(1):442‐7. ">Lin 2017</a>). </p> </section> <section id="CD013244-sec-0049"> <h6 class="title">Secondary outcomes</h6> <section id="CD013244-sec-0050"> <p><b>Best‐corrected visual acuity</b></p> <p>One cross‐over trial measured logMAR visual acuity (<a href="./references#CD013244-bbs2-0009" title="Hammond, BR. Attenuating photostress and glare disability in pseudophakic patients through the addition of a short-wave absorbing filter. Journal of Ophthalmology2015;2015:Article ID 607635. [DOI: 10.1155/2015/607635]NCT01938989. Effect of blue light filtration on visual performance. clinicaltrials.gov/ct2/show/NCT01938989 (first received 11 September 2013). ">Hammond 2015</a>). The unit of analysis in this study was a randomly selected eye (right or left). BCVA was quantified by having participants wear each of the study lenses in a randomised order. </p> </section> <section id="CD013244-sec-0051"> <p><b>Daytime alertness</b></p> <p>Although none of the included studies explicitly reported the proportion of participants who had reduced daytime alertness, two trials quantified parameters relevant to this outcome (<a href="./references#CD013244-bbs2-0109" title="JankuK , SmotekM , FarkovaE , KoprivovaJ . Block the light and sleep well: Evening blue light filtration as a part of cognitive behavioral therapy for insomnia. Chronobiology International2020;37(2):248-59.">Janku 2020</a>; <a href="./references#CD013244-bbs2-0013" title="KnufinkeM , Fittkau-KochL , MøstEI , KompierMA , NieuwenhuysA . Restricting short-wavelength light in the evening to improve sleep in recreational athletes - A pilot study. European Journal of Sport Science2019;19(6):728‐35. ">Knufinke 2019</a>). One trial measured daytime alertness using the Hyperarousal Scale (HAS), with scores ranging from 0 to 73, and reported change from baseline (<a href="./references#CD013244-bbs2-0109" title="JankuK , SmotekM , FarkovaE , KoprivovaJ . Block the light and sleep well: Evening blue light filtration as a part of cognitive behavioral therapy for insomnia. Chronobiology International2020;37(2):248-59.">Janku 2020</a>). Another trial measured morning and evening alertness using the Karolinska Sleepiness Scale (KSS), with scores ranging from 0 to 9, and reported the daily average change in outcome, rather than change from baseline or endpoint data (<a href="./references#CD013244-bbs2-0013" title="KnufinkeM , Fittkau-KochL , MøstEI , KompierMA , NieuwenhuysA . Restricting short-wavelength light in the evening to improve sleep in recreational athletes - A pilot study. European Journal of Sport Science2019;19(6):728‐35. ">Knufinke 2019</a>). </p> </section> <section id="CD013244-sec-0052"> <p><b>Sleep quality</b></p> <p>Six trials assessed outcomes related to subjective sleep quality (<a href="./references#CD013244-bbs2-0004" title="BurkhartK , PhelpsJR . Amber lenses to block blue light and improve sleep: a randomized trial. Chronobiology International2009;26(8):1602‐12. ">Burkhart 2009</a>; <a href="./references#CD013244-bbs2-0007" title="EsakiY , KitajimaT , TakeuchiI , TsuboiS , FurukawaO , MoriwakiM , et al. Effect of blue-blocking glasses in major depressive disorder with sleep onset insomnia: a randomized, double-blind, placebo-controlled study. Chronobiology international2017;34(6):753‐61. ">Esaki 2017</a>; <a href="./references#CD013244-bbs2-0008" title="EsakiY , TakeuchiI , TsuboiS , FujitaK , IwataN , KitajimaT . A double-blind, randomized, placebo-controlled trial of adjunctive blue-blocking glasses for the treatment of sleep and circadian rhythm in patients with bipolar disorder. Bipolar Disorders2020;22(7):739-48. ">Esaki 2020</a>; <a href="./references#CD013244-bbs2-0109" title="JankuK , SmotekM , FarkovaE , KoprivovaJ . Block the light and sleep well: Evening blue light filtration as a part of cognitive behavioral therapy for insomnia. Chronobiology International2020;37(2):248-59.">Janku 2020</a>; <a href="./references#CD013244-bbs2-0013" title="KnufinkeM , Fittkau-KochL , MøstEI , KompierMA , NieuwenhuysA . Restricting short-wavelength light in the evening to improve sleep in recreational athletes - A pilot study. European Journal of Sport Science2019;19(6):728‐35. ">Knufinke 2019</a>; <a href="./references#CD013244-bbs2-0016" title="ShechterA , KimEW , St-OngeMP , WestwoodAJ . Blocking nocturnal blue light for insomnia: a randomized controlled trial. Journal of Psychiatric Research2018;96:196‐202. ">Shechter 2018</a>). Of these, four trials used Likert scales (<a href="./references#CD013244-bbs2-0004" title="BurkhartK , PhelpsJR . Amber lenses to block blue light and improve sleep: a randomized trial. Chronobiology International2009;26(8):1602‐12. ">Burkhart 2009</a>; <a href="./references#CD013244-bbs2-0012" title="JankuK , SmotekM , FarkovaE , KoprivovaJ . Block the light and sleep well: Evening blue light filtration as a part of cognitive behavioral therapy for insomnia. Chronobiology International2020;37(2):248-59. JankuK , SmotekM , FarkovaE , MiletínováE , KoprivovaJ . Blue light blocking glasses and CBT-I: effect on subjective and objective sleep quality. Sleep Medicine2019;64(Suppl 1):S174. ">Janku 2020</a>; <a href="./references#CD013244-bbs2-0013" title="KnufinkeM , Fittkau-KochL , MøstEI , KompierMA , NieuwenhuysA . Restricting short-wavelength light in the evening to improve sleep in recreational athletes - A pilot study. European Journal of Sport Science2019;19(6):728‐35. ">Knufinke 2019</a>; <a href="./references#CD013244-bbs2-0016" title="ShechterA , KimEW , St-OngeMP , WestwoodAJ . Blocking nocturnal blue light for insomnia: a randomized controlled trial. Journal of Psychiatric Research2018;96:196‐202. ">Shechter 2018</a>), and two trials used a visual analogue scale (<a href="./references#CD013244-bbs2-0007" title="EsakiY , KitajimaT , TakeuchiI , TsuboiS , FurukawaO , MoriwakiM , et al. Effect of blue-blocking glasses in major depressive disorder with sleep onset insomnia: a randomized, double-blind, placebo-controlled study. Chronobiology international2017;34(6):753‐61. ">Esaki 2017</a>; <a href="./references#CD013244-bbs2-0008" title="EsakiY , TakeuchiI , TsuboiS , FujitaK , IwataN , KitajimaT . A double-blind, randomized, placebo-controlled trial of adjunctive blue-blocking glasses for the treatment of sleep and circadian rhythm in patients with bipolar disorder. Bipolar Disorders2020;22(7):739-48. ">Esaki 2020</a>). One study did not provide quantitative data (<a href="./references#CD013244-bbs2-0004" title="BurkhartK , PhelpsJR . Amber lenses to block blue light and improve sleep: a randomized trial. Chronobiology International2009;26(8):1602‐12. ">Burkhart 2009</a>), three trials reported change from baseline data (<a href="./references#CD013244-bbs2-0007" title="EsakiY , KitajimaT , TakeuchiI , TsuboiS , FurukawaO , MoriwakiM , et al. Effect of blue-blocking glasses in major depressive disorder with sleep onset insomnia: a randomized, double-blind, placebo-controlled study. Chronobiology international2017;34(6):753‐61. ">Esaki 2017</a>; <a href="./references#CD013244-bbs2-0008" title="EsakiY , TakeuchiI , TsuboiS , FujitaK , IwataN , KitajimaT . A double-blind, randomized, placebo-controlled trial of adjunctive blue-blocking glasses for the treatment of sleep and circadian rhythm in patients with bipolar disorder. Bipolar Disorders2020;22(7):739-48. ">Esaki 2020</a>; <a href="./references#CD013244-bbs2-0012" title="JankuK , SmotekM , FarkovaE , KoprivovaJ . Block the light and sleep well: Evening blue light filtration as a part of cognitive behavioral therapy for insomnia. Chronobiology International2020;37(2):248-59. JankuK , SmotekM , FarkovaE , MiletínováE , KoprivovaJ . Blue light blocking glasses and CBT-I: effect on subjective and objective sleep quality. Sleep Medicine2019;64(Suppl 1):S174. ">Janku 2020</a>), and two studies reported the daily average change in the outcome rather than the change from baseline or endpoint data (<a href="./references#CD013244-bbs2-0013" title="KnufinkeM , Fittkau-KochL , MøstEI , KompierMA , NieuwenhuysA . Restricting short-wavelength light in the evening to improve sleep in recreational athletes - A pilot study. European Journal of Sport Science2019;19(6):728‐35. ">Knufinke 2019</a>; <a href="./references#CD013244-bbs2-0016" title="ShechterA , KimEW , St-OngeMP , WestwoodAJ . Blocking nocturnal blue light for insomnia: a randomized controlled trial. Journal of Psychiatric Research2018;96:196‐202. ">Shechter 2018</a>). </p> </section> <section id="CD013244-sec-0053"> <p><b>Other outcomes</b></p> <p>None of the included trials assessed the following outcomes:</p> <p> <ul id="CD013244-list-0008"> <li> <p>change in contrast sensitivity, measured in log contrast sensitivity, with and without (disability) glare; </p> </li> <li> <p>change in discomfort glare, measured using a questionnaire (e.g. de Boer scale) or objectively (e.g. electromyogram); </p> </li> <li> <p>proportion of eyes, or individuals (as determined by the unit of analysis), with a finding of a pathological structural change at the macula, detected by clinical observation, optical coherence tomography (OCT) or retinal fundus photography; </p> </li> <li> <p>change in colour discrimination, considered as the standard mean difference for panel tests (e.g. Farnsworth D15 and 100‐hue) or the number of errors on plate tests (e.g. Ishihara), measured under photopic, mesopic or scotopic conditions; </p> </li> <li> <p>change in serum melatonin levels, measured in pg/mL;</p> </li> <li> <p>overall patient satisfaction with their visual performance, measured using questionnaires or rating scales. </p> </li> </ul> </p> </section> <section id="CD013244-sec-0054"> <p><b>Adverse events</b></p> <p>Among the 17 included trials, nine assessed adverse events (<a href="./references#CD013244-bbs2-0006" title="DanilenkoK , LebedinskaiaMY , GadetskaiaEV , MarkovAA , IvanovaYA , AftanasLI . Six day combined partial wake and light therapy for unipolar depression. European Neuropsychopharmacology2019;29:S410‐11. DanilenkoKV , LebedinskaiaMY , GadetskaiaEV , MarkovAA , IvanovaYA , AftanasLI . A 6-day combined wake and light therapy trial for unipolar depression. Journal of Affective Disorders2019;259:355-61. ">Danilenko 2019</a>; <a href="./references#CD013244-bbs2-0004" title="BurkhartK , PhelpsJR . Amber lenses to block blue light and improve sleep: a randomized trial. Chronobiology International2009;26(8):1602‐12. ">Burkhart 2009</a>; <a href="./references#CD013244-bbs2-0007" title="EsakiY , KitajimaT , TakeuchiI , TsuboiS , FurukawaO , MoriwakiM , et al. Effect of blue-blocking glasses in major depressive disorder with sleep onset insomnia: a randomized, double-blind, placebo-controlled study. Chronobiology international2017;34(6):753‐61. ">Esaki 2017</a>; <a href="./references#CD013244-bbs2-0008" title="EsakiY , TakeuchiI , TsuboiS , FujitaK , IwataN , KitajimaT . A double-blind, randomized, placebo-controlled trial of adjunctive blue-blocking glasses for the treatment of sleep and circadian rhythm in patients with bipolar disorder. Bipolar Disorders2020;22(7):739-48. ">Esaki 2020</a>; <a href="./references#CD013244-bbs2-0010" title="HenriksenTE , SkredeS , FasmerOB , SchoeyenH , LeskauskaiteI , Bjørke-BertheussenJ , et al. Blue-blocking glasses as additive treatment for mania: a randomized placebo-controlled trial. Bipolar Disorders2016;18(3):221‐32. ">Henriksen 2016</a>; <a href="./references#CD013244-bbs2-0109" title="JankuK , SmotekM , FarkovaE , KoprivovaJ . Block the light and sleep well: Evening blue light filtration as a part of cognitive behavioral therapy for insomnia. Chronobiology International2020;37(2):248-59.">Janku 2020</a>; <a href="./references#CD013244-bbs2-0015" title="Perez AlgortaG , Van MeterA , DubickaB , JonesS , YoungstromE , LobbanF . Blue blocking glasses worn at night in first year higher education students with sleep complaints: a feasibility study. Pilot and Feasibility Studies2018;4:166. ">Perez Algorta 2018</a>; <a href="./references#CD013244-bbs2-0016" title="ShechterA , KimEW , St-OngeMP , WestwoodAJ . Blocking nocturnal blue light for insomnia: a randomized controlled trial. Journal of Psychiatric Research2018;96:196‐202. ">Shechter 2018</a>; <a href="./references#CD013244-bbs2-0017" title="SinghS , DownieLE , AndersonAJ . Do blue-blocking lenses reduce eye strain from extended screen time? A double-masked, randomized controlled trial. American Journal of Ophthalmology2021;226:243–51. [DOI: 10.1016/j.ajo.2021.02.010]">Singh 2021</a>). Together, these studies included 333 participants. Of these, four studies (n = 130) reported an adverse event (<a href="./references#CD013244-bbs2-0006" title="DanilenkoK , LebedinskaiaMY , GadetskaiaEV , MarkovAA , IvanovaYA , AftanasLI . Six day combined partial wake and light therapy for unipolar depression. European Neuropsychopharmacology2019;29:S410‐11. DanilenkoKV , LebedinskaiaMY , GadetskaiaEV , MarkovAA , IvanovaYA , AftanasLI . A 6-day combined wake and light therapy trial for unipolar depression. Journal of Affective Disorders2019;259:355-61. ">Danilenko 2019</a>; <a href="./references#CD013244-bbs2-0007" title="EsakiY , KitajimaT , TakeuchiI , TsuboiS , FurukawaO , MoriwakiM , et al. Effect of blue-blocking glasses in major depressive disorder with sleep onset insomnia: a randomized, double-blind, placebo-controlled study. Chronobiology international2017;34(6):753‐61. ">Esaki 2017</a>; <a href="./references#CD013244-bbs2-0008" title="EsakiY , TakeuchiI , TsuboiS , FujitaK , IwataN , KitajimaT . A double-blind, randomized, placebo-controlled trial of adjunctive blue-blocking glasses for the treatment of sleep and circadian rhythm in patients with bipolar disorder. Bipolar Disorders2020;22(7):739-48. ">Esaki 2020</a>; <a href="./references#CD013244-bbs2-0010" title="HenriksenTE , SkredeS , FasmerOB , SchoeyenH , LeskauskaiteI , Bjørke-BertheussenJ , et al. Blue-blocking glasses as additive treatment for mania: a randomized placebo-controlled trial. Bipolar Disorders2016;18(3):221‐32. ">Henriksen 2016</a>); details relating to these adverse events are summarised in <a href="#CD013244-tbl-0003">Table 2</a>. </p> <div class="table" id="CD013244-tbl-0003"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Table 2. Summary of adverse effects reported in included trials</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study ID</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Number of participants and study population</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Adverse event(s)</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013244-bbs2-0004" title="BurkhartK , PhelpsJR . Amber lenses to block blue light and improve sleep: a randomized trial. Chronobiology International2009;26(8):1602‐12. ">Burkhart 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20 participants with sleep difficulty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013244-bbs2-0006" title="DanilenkoK , LebedinskaiaMY , GadetskaiaEV , MarkovAA , IvanovaYA , AftanasLI . Six day combined partial wake and light therapy for unipolar depression. European Neuropsychopharmacology2019;29:S410‐11. DanilenkoKV , LebedinskaiaMY , GadetskaiaEV , MarkovAA , IvanovaYA , AftanasLI . A 6-day combined wake and light therapy trial for unipolar depression. Journal of Affective Disorders2019;259:355-61. ">Danilenko 2019</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>35 participants with major depressive disorder or persistent depressive disorder (dysthymia)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>“No eye‐related adverse events were reported. All patients successfully resisted sleep during daytime, verified by actimetric data. Two patients – both from the white light group – were occasionally hyperthymic following treatment (not reaching hypomania as documented by both patient‐reported questionnaire and psychiatrist).” </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013244-bbs2-0008" title="EsakiY , TakeuchiI , TsuboiS , FujitaK , IwataN , KitajimaT . A double-blind, randomized, placebo-controlled trial of adjunctive blue-blocking glasses for the treatment of sleep and circadian rhythm in patients with bipolar disorder. Bipolar Disorders2020;22(7):739-48. ">Esaki 2020</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>43 participants with bipolar disorder</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events in general involved discomfort from wearing the glasses (BB group, 2; placebo group, 3) and pain from the contacting part of the glasses (BB group, 1; placebo group, 4), as well as lowered mood (BB group, 1). All participants reported that the discomfort or pain improved after removing the glasses. One participant in the BB group reported lowered mood after intervention week 1.” </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013244-bbs2-0007" title="EsakiY , KitajimaT , TakeuchiI , TsuboiS , FurukawaO , MoriwakiM , et al. Effect of blue-blocking glasses in major depressive disorder with sleep onset insomnia: a randomized, double-blind, placebo-controlled study. Chronobiology international2017;34(6):753‐61. ">Esaki 2017</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20 participants with major depressive disorder with sleep onset insomnia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>“Adverse events involved discomfort from wearing the glasses (BB group n = 1) or pain from the contacting part of the glasses (BB group n = 3, placebo group n = 4).” </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013244-bbs2-0010" title="HenriksenTE , SkredeS , FasmerOB , SchoeyenH , LeskauskaiteI , Bjørke-BertheussenJ , et al. Blue-blocking glasses as additive treatment for mania: a randomized placebo-controlled trial. Bipolar Disorders2016;18(3):221‐32. ">Henriksen 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32 participants with bipolar disorder</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>“With regard to side effects, two patients in the BB group reported emerging depressive symptoms on days 6 and 7, respectively.” </p> <p>“One patient, with comorbid migraine, reported headache associated with the use of BB glasses, causing dropout on the second night of the intervention.” </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013244-bbs2-0012" title="JankuK , SmotekM , FarkovaE , KoprivovaJ . Block the light and sleep well: Evening blue light filtration as a part of cognitive behavioral therapy for insomnia. Chronobiology International2020;37(2):248-59. JankuK , SmotekM , FarkovaE , MiletínováE , KoprivovaJ . Blue light blocking glasses and CBT-I: effect on subjective and objective sleep quality. Sleep Medicine2019;64(Suppl 1):S174. ">Janku 2020</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>35 participants with insomnia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013244-bbs2-0015" title="Perez AlgortaG , Van MeterA , DubickaB , JonesS , YoungstromE , LobbanF . Blue blocking glasses worn at night in first year higher education students with sleep complaints: a feasibility study. Pilot and Feasibility Studies2018;4:166. ">Perez Algorta 2018</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13 participants with with sleep complaints/disorders</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013244-bbs2-0016" title="ShechterA , KimEW , St-OngeMP , WestwoodAJ . Blocking nocturnal blue light for insomnia: a randomized controlled trial. Journal of Psychiatric Research2018;96:196‐202. ">Shechter 2018</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15 participants with chronic insomnia symptoms</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013244-bbs2-0017" title="SinghS , DownieLE , AndersonAJ . Do blue-blocking lenses reduce eye strain from extended screen time? A double-masked, randomized controlled trial. American Journal of Ophthalmology2021;226:243–51. [DOI: 10.1016/j.ajo.2021.02.010]">Singh 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>120 symptomatic computer users</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>Abbreviations: BB, blue block.</p> </div> </div> </section> </section> </section> </section> <section id="CD013244-sec-0055"> <h4 class="title">Excluded studies</h4> <p>Following the full‐text screening stage, we excluded 32 studies. The primary reason(s) for excluding each study is provided in the <a href="./references#CD013244-sec-0105" title="">Characteristics of excluded studies</a> table. </p> <p>The most common reasons for excluding studies were due to the study having an ineligible design (non‐RCT) (<a href="./references#CD013244-bbs2-0058" title="Al-AzawiFW . Vision and geographical information system: Toward spatial statistical analysis in parts of Iraq. Indian Journal of Public Health Research and Development2019;10(5):419-24.">Al‐Azawi 2019</a>; <a href="./references#CD013244-bbs2-0020" title="CozzaF , CompagnoniMM , AiroldiC , BragaC , NigrottiG , VlasakN , et al. The effects of two longpass filters on visual performance. Journal of Optometry2020;13(2):102-12. ">Cozza 2020</a>; <a href="./references#CD013244-bbs2-0025" title="IdeT , TodaI , Miki, E, TsubotaK . Effect of blue light-reducing eye glasses on critical flicker frequency. Asia-Pacific Journal of Ophthalmology2015;4(2):80-5. ">Ide 2015</a>; <a href="./references#CD013244-bbs2-0026" title="IshizawaM , UchiumiT , TakahataM , YamakiM , SatoT . Effects of pre-bedtime blue-light exposure on ratio of deep sleep in healthy young men. Sleep Medicine2021;84:303-7. ">Ishizawa 2021</a>; <a href="./references#CD013244-bbs2-0027" title="KaidoM , TodaI , Oobayashi, T, KawashimaM , KatadaY , TsubotaK . Reducing sh ort-wavelength blue light in dry eye patients with unstable tear film improves performance on tests of visual acuity. Plos One2016;11(4):e0152936. ">Kaido 2016</a>; <a href="./references#CD013244-bbs2-0028" title="LeungTW , LiRW , KeeCS . Blue-light filtering spectacle lenses: optical and clinical performances. Plos One2017;12(1):e0169114. ">Leung 2017</a>; <a href="./references#CD013244-bbs2-0029" title="LuriaSM . Vision with chromatic filters. American Journal of Optometry and Archives of American Academy of Optometry1972;49(10):818‐29. ">Luria 1972</a>; <a href="./references#CD013244-bbs2-0030" title="MonteiroL , CardosoJ , RibeiroA , CoutinhoR , GracaJ , CarvalhoF . Blue-blocking glasses as additive treatment for delirium in Oncology: A randomized-control trial. Psycho-Oncology2017;26(Suppl 3):159. ">Monteiro 2017</a>; <a href="./references#CD013244-bbs2-0033" title="NCT04076410. Efficacy of lenses in abolishing photoparoxysmal responses (PPRs) [Efficacy of new lenses in abolishing photoparoxysmal responses in paediatric patients with photosensitive epilepsy (PSE)]. clinicaltrials.gov/ct2/show/NCT04076410 (first received 3 September 2019). ">NCT04076410</a>; <a href="./references#CD013244-bbs2-0039" title="OtsukaY , OishiA , MiyataM , OishiM , HasegawaT , NumaS , et al. Wavelength of light and photophobia in inherited retinal dystrophy. Scientific Reports2020;10(1):14798. ">Otsuka 2020</a>; <a href="./references#CD013244-bbs2-0040" title="PhelpsJ . A powerful non-pharmacologic treatment for mania - virtually. Bipolar Disorders2016;18(4):379-82. ">Phelps 2016</a>; <a href="./references#CD013244-bbs2-0043" title="RosenfieldM , LiRT , KirschNT . A double-blind test of blue-blocking filters on symptoms of digital eye strain. Work2020;65(2):343-8. ">Rosenfield 2020</a>; <a href="./references#CD013244-bbs2-0044" title="SassevilleA , PaquetN , SevignyJ , HebertM . Blue blocker glasses impede the capacity of bright light to suppress melatonin production. Journal of Pineal Research2006;41(1):73-8. ">Sasseville 2006</a>; <a href="./references#CD013244-bbs2-0046" title="ShirahamaM , TeraoT , HatanoK , HirakawaH , IshiiN . Use of gray sunglasses to alleviate hypomanic state in two patients with bipolar II disorder. Bipolar Disorders2018;21(2):182-4. ">Shirahama 2018</a>; <a href="./references#CD013244-bbs2-0047" title="SmotekM , JankuK , FarkovaE , MiletinovaE , KoprivovaJ . Augmenting CBT-I with blue-light blocking glasses improves anxiety in insomnia patients. Sleep Medicine2019;64:S358‐9. ">Smotek 2019</a>; <a href="./references#CD013244-bbs2-0048" title="TeranE , Yee-RendonCM , Ortega-SalazarJ , De GraciaP , Garcia-RomoE , WoodsRL . Evaluation of two strategies for alleviating the impact on the circadian cycle of smartphone screens. Optometry and VIsion Science2020;97(3):207-7. ">Teran 2020</a>), not investigating blue‐light filtering spectacle lenses (<a href="./references#CD013244-bbs2-0019" title="BennettS , AlpertM , KubulinsV , Hansler Rl. Use of modified spectacles and light bulbs to block blue light at night may prevent postpartum depression. Medical Hypotheses2009;73(2):251‐3. ">Bennett 2009</a>; <a href="./references#CD013244-bbs2-0021" title="DanilenkoKV , LebedinskaiaMY , GadetskaiaEV , BeklemishevaAA , NikolenkoED , AftanasLI . 6-day combined partial wake and light therapy for depression. Neuropsychobiology2016;74(4):235. [DOI: 10.1159/000477426]">Danilenko 2016</a>; <a href="./references#CD013244-bbs2-0093" title="FigueiroMG , WoodB , PlitnickB , ReaMS . The impact of light from computer monitors on melatonin levels in college students. Neuroendocrinology Letters2011;32(2):158‐63.">Figueiro 2011</a>; <a href="./references#CD013244-bbs2-0023" title="FigueiroM , ReaMS . The impact of self-luminous displays on evening melatonin levels. Sleep2013;1:A184. ">Figueiro 2013</a>; <a href="./references#CD013244-bbs2-0024" title="FigueiroMG , PedlerD . Red light: A novel, non-pharmacological intervention to promote alertness in shift workers. Journal of Safety Research2020;74:169-77. ">Figueiro 2020</a>; <a href="./references#CD013244-bbs2-0031" title="NCT02982239. Recovery enhancement and sleep training (REST). clinicaltrials.gov/show/nct02982239 (first received 5 December 2016). ">NCT02982239</a>; <a href="./references#CD013244-bbs2-0032" title="NCT03831919. Trial of Hoya SYNC III design lenses [Randomised controlled trial of Hoya SYNC III design lenses]. clinicaltrials.gov/show/NCT03831919 (first received 6 February 2019). ">NCT03831919</a>; <a href="./references#CD013244-bbs2-0038" title="NL9458. DBBO night shift support study [The effectiveness of blue light glasses in night shift work of defense security personnel]. trialregister.nl/trial/9458 (first received 11 May 2021). ">NL9458</a>; <a href="./references#CD013244-bbs2-0042" title="RedondoB , VeraJ , Ortega-SanchezA , MolinaR , JimenezR . Effects of a blue-blocking screen filter on accommodative accuracy and visual discomfort. Ophthalmic and Physiological Optics2020;40(6):790-800. ">Redondo 2020</a>; <a href="./references#CD013244-bbs2-0044" title="SassevilleA , PaquetN , SevignyJ , HebertM . Blue blocker glasses impede the capacity of bright light to suppress melatonin production. Journal of Pineal Research2006;41(1):73-8. ">Sasseville 2006</a>; <a href="./references#CD013244-bbs2-0049" title="WoodB , ReaMS , PlitnickB , FigueiroMG . Light level and duration of exposure determine the impact of self-luminous tablets on melatonin suppression. Applied Ergonomics2013;44(2):237-40. ">Wood 2013</a>), the comparator not being a non‐blue‐light filtering lens (<a href="./references#CD013244-bbs2-0034" title="NCT04463498. Sleep in psychiatric care (SIP): a transdiagnostic group-based sleep-school as treatment for comorbid insomnia. clinicaltrials.gov/show/NCT04463498 (first received 9 July 2020). ">NCT04463498</a>; <a href="./references#CD013244-bbs2-0035" title="NCT04804501. Effect of blue light glasses on screen usage after a concussion in college students. clinicaltrials.gov/show/NCT04804501 (first received 18 March 2021). ">NCT04804501</a>; <a href="./references#CD013244-bbs2-0041" title="RBR-3snw7t. Influence of wearing glasses to filter blue light in the nighttime period on the perception of sleep quality and clinical parameters of critically ill patients [Influence the blue light filter in the nighttime period on the perception of sleep quality and clinical parameters of critically ill patients]. trialsearch.who.int/?TrialID=RBR-3snw7t (first received 24 October 2019). ">RBR‐3snw7t</a>, <a href="./references#CD013244-bbs2-0037" title="NCT05177055. Sleep in psychiatric care (SIP): treatment for comorbid delayed sleep-wake phase disorder (DSWPD) [Sleep in psychiatric care (SIP): a transdiagnostic group-based sleep-school as treatment for comorbid delayed sleep-wake phase disorder (DSWPD)]. clinicaltrials.gov/show/NCT05177055 (first received 4 January 2022). ">NCT05177055</a>), or the spectacle lenses not being similar across the intervention and comparator groups (<a href="./references#CD013244-bbs2-0036" title="NCT04827446. Lighting intervention for cancer-related fatigue [A randomized trial Of the SYNC APP]. clinicaltrials.gov/ct2/show/NCT04827446 (first received 1 April 2021). ">NCT04827446</a>). </p> <p>Five trials were listed as ‘ongoing’; study details are provided in the <a href="./references#CD013244-sec-0107" title="">Characteristics of ongoing studies</a> table. </p> </section> </section> <section id="CD013244-sec-0056"> <h3 class="title">Risk of bias in included studies</h3> <p><a href="#CD013244-fig-0002">Figure 2</a> and <a href="#CD013244-fig-0003">Figure 3</a> summarise the risk of bias assessments for the included studies. Details related to risk of bias judgements for individual studies are summarised in the <a href="./references#CD013244-sec-0104" title="">Characteristics of included studies</a> table. </p> <div class="figure" id="CD013244-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study" data-id="CD013244-fig-0002" src="/cdsr/doi/10.1002/14651858.CD013244.pub2/media/CDSR/CD013244/image_n/nCD013244-FIG-02.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study </p> </div> </div> </div> <div class="figure" id="CD013244-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies" data-id="CD013244-fig-0003" src="/cdsr/doi/10.1002/14651858.CD013244.pub2/media/CDSR/CD013244/image_n/nCD013244-FIG-03.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies </p> </div> </div> </div> <p>Of the 17 included trials, none were judged to have a low risk of bias across all seven domains. We judged three studies to have low risks of bias in six out of seven domains (<a href="./references#CD013244-bbs2-0007" title="EsakiY , KitajimaT , TakeuchiI , TsuboiS , FurukawaO , MoriwakiM , et al. Effect of blue-blocking glasses in major depressive disorder with sleep onset insomnia: a randomized, double-blind, placebo-controlled study. Chronobiology international2017;34(6):753‐61. ">Esaki 2017</a>; <a href="./references#CD013244-bbs2-0008" title="EsakiY , TakeuchiI , TsuboiS , FujitaK , IwataN , KitajimaT . A double-blind, randomized, placebo-controlled trial of adjunctive blue-blocking glasses for the treatment of sleep and circadian rhythm in patients with bipolar disorder. Bipolar Disorders2020;22(7):739-48. ">Esaki 2020</a>; <a href="./references#CD013244-bbs2-0017" title="SinghS , DownieLE , AndersonAJ . Do blue-blocking lenses reduce eye strain from extended screen time? A double-masked, randomized controlled trial. American Journal of Ophthalmology2021;226:243–51. [DOI: 10.1016/j.ajo.2021.02.010]">Singh 2021</a>). </p> <p>Across all eligible trials, the most well‐reported domain was incomplete outcome data (attrition bias), with 76% of included trials considered to have low risk of bias in this methodological criterion. We judged more than half of the studies to have a high risk of performance bias and detection bias, due to the studies not masking participants, personnel, or outcome assessors, or at least one of these parties. </p> <section id="CD013244-sec-0057"> <h4 class="title">Allocation</h4> <section id="CD013244-sec-0058"> <h5 class="title">Sequence generation</h5> <p>Eight trials (40%) reported how the randomisation sequence was generated, and we judged these to have a low risk of bias in this domain. Six trials used computer software (<a href="./references#CD013244-bbs2-0001" title="AlzahraniHS , KhuuSK , AliA , RoyM . The effect of blue-blocking lenses on photostress recovery times. Optometry and Vision Science2020;97(11):995-1004. ">Alzahrani 2020</a>; <a href="./references#CD013244-bbs2-0007" title="EsakiY , KitajimaT , TakeuchiI , TsuboiS , FurukawaO , MoriwakiM , et al. Effect of blue-blocking glasses in major depressive disorder with sleep onset insomnia: a randomized, double-blind, placebo-controlled study. Chronobiology international2017;34(6):753‐61. ">Esaki 2017</a>; <a href="./references#CD013244-bbs2-0008" title="EsakiY , TakeuchiI , TsuboiS , FujitaK , IwataN , KitajimaT . A double-blind, randomized, placebo-controlled trial of adjunctive blue-blocking glasses for the treatment of sleep and circadian rhythm in patients with bipolar disorder. Bipolar Disorders2020;22(7):739-48. ">Esaki 2020</a>; <a href="./references#CD013244-bbs2-0015" title="Perez AlgortaG , Van MeterA , DubickaB , JonesS , YoungstromE , LobbanF . Blue blocking glasses worn at night in first year higher education students with sleep complaints: a feasibility study. Pilot and Feasibility Studies2018;4:166. ">Perez Algorta 2018</a>; <a href="./references#CD013244-bbs2-0016" title="ShechterA , KimEW , St-OngeMP , WestwoodAJ . Blocking nocturnal blue light for insomnia: a randomized controlled trial. Journal of Psychiatric Research2018;96:196‐202. ">Shechter 2018</a>; <a href="./references#CD013244-bbs2-0017" title="SinghS , DownieLE , AndersonAJ . Do blue-blocking lenses reduce eye strain from extended screen time? A double-masked, randomized controlled trial. American Journal of Ophthalmology2021;226:243–51. [DOI: 10.1016/j.ajo.2021.02.010]">Singh 2021</a>), and two trials from the same research group used a manual drawing method (<a href="./references#CD013244-bbs2-0010" title="HenriksenTE , SkredeS , FasmerOB , SchoeyenH , LeskauskaiteI , Bjørke-BertheussenJ , et al. Blue-blocking glasses as additive treatment for mania: a randomized placebo-controlled trial. Bipolar Disorders2016;18(3):221‐32. ">Henriksen 2016</a>; <a href="./references#CD013244-bbs2-0011" title="HenriksenTEG , GrønliJ , AssmusJ , FasmerOB , SchoeyenH , LeskauskaiteI , et al. Blue-blocking glasses as additive treatment for mania: Effects on actigraphy-derived sleep parameters. Journal of Sleep Research2020;29(5):e12984. [DOI: 10.1111/jsr.12984]">Henriksen 2020</a>). Nine trials were described as 'randomised' but did not report how the random sequence was generated; we judged these trials to have an unclear risk of bias for this domain (<a href="./references#CD013244-bbs2-0002" title="AlzahranHS , RoyM , HonsonV , KhuuSK . Effect of blue-blocking lenses on colour contrast sensitivity. Clinical and Experimental Optometry2021;104(2):207-14. ">Alzahrani 2021</a>; <a href="./references#CD013244-bbs2-0003" title="BigalkeJA , GreenlundIM , NicevskiJR , CarterJR . Effect of evening blue light blocking glasses on subjective and objective sleep in healthy adults: a randomized control trial. Sleep Health2021;7(4):485–90. ">Bigalke 2021</a>; <a href="./references#CD013244-bbs2-0004" title="BurkhartK , PhelpsJR . Amber lenses to block blue light and improve sleep: a randomized trial. Chronobiology International2009;26(8):1602‐12. ">Burkhart 2009</a>; <a href="./references#CD013244-bbs2-0005" title="DabrowieckiA , VillalobosA , KrupinskiEA . Impact of blue light filtering glasses on computer vision syndrome in radiology residents: a pilot study. Journal of Medical Imaging2020;7(2):022402. ">Dabrowiecki 2020</a>; <a href="./references#CD013244-bbs2-0006" title="DanilenkoK , LebedinskaiaMY , GadetskaiaEV , MarkovAA , IvanovaYA , AftanasLI . Six day combined partial wake and light therapy for unipolar depression. European Neuropsychopharmacology2019;29:S410‐11. DanilenkoKV , LebedinskaiaMY , GadetskaiaEV , MarkovAA , IvanovaYA , AftanasLI . A 6-day combined wake and light therapy trial for unipolar depression. Journal of Affective Disorders2019;259:355-61. ">Danilenko 2019</a>; <a href="./references#CD013244-bbs2-0009" title="Hammond, BR. Attenuating photostress and glare disability in pseudophakic patients through the addition of a short-wave absorbing filter. Journal of Ophthalmology2015;2015:Article ID 607635. [DOI: 10.1155/2015/607635]NCT01938989. Effect of blue light filtration on visual performance. clinicaltrials.gov/ct2/show/NCT01938989 (first received 11 September 2013). ">Hammond 2015</a>; <a href="./references#CD013244-bbs2-0109" title="JankuK , SmotekM , FarkovaE , KoprivovaJ . Block the light and sleep well: Evening blue light filtration as a part of cognitive behavioral therapy for insomnia. Chronobiology International2020;37(2):248-59.">Janku 2020</a>; <a href="./references#CD013244-bbs2-0013" title="KnufinkeM , Fittkau-KochL , MøstEI , KompierMA , NieuwenhuysA . Restricting short-wavelength light in the evening to improve sleep in recreational athletes - A pilot study. European Journal of Sport Science2019;19(6):728‐35. ">Knufinke 2019</a>; <a href="./references#CD013244-bbs2-0014" title="LinJB , GerrattBW , BassiCJ , ApteRS . Short-wavelength light-blocking eyeglasses attenuate symptoms of eye fatigue. Investigative Ophthalmology and Visual Science2017;58(1):442‐7. ">Lin 2017</a>). None of the trials had a high risk of bias for this domain. </p> </section> <section id="CD013244-sec-0059"> <h5 class="title">Allocation concealment</h5> <p>We judged three trials (18%) to have a low risk of bias for allocation concealment. One study used computer‐generated files that concealed the allocation (<a href="./references#CD013244-bbs2-0017" title="SinghS , DownieLE , AndersonAJ . Do blue-blocking lenses reduce eye strain from extended screen time? A double-masked, randomized controlled trial. American Journal of Ophthalmology2021;226:243–51. [DOI: 10.1016/j.ajo.2021.02.010]">Singh 2021</a>), one study used sealed envelopes (<a href="./references#CD013244-bbs2-0007" title="EsakiY , KitajimaT , TakeuchiI , TsuboiS , FurukawaO , MoriwakiM , et al. Effect of blue-blocking glasses in major depressive disorder with sleep onset insomnia: a randomized, double-blind, placebo-controlled study. Chronobiology international2017;34(6):753‐61. ">Esaki 2017</a>), and in another study allocation was performed by personnel not otherwise involved in the study (<a href="./references#CD013244-bbs2-0008" title="EsakiY , TakeuchiI , TsuboiS , FujitaK , IwataN , KitajimaT . A double-blind, randomized, placebo-controlled trial of adjunctive blue-blocking glasses for the treatment of sleep and circadian rhythm in patients with bipolar disorder. Bipolar Disorders2020;22(7):739-48. ">Esaki 2020</a>). </p> <p>Thirteen trials (76%) did not report the method of allocation concealment, and we judged these to have an unclear risk of bias in this domain (<a href="./references#CD013244-bbs2-0002" title="AlzahranHS , RoyM , HonsonV , KhuuSK . Effect of blue-blocking lenses on colour contrast sensitivity. Clinical and Experimental Optometry2021;104(2):207-14. ">Alzahrani 2021</a>; <a href="./references#CD013244-bbs2-0001" title="AlzahraniHS , KhuuSK , AliA , RoyM . The effect of blue-blocking lenses on photostress recovery times. Optometry and Vision Science2020;97(11):995-1004. ">Alzahrani 2020</a>; <a href="./references#CD013244-bbs2-0003" title="BigalkeJA , GreenlundIM , NicevskiJR , CarterJR . Effect of evening blue light blocking glasses on subjective and objective sleep in healthy adults: a randomized control trial. Sleep Health2021;7(4):485–90. ">Bigalke 2021</a>; <a href="./references#CD013244-bbs2-0004" title="BurkhartK , PhelpsJR . Amber lenses to block blue light and improve sleep: a randomized trial. Chronobiology International2009;26(8):1602‐12. ">Burkhart 2009</a>; <a href="./references#CD013244-bbs2-0005" title="DabrowieckiA , VillalobosA , KrupinskiEA . Impact of blue light filtering glasses on computer vision syndrome in radiology residents: a pilot study. Journal of Medical Imaging2020;7(2):022402. ">Dabrowiecki 2020</a>; <a href="./references#CD013244-bbs2-0006" title="DanilenkoK , LebedinskaiaMY , GadetskaiaEV , MarkovAA , IvanovaYA , AftanasLI . Six day combined partial wake and light therapy for unipolar depression. European Neuropsychopharmacology2019;29:S410‐11. DanilenkoKV , LebedinskaiaMY , GadetskaiaEV , MarkovAA , IvanovaYA , AftanasLI . A 6-day combined wake and light therapy trial for unipolar depression. Journal of Affective Disorders2019;259:355-61. ">Danilenko 2019</a>; <a href="./references#CD013244-bbs2-0009" title="Hammond, BR. Attenuating photostress and glare disability in pseudophakic patients through the addition of a short-wave absorbing filter. Journal of Ophthalmology2015;2015:Article ID 607635. [DOI: 10.1155/2015/607635]NCT01938989. Effect of blue light filtration on visual performance. clinicaltrials.gov/ct2/show/NCT01938989 (first received 11 September 2013). ">Hammond 2015</a>; <a href="./references#CD013244-bbs2-0010" title="HenriksenTE , SkredeS , FasmerOB , SchoeyenH , LeskauskaiteI , Bjørke-BertheussenJ , et al. Blue-blocking glasses as additive treatment for mania: a randomized placebo-controlled trial. Bipolar Disorders2016;18(3):221‐32. ">Henriksen 2016</a>; <a href="./references#CD013244-bbs2-0011" title="HenriksenTEG , GrønliJ , AssmusJ , FasmerOB , SchoeyenH , LeskauskaiteI , et al. Blue-blocking glasses as additive treatment for mania: Effects on actigraphy-derived sleep parameters. Journal of Sleep Research2020;29(5):e12984. [DOI: 10.1111/jsr.12984]">Henriksen 2020</a>; <a href="./references#CD013244-bbs2-0109" title="JankuK , SmotekM , FarkovaE , KoprivovaJ . Block the light and sleep well: Evening blue light filtration as a part of cognitive behavioral therapy for insomnia. Chronobiology International2020;37(2):248-59.">Janku 2020</a>; <a href="./references#CD013244-bbs2-0013" title="KnufinkeM , Fittkau-KochL , MøstEI , KompierMA , NieuwenhuysA . Restricting short-wavelength light in the evening to improve sleep in recreational athletes - A pilot study. European Journal of Sport Science2019;19(6):728‐35. ">Knufinke 2019</a>; <a href="./references#CD013244-bbs2-0014" title="LinJB , GerrattBW , BassiCJ , ApteRS . Short-wavelength light-blocking eyeglasses attenuate symptoms of eye fatigue. Investigative Ophthalmology and Visual Science2017;58(1):442‐7. ">Lin 2017</a>; <a href="./references#CD013244-bbs2-0016" title="ShechterA , KimEW , St-OngeMP , WestwoodAJ . Blocking nocturnal blue light for insomnia: a randomized controlled trial. Journal of Psychiatric Research2018;96:196‐202. ">Shechter 2018</a>). We considered one study to have a high risk of bias as the principal investigator delivered the study intervention and no information was provided about allocation concealment (<a href="./references#CD013244-bbs2-0015" title="Perez AlgortaG , Van MeterA , DubickaB , JonesS , YoungstromE , LobbanF . Blue blocking glasses worn at night in first year higher education students with sleep complaints: a feasibility study. Pilot and Feasibility Studies2018;4:166. ">Perez Algorta 2018</a>). </p> </section> </section> <section id="CD013244-sec-0060"> <h4 class="title">Blinding</h4> <p>For performance bias, three studies clearly specified the masking of study participants and study personnel, and we judged these to have a low risk of bias (<a href="./references#CD013244-bbs2-0007" title="EsakiY , KitajimaT , TakeuchiI , TsuboiS , FurukawaO , MoriwakiM , et al. Effect of blue-blocking glasses in major depressive disorder with sleep onset insomnia: a randomized, double-blind, placebo-controlled study. Chronobiology international2017;34(6):753‐61. ">Esaki 2017</a>; <a href="./references#CD013244-bbs2-0008" title="EsakiY , TakeuchiI , TsuboiS , FujitaK , IwataN , KitajimaT . A double-blind, randomized, placebo-controlled trial of adjunctive blue-blocking glasses for the treatment of sleep and circadian rhythm in patients with bipolar disorder. Bipolar Disorders2020;22(7):739-48. ">Esaki 2020</a>; <a href="./references#CD013244-bbs2-0017" title="SinghS , DownieLE , AndersonAJ . Do blue-blocking lenses reduce eye strain from extended screen time? A double-masked, randomized controlled trial. American Journal of Ophthalmology2021;226:243–51. [DOI: 10.1016/j.ajo.2021.02.010]">Singh 2021</a>). Four trials only masked study participants, and no information was provided about possible masking of the study personnel involved with delivering the intervention. Hence, we judged the potential risk of performance bias for these studies to be unclear (<a href="./references#CD013244-bbs2-0005" title="DabrowieckiA , VillalobosA , KrupinskiEA . Impact of blue light filtering glasses on computer vision syndrome in radiology residents: a pilot study. Journal of Medical Imaging2020;7(2):022402. ">Dabrowiecki 2020</a>; <a href="./references#CD013244-bbs2-0006" title="DanilenkoK , LebedinskaiaMY , GadetskaiaEV , MarkovAA , IvanovaYA , AftanasLI . Six day combined partial wake and light therapy for unipolar depression. European Neuropsychopharmacology2019;29:S410‐11. DanilenkoKV , LebedinskaiaMY , GadetskaiaEV , MarkovAA , IvanovaYA , AftanasLI . A 6-day combined wake and light therapy trial for unipolar depression. Journal of Affective Disorders2019;259:355-61. ">Danilenko 2019</a>; <a href="./references#CD013244-bbs2-0009" title="Hammond, BR. Attenuating photostress and glare disability in pseudophakic patients through the addition of a short-wave absorbing filter. Journal of Ophthalmology2015;2015:Article ID 607635. [DOI: 10.1155/2015/607635]NCT01938989. Effect of blue light filtration on visual performance. clinicaltrials.gov/ct2/show/NCT01938989 (first received 11 September 2013). ">Hammond 2015</a>; <a href="./references#CD013244-bbs2-0011" title="HenriksenTEG , GrønliJ , AssmusJ , FasmerOB , SchoeyenH , LeskauskaiteI , et al. Blue-blocking glasses as additive treatment for mania: Effects on actigraphy-derived sleep parameters. Journal of Sleep Research2020;29(5):e12984. [DOI: 10.1111/jsr.12984]">Henriksen 2020</a>). Nine trials did not report whether participants and study personnel were masked (<a href="./references#CD013244-bbs2-0002" title="AlzahranHS , RoyM , HonsonV , KhuuSK . Effect of blue-blocking lenses on colour contrast sensitivity. Clinical and Experimental Optometry2021;104(2):207-14. ">Alzahrani 2021</a>; <a href="./references#CD013244-bbs2-0001" title="AlzahraniHS , KhuuSK , AliA , RoyM . The effect of blue-blocking lenses on photostress recovery times. Optometry and Vision Science2020;97(11):995-1004. ">Alzahrani 2020</a>; <a href="./references#CD013244-bbs2-0003" title="BigalkeJA , GreenlundIM , NicevskiJR , CarterJR . Effect of evening blue light blocking glasses on subjective and objective sleep in healthy adults: a randomized control trial. Sleep Health2021;7(4):485–90. ">Bigalke 2021</a>; <a href="./references#CD013244-bbs2-0004" title="BurkhartK , PhelpsJR . Amber lenses to block blue light and improve sleep: a randomized trial. Chronobiology International2009;26(8):1602‐12. ">Burkhart 2009</a>; <a href="./references#CD013244-bbs2-0109" title="JankuK , SmotekM , FarkovaE , KoprivovaJ . Block the light and sleep well: Evening blue light filtration as a part of cognitive behavioral therapy for insomnia. Chronobiology International2020;37(2):248-59.">Janku 2020</a>; <a href="./references#CD013244-bbs2-0013" title="KnufinkeM , Fittkau-KochL , MøstEI , KompierMA , NieuwenhuysA . Restricting short-wavelength light in the evening to improve sleep in recreational athletes - A pilot study. European Journal of Sport Science2019;19(6):728‐35. ">Knufinke 2019</a>; <a href="./references#CD013244-bbs2-0014" title="LinJB , GerrattBW , BassiCJ , ApteRS . Short-wavelength light-blocking eyeglasses attenuate symptoms of eye fatigue. Investigative Ophthalmology and Visual Science2017;58(1):442‐7. ">Lin 2017</a>; <a href="./references#CD013244-bbs2-0015" title="Perez AlgortaG , Van MeterA , DubickaB , JonesS , YoungstromE , LobbanF . Blue blocking glasses worn at night in first year higher education students with sleep complaints: a feasibility study. Pilot and Feasibility Studies2018;4:166. ">Perez Algorta 2018</a>; <a href="./references#CD013244-bbs2-0016" title="ShechterA , KimEW , St-OngeMP , WestwoodAJ . Blocking nocturnal blue light for insomnia: a randomized controlled trial. Journal of Psychiatric Research2018;96:196‐202. ">Shechter 2018</a>), and in one study participants were masked, but the study personnel involved with delivering the study intervention were not masked (<a href="./references#CD013244-bbs2-0010" title="HenriksenTE , SkredeS , FasmerOB , SchoeyenH , LeskauskaiteI , Bjørke-BertheussenJ , et al. Blue-blocking glasses as additive treatment for mania: a randomized placebo-controlled trial. Bipolar Disorders2016;18(3):221‐32. ">Henriksen 2016</a>). We judged these 10 trials to have a high risk of performance bias. </p> <p>For masking of outcome assessors (detection bias), we judged four trials to have a low risk of bias (<a href="./references#CD013244-bbs2-0006" title="DanilenkoK , LebedinskaiaMY , GadetskaiaEV , MarkovAA , IvanovaYA , AftanasLI . Six day combined partial wake and light therapy for unipolar depression. European Neuropsychopharmacology2019;29:S410‐11. DanilenkoKV , LebedinskaiaMY , GadetskaiaEV , MarkovAA , IvanovaYA , AftanasLI . A 6-day combined wake and light therapy trial for unipolar depression. Journal of Affective Disorders2019;259:355-61. ">Danilenko 2019</a>; <a href="./references#CD013244-bbs2-0007" title="EsakiY , KitajimaT , TakeuchiI , TsuboiS , FurukawaO , MoriwakiM , et al. Effect of blue-blocking glasses in major depressive disorder with sleep onset insomnia: a randomized, double-blind, placebo-controlled study. Chronobiology international2017;34(6):753‐61. ">Esaki 2017</a>; <a href="./references#CD013244-bbs2-0109" title="JankuK , SmotekM , FarkovaE , KoprivovaJ . Block the light and sleep well: Evening blue light filtration as a part of cognitive behavioral therapy for insomnia. Chronobiology International2020;37(2):248-59.">Janku 2020</a>; <a href="./references#CD013244-bbs2-0014" title="LinJB , GerrattBW , BassiCJ , ApteRS . Short-wavelength light-blocking eyeglasses attenuate symptoms of eye fatigue. Investigative Ophthalmology and Visual Science2017;58(1):442‐7. ">Lin 2017</a>). One trial was described as 'double‐blind', but did not provide details with regard to how this was achieved (<a href="./references#CD013244-bbs2-0008" title="EsakiY , TakeuchiI , TsuboiS , FujitaK , IwataN , KitajimaT . A double-blind, randomized, placebo-controlled trial of adjunctive blue-blocking glasses for the treatment of sleep and circadian rhythm in patients with bipolar disorder. Bipolar Disorders2020;22(7):739-48. ">Esaki 2020</a>). One trial reported how the masking of outcome assessors was achieved, but on analysing the outcome assessors' guessing of participant assignment to the study groups, this level of masking was reported to be unsuccessful (<a href="./references#CD013244-bbs2-0017" title="SinghS , DownieLE , AndersonAJ . Do blue-blocking lenses reduce eye strain from extended screen time? A double-masked, randomized controlled trial. American Journal of Ophthalmology2021;226:243–51. [DOI: 10.1016/j.ajo.2021.02.010]">Singh 2021</a>). We considered both of these studies to have an unclear risk of detection bias. Eleven trials had a high risk of bias for this domain, due to the studies providing no information relating to the masking of outcome assessors (<a href="./references#CD013244-bbs2-0002" title="AlzahranHS , RoyM , HonsonV , KhuuSK . Effect of blue-blocking lenses on colour contrast sensitivity. Clinical and Experimental Optometry2021;104(2):207-14. ">Alzahrani 2021</a>; <a href="./references#CD013244-bbs2-0001" title="AlzahraniHS , KhuuSK , AliA , RoyM . The effect of blue-blocking lenses on photostress recovery times. Optometry and Vision Science2020;97(11):995-1004. ">Alzahrani 2020</a>; <a href="./references#CD013244-bbs2-0003" title="BigalkeJA , GreenlundIM , NicevskiJR , CarterJR . Effect of evening blue light blocking glasses on subjective and objective sleep in healthy adults: a randomized control trial. Sleep Health2021;7(4):485–90. ">Bigalke 2021</a>; <a href="./references#CD013244-bbs2-0004" title="BurkhartK , PhelpsJR . Amber lenses to block blue light and improve sleep: a randomized trial. Chronobiology International2009;26(8):1602‐12. ">Burkhart 2009</a>; <a href="./references#CD013244-bbs2-0005" title="DabrowieckiA , VillalobosA , KrupinskiEA . Impact of blue light filtering glasses on computer vision syndrome in radiology residents: a pilot study. Journal of Medical Imaging2020;7(2):022402. ">Dabrowiecki 2020</a>; <a href="./references#CD013244-bbs2-0009" title="Hammond, BR. Attenuating photostress and glare disability in pseudophakic patients through the addition of a short-wave absorbing filter. Journal of Ophthalmology2015;2015:Article ID 607635. [DOI: 10.1155/2015/607635]NCT01938989. Effect of blue light filtration on visual performance. clinicaltrials.gov/ct2/show/NCT01938989 (first received 11 September 2013). ">Hammond 2015</a>; <a href="./references#CD013244-bbs2-0011" title="HenriksenTEG , GrønliJ , AssmusJ , FasmerOB , SchoeyenH , LeskauskaiteI , et al. Blue-blocking glasses as additive treatment for mania: Effects on actigraphy-derived sleep parameters. Journal of Sleep Research2020;29(5):e12984. [DOI: 10.1111/jsr.12984]">Henriksen 2020</a>; <a href="./references#CD013244-bbs2-0013" title="KnufinkeM , Fittkau-KochL , MøstEI , KompierMA , NieuwenhuysA . Restricting short-wavelength light in the evening to improve sleep in recreational athletes - A pilot study. European Journal of Sport Science2019;19(6):728‐35. ">Knufinke 2019</a>; <a href="./references#CD013244-bbs2-0015" title="Perez AlgortaG , Van MeterA , DubickaB , JonesS , YoungstromE , LobbanF . Blue blocking glasses worn at night in first year higher education students with sleep complaints: a feasibility study. Pilot and Feasibility Studies2018;4:166. ">Perez Algorta 2018</a>; <a href="./references#CD013244-bbs2-0016" title="ShechterA , KimEW , St-OngeMP , WestwoodAJ . Blocking nocturnal blue light for insomnia: a randomized controlled trial. Journal of Psychiatric Research2018;96:196‐202. ">Shechter 2018</a>), or the study explicitly reporting that the outcome assessor was not masked (<a href="./references#CD013244-bbs2-0010" title="HenriksenTE , SkredeS , FasmerOB , SchoeyenH , LeskauskaiteI , Bjørke-BertheussenJ , et al. Blue-blocking glasses as additive treatment for mania: a randomized placebo-controlled trial. Bipolar Disorders2016;18(3):221‐32. ">Henriksen 2016</a>). </p> </section> <section id="CD013244-sec-0061"> <h4 class="title">Incomplete outcome data</h4> <p>Thirteen trials (76%) had a low risk of attrition bias (<a href="./references#CD013244-bbs2-0001" title="AlzahraniHS , KhuuSK , AliA , RoyM . The effect of blue-blocking lenses on photostress recovery times. Optometry and Vision Science2020;97(11):995-1004. ">Alzahrani 2020</a>; <a href="./references#CD013244-bbs2-0003" title="BigalkeJA , GreenlundIM , NicevskiJR , CarterJR . Effect of evening blue light blocking glasses on subjective and objective sleep in healthy adults: a randomized control trial. Sleep Health2021;7(4):485–90. ">Bigalke 2021</a>; <a href="./references#CD013244-bbs2-0004" title="BurkhartK , PhelpsJR . Amber lenses to block blue light and improve sleep: a randomized trial. Chronobiology International2009;26(8):1602‐12. ">Burkhart 2009</a>; <a href="./references#CD013244-bbs2-0005" title="DabrowieckiA , VillalobosA , KrupinskiEA . Impact of blue light filtering glasses on computer vision syndrome in radiology residents: a pilot study. Journal of Medical Imaging2020;7(2):022402. ">Dabrowiecki 2020</a>; <a href="./references#CD013244-bbs2-0006" title="DanilenkoK , LebedinskaiaMY , GadetskaiaEV , MarkovAA , IvanovaYA , AftanasLI . Six day combined partial wake and light therapy for unipolar depression. European Neuropsychopharmacology2019;29:S410‐11. DanilenkoKV , LebedinskaiaMY , GadetskaiaEV , MarkovAA , IvanovaYA , AftanasLI . A 6-day combined wake and light therapy trial for unipolar depression. Journal of Affective Disorders2019;259:355-61. ">Danilenko 2019</a>; <a href="./references#CD013244-bbs2-0007" title="EsakiY , KitajimaT , TakeuchiI , TsuboiS , FurukawaO , MoriwakiM , et al. Effect of blue-blocking glasses in major depressive disorder with sleep onset insomnia: a randomized, double-blind, placebo-controlled study. Chronobiology international2017;34(6):753‐61. ">Esaki 2017</a>; <a href="./references#CD013244-bbs2-0008" title="EsakiY , TakeuchiI , TsuboiS , FujitaK , IwataN , KitajimaT . A double-blind, randomized, placebo-controlled trial of adjunctive blue-blocking glasses for the treatment of sleep and circadian rhythm in patients with bipolar disorder. Bipolar Disorders2020;22(7):739-48. ">Esaki 2020</a>; <a href="./references#CD013244-bbs2-0009" title="Hammond, BR. Attenuating photostress and glare disability in pseudophakic patients through the addition of a short-wave absorbing filter. Journal of Ophthalmology2015;2015:Article ID 607635. [DOI: 10.1155/2015/607635]NCT01938989. Effect of blue light filtration on visual performance. clinicaltrials.gov/ct2/show/NCT01938989 (first received 11 September 2013). ">Hammond 2015</a>; <a href="./references#CD013244-bbs2-0109" title="JankuK , SmotekM , FarkovaE , KoprivovaJ . Block the light and sleep well: Evening blue light filtration as a part of cognitive behavioral therapy for insomnia. Chronobiology International2020;37(2):248-59.">Janku 2020</a>; <a href="./references#CD013244-bbs2-0014" title="LinJB , GerrattBW , BassiCJ , ApteRS . Short-wavelength light-blocking eyeglasses attenuate symptoms of eye fatigue. Investigative Ophthalmology and Visual Science2017;58(1):442‐7. ">Lin 2017</a>; <a href="./references#CD013244-bbs2-0015" title="Perez AlgortaG , Van MeterA , DubickaB , JonesS , YoungstromE , LobbanF . Blue blocking glasses worn at night in first year higher education students with sleep complaints: a feasibility study. Pilot and Feasibility Studies2018;4:166. ">Perez Algorta 2018</a>; <a href="./references#CD013244-bbs2-0016" title="ShechterA , KimEW , St-OngeMP , WestwoodAJ . Blocking nocturnal blue light for insomnia: a randomized controlled trial. Journal of Psychiatric Research2018;96:196‐202. ">Shechter 2018</a>; <a href="./references#CD013244-bbs2-0017" title="SinghS , DownieLE , AndersonAJ . Do blue-blocking lenses reduce eye strain from extended screen time? A double-masked, randomized controlled trial. American Journal of Ophthalmology2021;226:243–51. [DOI: 10.1016/j.ajo.2021.02.010]">Singh 2021</a>), either because there were no losses to follow‐up, or missing data were less than 20% and there was equal follow‐up between the study arms with no obvious reasons for the loss of follow‐up to be linked to the outcome. We judged the risk of attrition bias to be unclear in four studies, as the follow‐up was not clearly stated (<a href="./references#CD013244-bbs2-0002" title="AlzahranHS , RoyM , HonsonV , KhuuSK . Effect of blue-blocking lenses on colour contrast sensitivity. Clinical and Experimental Optometry2021;104(2):207-14. ">Alzahrani 2021</a>; <a href="./references#CD013244-bbs2-0013" title="KnufinkeM , Fittkau-KochL , MøstEI , KompierMA , NieuwenhuysA . Restricting short-wavelength light in the evening to improve sleep in recreational athletes - A pilot study. European Journal of Sport Science2019;19(6):728‐35. ">Knufinke 2019</a>), or the trials had missing data of more than 20% with equal follow‐up across the study arms (<a href="./references#CD013244-bbs2-0010" title="HenriksenTE , SkredeS , FasmerOB , SchoeyenH , LeskauskaiteI , Bjørke-BertheussenJ , et al. Blue-blocking glasses as additive treatment for mania: a randomized placebo-controlled trial. Bipolar Disorders2016;18(3):221‐32. ">Henriksen 2016</a>; <a href="./references#CD013244-bbs2-0011" title="HenriksenTEG , GrønliJ , AssmusJ , FasmerOB , SchoeyenH , LeskauskaiteI , et al. Blue-blocking glasses as additive treatment for mania: Effects on actigraphy-derived sleep parameters. Journal of Sleep Research2020;29(5):e12984. [DOI: 10.1111/jsr.12984]">Henriksen 2020</a>). Two studies specifically reported undertaking intention‐to treat analyses (<a href="./references#CD013244-bbs2-0008" title="EsakiY , TakeuchiI , TsuboiS , FujitaK , IwataN , KitajimaT . A double-blind, randomized, placebo-controlled trial of adjunctive blue-blocking glasses for the treatment of sleep and circadian rhythm in patients with bipolar disorder. Bipolar Disorders2020;22(7):739-48. ">Esaki 2020</a>; <a href="./references#CD013244-bbs2-0010" title="HenriksenTE , SkredeS , FasmerOB , SchoeyenH , LeskauskaiteI , Bjørke-BertheussenJ , et al. Blue-blocking glasses as additive treatment for mania: a randomized placebo-controlled trial. Bipolar Disorders2016;18(3):221‐32. ">Henriksen 2016</a>). We did not judge any of the trials to have a high risk of attrition bias. </p> </section> <section id="CD013244-sec-0062"> <h4 class="title">Selective reporting</h4> <p>Eleven trials (65%) did not report information about registration in a clinical trial registry, and lack of this information led to a judgement of an unclear risk of reporting bias (<a href="./references#CD013244-bbs2-0002" title="AlzahranHS , RoyM , HonsonV , KhuuSK . Effect of blue-blocking lenses on colour contrast sensitivity. Clinical and Experimental Optometry2021;104(2):207-14. ">Alzahrani 2021</a>; <a href="./references#CD013244-bbs2-0001" title="AlzahraniHS , KhuuSK , AliA , RoyM . The effect of blue-blocking lenses on photostress recovery times. Optometry and Vision Science2020;97(11):995-1004. ">Alzahrani 2020</a>; <a href="./references#CD013244-bbs2-0003" title="BigalkeJA , GreenlundIM , NicevskiJR , CarterJR . Effect of evening blue light blocking glasses on subjective and objective sleep in healthy adults: a randomized control trial. Sleep Health2021;7(4):485–90. ">Bigalke 2021</a>; <a href="./references#CD013244-bbs2-0004" title="BurkhartK , PhelpsJR . Amber lenses to block blue light and improve sleep: a randomized trial. Chronobiology International2009;26(8):1602‐12. ">Burkhart 2009</a>; <a href="./references#CD013244-bbs2-0005" title="DabrowieckiA , VillalobosA , KrupinskiEA . Impact of blue light filtering glasses on computer vision syndrome in radiology residents: a pilot study. Journal of Medical Imaging2020;7(2):022402. ">Dabrowiecki 2020</a>; <a href="./references#CD013244-bbs2-0006" title="DanilenkoK , LebedinskaiaMY , GadetskaiaEV , MarkovAA , IvanovaYA , AftanasLI . Six day combined partial wake and light therapy for unipolar depression. European Neuropsychopharmacology2019;29:S410‐11. DanilenkoKV , LebedinskaiaMY , GadetskaiaEV , MarkovAA , IvanovaYA , AftanasLI . A 6-day combined wake and light therapy trial for unipolar depression. Journal of Affective Disorders2019;259:355-61. ">Danilenko 2019</a>; <a href="./references#CD013244-bbs2-0010" title="HenriksenTE , SkredeS , FasmerOB , SchoeyenH , LeskauskaiteI , Bjørke-BertheussenJ , et al. Blue-blocking glasses as additive treatment for mania: a randomized placebo-controlled trial. Bipolar Disorders2016;18(3):221‐32. ">Henriksen 2016</a>; <a href="./references#CD013244-bbs2-0109" title="JankuK , SmotekM , FarkovaE , KoprivovaJ . Block the light and sleep well: Evening blue light filtration as a part of cognitive behavioral therapy for insomnia. Chronobiology International2020;37(2):248-59.">Janku 2020</a>; <a href="./references#CD013244-bbs2-0013" title="KnufinkeM , Fittkau-KochL , MøstEI , KompierMA , NieuwenhuysA . Restricting short-wavelength light in the evening to improve sleep in recreational athletes - A pilot study. European Journal of Sport Science2019;19(6):728‐35. ">Knufinke 2019</a>; <a href="./references#CD013244-bbs2-0014" title="LinJB , GerrattBW , BassiCJ , ApteRS . Short-wavelength light-blocking eyeglasses attenuate symptoms of eye fatigue. Investigative Ophthalmology and Visual Science2017;58(1):442‐7. ">Lin 2017</a>; <a href="./references#CD013244-bbs2-0015" title="Perez AlgortaG , Van MeterA , DubickaB , JonesS , YoungstromE , LobbanF . Blue blocking glasses worn at night in first year higher education students with sleep complaints: a feasibility study. Pilot and Feasibility Studies2018;4:166. ">Perez Algorta 2018</a>). We considered one other study to have an unclear risk of bias, as the study commenced recruitment in February 2012 but only registered the study protocol in March 2013 (<a href="./references#CD013244-bbs2-0011" title="HenriksenTEG , GrønliJ , AssmusJ , FasmerOB , SchoeyenH , LeskauskaiteI , et al. Blue-blocking glasses as additive treatment for mania: Effects on actigraphy-derived sleep parameters. Journal of Sleep Research2020;29(5):e12984. [DOI: 10.1111/jsr.12984]">Henriksen 2020</a>). We judged four trials to have a low risk of reporting bias as they reported all the prespecified study protocol outcomes in the final published paper (<a href="./references#CD013244-bbs2-0007" title="EsakiY , KitajimaT , TakeuchiI , TsuboiS , FurukawaO , MoriwakiM , et al. Effect of blue-blocking glasses in major depressive disorder with sleep onset insomnia: a randomized, double-blind, placebo-controlled study. Chronobiology international2017;34(6):753‐61. ">Esaki 2017</a>; <a href="./references#CD013244-bbs2-0008" title="EsakiY , TakeuchiI , TsuboiS , FujitaK , IwataN , KitajimaT . A double-blind, randomized, placebo-controlled trial of adjunctive blue-blocking glasses for the treatment of sleep and circadian rhythm in patients with bipolar disorder. Bipolar Disorders2020;22(7):739-48. ">Esaki 2020</a>; <a href="./references#CD013244-bbs2-0016" title="ShechterA , KimEW , St-OngeMP , WestwoodAJ . Blocking nocturnal blue light for insomnia: a randomized controlled trial. Journal of Psychiatric Research2018;96:196‐202. ">Shechter 2018</a>; <a href="./references#CD013244-bbs2-0017" title="SinghS , DownieLE , AndersonAJ . Do blue-blocking lenses reduce eye strain from extended screen time? A double-masked, randomized controlled trial. American Journal of Ophthalmology2021;226:243–51. [DOI: 10.1016/j.ajo.2021.02.010]">Singh 2021</a>). We judged one trial to be at high risk of reporting bias, as a "glare disability threshold" outcome was reported in the final published paper but not mentioned in the prior registered study protocol (<a href="./references#CD013244-bbs2-0009" title="Hammond, BR. Attenuating photostress and glare disability in pseudophakic patients through the addition of a short-wave absorbing filter. Journal of Ophthalmology2015;2015:Article ID 607635. [DOI: 10.1155/2015/607635]NCT01938989. Effect of blue light filtration on visual performance. clinicaltrials.gov/ct2/show/NCT01938989 (first received 11 September 2013). ">Hammond 2015</a>). </p> </section> <section id="CD013244-sec-0063"> <h4 class="title">Other potential sources of bias</h4> <p>No other potential sources of bias were identified in 13 trials (<a href="./references#CD013244-bbs2-0002" title="AlzahranHS , RoyM , HonsonV , KhuuSK . Effect of blue-blocking lenses on colour contrast sensitivity. Clinical and Experimental Optometry2021;104(2):207-14. ">Alzahrani 2021</a>; <a href="./references#CD013244-bbs2-0001" title="AlzahraniHS , KhuuSK , AliA , RoyM . The effect of blue-blocking lenses on photostress recovery times. Optometry and Vision Science2020;97(11):995-1004. ">Alzahrani 2020</a>; <a href="./references#CD013244-bbs2-0003" title="BigalkeJA , GreenlundIM , NicevskiJR , CarterJR . Effect of evening blue light blocking glasses on subjective and objective sleep in healthy adults: a randomized control trial. Sleep Health2021;7(4):485–90. ">Bigalke 2021</a>; <a href="./references#CD013244-bbs2-0005" title="DabrowieckiA , VillalobosA , KrupinskiEA . Impact of blue light filtering glasses on computer vision syndrome in radiology residents: a pilot study. Journal of Medical Imaging2020;7(2):022402. ">Dabrowiecki 2020</a>; <a href="./references#CD013244-bbs2-0006" title="DanilenkoK , LebedinskaiaMY , GadetskaiaEV , MarkovAA , IvanovaYA , AftanasLI . Six day combined partial wake and light therapy for unipolar depression. European Neuropsychopharmacology2019;29:S410‐11. DanilenkoKV , LebedinskaiaMY , GadetskaiaEV , MarkovAA , IvanovaYA , AftanasLI . A 6-day combined wake and light therapy trial for unipolar depression. Journal of Affective Disorders2019;259:355-61. ">Danilenko 2019</a>; <a href="./references#CD013244-bbs2-0008" title="EsakiY , TakeuchiI , TsuboiS , FujitaK , IwataN , KitajimaT . A double-blind, randomized, placebo-controlled trial of adjunctive blue-blocking glasses for the treatment of sleep and circadian rhythm in patients with bipolar disorder. Bipolar Disorders2020;22(7):739-48. ">Esaki 2020</a>; <a href="./references#CD013244-bbs2-0009" title="Hammond, BR. Attenuating photostress and glare disability in pseudophakic patients through the addition of a short-wave absorbing filter. Journal of Ophthalmology2015;2015:Article ID 607635. [DOI: 10.1155/2015/607635]NCT01938989. Effect of blue light filtration on visual performance. clinicaltrials.gov/ct2/show/NCT01938989 (first received 11 September 2013). ">Hammond 2015</a>; <a href="./references#CD013244-bbs2-0011" title="HenriksenTEG , GrønliJ , AssmusJ , FasmerOB , SchoeyenH , LeskauskaiteI , et al. Blue-blocking glasses as additive treatment for mania: Effects on actigraphy-derived sleep parameters. Journal of Sleep Research2020;29(5):e12984. [DOI: 10.1111/jsr.12984]">Henriksen 2020</a>; <a href="./references#CD013244-bbs2-0012" title="JankuK , SmotekM , FarkovaE , KoprivovaJ . Block the light and sleep well: Evening blue light filtration as a part of cognitive behavioral therapy for insomnia. Chronobiology International2020;37(2):248-59. JankuK , SmotekM , FarkovaE , MiletínováE , KoprivovaJ . Blue light blocking glasses and CBT-I: effect on subjective and objective sleep quality. Sleep Medicine2019;64(Suppl 1):S174. ">Janku 2020</a>; <a href="./references#CD013244-bbs2-0014" title="LinJB , GerrattBW , BassiCJ , ApteRS . Short-wavelength light-blocking eyeglasses attenuate symptoms of eye fatigue. Investigative Ophthalmology and Visual Science2017;58(1):442‐7. ">Lin 2017</a>; <a href="./references#CD013244-bbs2-0015" title="Perez AlgortaG , Van MeterA , DubickaB , JonesS , YoungstromE , LobbanF . Blue blocking glasses worn at night in first year higher education students with sleep complaints: a feasibility study. Pilot and Feasibility Studies2018;4:166. ">Perez Algorta 2018</a>; <a href="./references#CD013244-bbs2-0016" title="ShechterA , KimEW , St-OngeMP , WestwoodAJ . Blocking nocturnal blue light for insomnia: a randomized controlled trial. Journal of Psychiatric Research2018;96:196‐202. ">Shechter 2018</a>; <a href="./references#CD013244-bbs2-0017" title="SinghS , DownieLE , AndersonAJ . Do blue-blocking lenses reduce eye strain from extended screen time? A double-masked, randomized controlled trial. American Journal of Ophthalmology2021;226:243–51. [DOI: 10.1016/j.ajo.2021.02.010]">Singh 2021</a>). Two trials had an unclear risk of 'other' sources of bias (<a href="./references#CD013244-bbs2-0010" title="HenriksenTE , SkredeS , FasmerOB , SchoeyenH , LeskauskaiteI , Bjørke-BertheussenJ , et al. Blue-blocking glasses as additive treatment for mania: a randomized placebo-controlled trial. Bipolar Disorders2016;18(3):221‐32. ">Henriksen 2016</a>; <a href="./references#CD013244-bbs2-0013" title="KnufinkeM , Fittkau-KochL , MøstEI , KompierMA , NieuwenhuysA . Restricting short-wavelength light in the evening to improve sleep in recreational athletes - A pilot study. European Journal of Sport Science2019;19(6):728‐35. ">Knufinke 2019</a>). <a href="./references#CD013244-bbs2-0010" title="HenriksenTE , SkredeS , FasmerOB , SchoeyenH , LeskauskaiteI , Bjørke-BertheussenJ , et al. Blue-blocking glasses as additive treatment for mania: a randomized placebo-controlled trial. Bipolar Disorders2016;18(3):221‐32. ">Henriksen 2016</a> stopped early due to growing public awareness on blue‐light filtering lenses. In <a href="./references#CD013244-bbs2-0013" title="KnufinkeM , Fittkau-KochL , MøstEI , KompierMA , NieuwenhuysA . Restricting short-wavelength light in the evening to improve sleep in recreational athletes - A pilot study. European Journal of Sport Science2019;19(6):728‐35. ">Knufinke 2019</a>, the effects of allowing only a one‐day washout period for one of the study intervention groups (light‐emitting goggles) was unclear, resulting in lack of complete information to judge this domain. We considered two trials to be at high risk of 'other' potential sources of bias due to reported significant baseline differences between the participant groups that might have impacted the overall study findings (<a href="./references#CD013244-bbs2-0004" title="BurkhartK , PhelpsJR . Amber lenses to block blue light and improve sleep: a randomized trial. Chronobiology International2009;26(8):1602‐12. ">Burkhart 2009</a>; <a href="./references#CD013244-bbs2-0007" title="EsakiY , KitajimaT , TakeuchiI , TsuboiS , FurukawaO , MoriwakiM , et al. Effect of blue-blocking glasses in major depressive disorder with sleep onset insomnia: a randomized, double-blind, placebo-controlled study. Chronobiology international2017;34(6):753‐61. ">Esaki 2017</a>). </p> </section> </section> <section id="CD013244-sec-0064"> <h3 class="title" id="CD013244-sec-0064">Effects of interventions</h3> <p>See: <a href="./full#CD013244-tbl-0001"><b>Summary of findings 1</b> Summary of findings 1: blue‐light filtering lenses compared to non‐blue‐light filtering lenses</a> </p> <p>See: <a href="./full#CD013244-tbl-0001">summary of findings Table 1</a> for the main comparison of blue‐light filtering lenses compared to non‐blue‐light filtering lenses for prespecified outcomes. </p> <section id="CD013244-sec-0065"> <h4 class="title">Primary outcome: change in visual fatigue or discomfort scores</h4> <p>Three trials reported data relating to visual fatigue or discomfort scores, with follow‐up periods ranging from less than one day (<a href="./references#CD013244-bbs2-0014" title="LinJB , GerrattBW , BassiCJ , ApteRS . Short-wavelength light-blocking eyeglasses attenuate symptoms of eye fatigue. Investigative Ophthalmology and Visual Science2017;58(1):442‐7. ">Lin 2017</a>; <a href="./references#CD013244-bbs2-0017" title="SinghS , DownieLE , AndersonAJ . Do blue-blocking lenses reduce eye strain from extended screen time? A double-masked, randomized controlled trial. American Journal of Ophthalmology2021;226:243–51. [DOI: 10.1016/j.ajo.2021.02.010]">Singh 2021</a>) to five days (<a href="./references#CD013244-bbs2-0005" title="DabrowieckiA , VillalobosA , KrupinskiEA . Impact of blue light filtering glasses on computer vision syndrome in radiology residents: a pilot study. Journal of Medical Imaging2020;7(2):022402. ">Dabrowiecki 2020</a>). These three trials included both parallel‐arm (<a href="./references#CD013244-bbs2-0014" title="LinJB , GerrattBW , BassiCJ , ApteRS . Short-wavelength light-blocking eyeglasses attenuate symptoms of eye fatigue. Investigative Ophthalmology and Visual Science2017;58(1):442‐7. ">Lin 2017</a>; <a href="./references#CD013244-bbs2-0017" title="SinghS , DownieLE , AndersonAJ . Do blue-blocking lenses reduce eye strain from extended screen time? A double-masked, randomized controlled trial. American Journal of Ophthalmology2021;226:243–51. [DOI: 10.1016/j.ajo.2021.02.010]">Singh 2021</a>) and cross‐over designs (<a href="./references#CD013244-bbs2-0005" title="DabrowieckiA , VillalobosA , KrupinskiEA . Impact of blue light filtering glasses on computer vision syndrome in radiology residents: a pilot study. Journal of Medical Imaging2020;7(2):022402. ">Dabrowiecki 2020</a>). Two trials reported change form baseline data (<a href="./references#CD013244-bbs2-0014" title="LinJB , GerrattBW , BassiCJ , ApteRS . Short-wavelength light-blocking eyeglasses attenuate symptoms of eye fatigue. Investigative Ophthalmology and Visual Science2017;58(1):442‐7. ">Lin 2017</a>; <a href="./references#CD013244-bbs2-0017" title="SinghS , DownieLE , AndersonAJ . Do blue-blocking lenses reduce eye strain from extended screen time? A double-masked, randomized controlled trial. American Journal of Ophthalmology2021;226:243–51. [DOI: 10.1016/j.ajo.2021.02.010]">Singh 2021</a>), and one study reported the average daily change in visual fatigue scores over the quantified five‐day period (<a href="./references#CD013244-bbs2-0005" title="DabrowieckiA , VillalobosA , KrupinskiEA . Impact of blue light filtering glasses on computer vision syndrome in radiology residents: a pilot study. Journal of Medical Imaging2020;7(2):022402. ">Dabrowiecki 2020</a>). Measurement tools included both Likert scales (<a href="./references#CD013244-bbs2-0005" title="DabrowieckiA , VillalobosA , KrupinskiEA . Impact of blue light filtering glasses on computer vision syndrome in radiology residents: a pilot study. Journal of Medical Imaging2020;7(2):022402. ">Dabrowiecki 2020</a>; <a href="./references#CD013244-bbs2-0014" title="LinJB , GerrattBW , BassiCJ , ApteRS . Short-wavelength light-blocking eyeglasses attenuate symptoms of eye fatigue. Investigative Ophthalmology and Visual Science2017;58(1):442‐7. ">Lin 2017</a>) and a visual analogue scale (<a href="./references#CD013244-bbs2-0017" title="SinghS , DownieLE , AndersonAJ . Do blue-blocking lenses reduce eye strain from extended screen time? A double-masked, randomized controlled trial. American Journal of Ophthalmology2021;226:243–51. [DOI: 10.1016/j.ajo.2021.02.010]">Singh 2021</a>). The participant eligibility criteria differed between the studies, involving the recruitment of healthy volunteers (<a href="./references#CD013244-bbs2-0014" title="LinJB , GerrattBW , BassiCJ , ApteRS . Short-wavelength light-blocking eyeglasses attenuate symptoms of eye fatigue. Investigative Ophthalmology and Visual Science2017;58(1):442‐7. ">Lin 2017</a>), symptomatic computer users (<a href="./references#CD013244-bbs2-0017" title="SinghS , DownieLE , AndersonAJ . Do blue-blocking lenses reduce eye strain from extended screen time? A double-masked, randomized controlled trial. American Journal of Ophthalmology2021;226:243–51. [DOI: 10.1016/j.ajo.2021.02.010]">Singh 2021</a>), and radiology residents (<a href="./references#CD013244-bbs2-0005" title="DabrowieckiA , VillalobosA , KrupinskiEA . Impact of blue light filtering glasses on computer vision syndrome in radiology residents: a pilot study. Journal of Medical Imaging2020;7(2):022402. ">Dabrowiecki 2020</a>). The unit of analysis was per participant for all three trials. </p> <p>We did not conduct a meta‐analysis as only one study reported quantitative data that could be used to calculate the effect size of interest (<a href="./references#CD013244-bbs2-0017" title="SinghS , DownieLE , AndersonAJ . Do blue-blocking lenses reduce eye strain from extended screen time? A double-masked, randomized controlled trial. American Journal of Ophthalmology2021;226:243–51. [DOI: 10.1016/j.ajo.2021.02.010]">Singh 2021</a>). <a href="./references#CD013244-bbs2-0017" title="SinghS , DownieLE , AndersonAJ . Do blue-blocking lenses reduce eye strain from extended screen time? A double-masked, randomized controlled trial. American Journal of Ophthalmology2021;226:243–51. [DOI: 10.1016/j.ajo.2021.02.010]">Singh 2021</a> reported no significant difference for the change in subjective visual fatigue scores among symptomatic computer users, measured as the change pre‐ and post‐computer task (two hours) with blue‐light filtering lenses compared to non‐blue‐light filtering lenses (mean difference (MD) 9.76 units, 95% confidence interval (CI) ‐33.95 to 53.47 units; P = 0.66; 120 participants). One trial that included 36 participants reported no significant difference between intervention arms for the change in visual fatigue score, but did not provide quantitative data (<a href="./references#CD013244-bbs2-0014" title="LinJB , GerrattBW , BassiCJ , ApteRS . Short-wavelength light-blocking eyeglasses attenuate symptoms of eye fatigue. Investigative Ophthalmology and Visual Science2017;58(1):442‐7. ">Lin 2017</a>). The third trial included 10 participants and reported no change for the average daily change in visual fatigue score with blue‐light filtering lenses compared to non‐blue‐light filtering lenses (<a href="./references#CD013244-bbs2-0005" title="DabrowieckiA , VillalobosA , KrupinskiEA . Impact of blue light filtering glasses on computer vision syndrome in radiology residents: a pilot study. Journal of Medical Imaging2020;7(2):022402. ">Dabrowiecki 2020</a>). </p> <p>We used the GRADE approach to judge the certainty of the body of evidence for this outcome and downgraded the certainty by two levels to low, as in two studies participant/personnel or outcome assessors were not masked, and one study had wide confidence intervals (<a href="./references#CD013244-bbs2-0017" title="SinghS , DownieLE , AndersonAJ . Do blue-blocking lenses reduce eye strain from extended screen time? A double-masked, randomized controlled trial. American Journal of Ophthalmology2021;226:243–51. [DOI: 10.1016/j.ajo.2021.02.010]">Singh 2021</a>). </p> </section> <section id="CD013244-sec-0066"> <h4 class="title">Primary outcome: change in CFF</h4> <p>Two trials reported data related to the change in CFF, with a follow‐up of less than one day (<a href="./references#CD013244-bbs2-0014" title="LinJB , GerrattBW , BassiCJ , ApteRS . Short-wavelength light-blocking eyeglasses attenuate symptoms of eye fatigue. Investigative Ophthalmology and Visual Science2017;58(1):442‐7. ">Lin 2017</a>; <a href="./references#CD013244-bbs2-0017" title="SinghS , DownieLE , AndersonAJ . Do blue-blocking lenses reduce eye strain from extended screen time? A double-masked, randomized controlled trial. American Journal of Ophthalmology2021;226:243–51. [DOI: 10.1016/j.ajo.2021.02.010]">Singh 2021</a>). Both trials used a parallel‐arm design. One trial recruited healthy participants (<a href="./references#CD013244-bbs2-0014" title="LinJB , GerrattBW , BassiCJ , ApteRS . Short-wavelength light-blocking eyeglasses attenuate symptoms of eye fatigue. Investigative Ophthalmology and Visual Science2017;58(1):442‐7. ">Lin 2017</a>) and the other recruited symptomatic computer users (<a href="./references#CD013244-bbs2-0017" title="SinghS , DownieLE , AndersonAJ . Do blue-blocking lenses reduce eye strain from extended screen time? A double-masked, randomized controlled trial. American Journal of Ophthalmology2021;226:243–51. [DOI: 10.1016/j.ajo.2021.02.010]">Singh 2021</a>). The unit of analysis was per participant for both trials. <a href="./references#CD013244-bbs2-0017" title="SinghS , DownieLE , AndersonAJ . Do blue-blocking lenses reduce eye strain from extended screen time? A double-masked, randomized controlled trial. American Journal of Ophthalmology2021;226:243–51. [DOI: 10.1016/j.ajo.2021.02.010]">Singh 2021</a> reported no change in CFF with blue‐light filtering lenses compared to non‐blue‐light filtering lenses (MD ‐1.13 Hz, 95% CI, ‐3.00 to 0.74 Hz; P = 0.24). <a href="./references#CD013244-bbs2-0014" title="LinJB , GerrattBW , BassiCJ , ApteRS . Short-wavelength light-blocking eyeglasses attenuate symptoms of eye fatigue. Investigative Ophthalmology and Visual Science2017;58(1):442‐7. ">Lin 2017</a>, involving 36 participants, described a significant difference between 'high' blue‐light filtering lenses compared to both 'low' blue‐light filtering (P = 0.008) and non‐blue‐light filtering lenses (P = 0.027). However, this trial did not report quantitative data (<a href="./references#CD013244-bbs2-0014" title="LinJB , GerrattBW , BassiCJ , ApteRS . Short-wavelength light-blocking eyeglasses attenuate symptoms of eye fatigue. Investigative Ophthalmology and Visual Science2017;58(1):442‐7. ">Lin 2017</a>). </p> <p>We judged the certainty of evidence as low for this outcome, downgrading by one level each for inconsistency of results (as one study reported no significant intergroup differences and one study reported a positive effect with 'high' block blue‐light filtering lenses), and risk of bias (as one study was at high risk of bias in the domain relating to masking of study participant and personnel). </p> </section> <section id="CD013244-sec-0067"> <h4 class="title">Secondary outcome: change in BCVA</h4> <p>One cross‐over trial reported findings relevant to the measure of BCVA, measured in logMAR units without glare conditions (<a href="./references#CD013244-bbs2-0009" title="Hammond, BR. Attenuating photostress and glare disability in pseudophakic patients through the addition of a short-wave absorbing filter. Journal of Ophthalmology2015;2015:Article ID 607635. [DOI: 10.1155/2015/607635]NCT01938989. Effect of blue light filtration on visual performance. clinicaltrials.gov/ct2/show/NCT01938989 (first received 11 September 2013). ">Hammond 2015</a>). This trial included 156 bilateral pseudophakic participants, and the unit of analysis was a single eye. The follow‐up period of this study was unclear. The trial reported no difference in logMAR BCVA between blue‐light filtering lenses and non‐blue‐light filtering lenses (MD 0.00, 95% CI ‐0.02 to 0.02 log units; P = 0.86). These results should be interpreted with caution as the study did not report the total number of participants included/excluded for this outcome measure; we made the assumption that all recruited participants completed the study. </p> <p>We judged the certainty of evidence for this outcome as moderate using GRADE, and downgraded by one level for risk of bias as the study outcome assessor was not masked in the study that assessed this outcome. </p> </section> <section id="CD013244-sec-0068"> <h4 class="title">Secondary outcome: change in contrast sensitivity</h4> <p>None of the 17 included trials provided data related to contrast sensitivity.</p> </section> <section id="CD013244-sec-0069"> <h4 class="title">Secondary outcome: change in discomfort glare</h4> <p>None of the 17 included trials provided data related to discomfort glare.</p> </section> <section id="CD013244-sec-0070"> <h4 class="title">Secondary outcome: proportion of eyes, or individuals, with a finding of pathological structural change at the macula </h4> <p>None of the 17 included trials reported on macular structural changes.</p> </section> <section id="CD013244-sec-0071"> <h4 class="title">Secondary outcome: change in colour discrimination</h4> <p>None of the 17 included trials provided data related to colour discrimination.</p> </section> <section id="CD013244-sec-0072"> <h4 class="title">Secondary outcome: daytime alertness, considered as the proportion of participants who had reduced daytime alertness </h4> <p>None of the included trials described the proportion of participants who had reduced daytime alertness. However, two studies measured alertness using Likert scale‐based questionnaires (<a href="./references#CD013244-bbs2-0109" title="JankuK , SmotekM , FarkovaE , KoprivovaJ . Block the light and sleep well: Evening blue light filtration as a part of cognitive behavioral therapy for insomnia. Chronobiology International2020;37(2):248-59.">Janku 2020</a>; <a href="./references#CD013244-bbs2-0013" title="KnufinkeM , Fittkau-KochL , MøstEI , KompierMA , NieuwenhuysA . Restricting short-wavelength light in the evening to improve sleep in recreational athletes - A pilot study. European Journal of Sport Science2019;19(6):728‐35. ">Knufinke 2019</a>); one used a cross‐over design (<a href="./references#CD013244-bbs2-0013" title="KnufinkeM , Fittkau-KochL , MøstEI , KompierMA , NieuwenhuysA . Restricting short-wavelength light in the evening to improve sleep in recreational athletes - A pilot study. European Journal of Sport Science2019;19(6):728‐35. ">Knufinke 2019</a>) and the other used a parallel‐group design (<a href="./references#CD013244-bbs2-0109" title="JankuK , SmotekM , FarkovaE , KoprivovaJ . Block the light and sleep well: Evening blue light filtration as a part of cognitive behavioral therapy for insomnia. Chronobiology International2020;37(2):248-59.">Janku 2020</a>). </p> <p><a href="./references#CD013244-bbs2-0109" title="JankuK , SmotekM , FarkovaE , KoprivovaJ . Block the light and sleep well: Evening blue light filtration as a part of cognitive behavioral therapy for insomnia. Chronobiology International2020;37(2):248-59.">Janku 2020</a>, involving 27 people diagnosed with insomnia, measured the change in daytime alertness using the Hyperarousal Scale (HAS), with scores ranging between 0 and 73 (scores above 40 indicate increased arousal levels). This trial reported no difference in HAS scores between participants using blue‐light filtering and non‐blue‐light filtering lenses over five weeks (MD 1.24 units 95% CI ‐4.93 to 7.41 units; P = 0.69). </p> <p>The cross‐over trial by <a href="./references#CD013244-bbs2-0013" title="KnufinkeM , Fittkau-KochL , MøstEI , KompierMA , NieuwenhuysA . Restricting short-wavelength light in the evening to improve sleep in recreational athletes - A pilot study. European Journal of Sport Science2019;19(6):728‐35. ">Knufinke 2019</a> involved 15 recreational athletes and reported endpoint data for morning and evening alertness, measured using the Karolinska Sleepiness Scale (KSS), with scores ranging from 0 to 9 (higher scores indicating higher sleepiness). This trial reported no significant difference in the average daily change for both morning and evening alertness scores, measured between blue‐light filtering and non‐blue‐light filtering lenses. However, this trial did not report change from baseline or endpoint outcome data. </p> <p>We judged the GRADE certainty of evidence as very low and downgraded by three levels for risk of bias and imprecision, as in one study the participants and personnel were not masked, and in another study the study participants, personnel, and outcome assessor(s) were not masked. Both studies had small sample sizes. </p> </section> <section id="CD013244-sec-0073"> <h4 class="title">Secondary outcome: change in serum melatonin levels</h4> <p>None of the 17 included trials provided information related to serum melatonin levels.</p> </section> <section id="CD013244-sec-0074"> <h4 class="title">Secondary outcome: sleep quality</h4> <p>Six trials reported findings related to subjective sleep quality (<a href="./references#CD013244-bbs2-0004" title="BurkhartK , PhelpsJR . Amber lenses to block blue light and improve sleep: a randomized trial. Chronobiology International2009;26(8):1602‐12. ">Burkhart 2009</a>; <a href="./references#CD013244-bbs2-0007" title="EsakiY , KitajimaT , TakeuchiI , TsuboiS , FurukawaO , MoriwakiM , et al. Effect of blue-blocking glasses in major depressive disorder with sleep onset insomnia: a randomized, double-blind, placebo-controlled study. Chronobiology international2017;34(6):753‐61. ">Esaki 2017</a>; <a href="./references#CD013244-bbs2-0008" title="EsakiY , TakeuchiI , TsuboiS , FujitaK , IwataN , KitajimaT . A double-blind, randomized, placebo-controlled trial of adjunctive blue-blocking glasses for the treatment of sleep and circadian rhythm in patients with bipolar disorder. Bipolar Disorders2020;22(7):739-48. ">Esaki 2020</a>; <a href="./references#CD013244-bbs2-0109" title="JankuK , SmotekM , FarkovaE , KoprivovaJ . Block the light and sleep well: Evening blue light filtration as a part of cognitive behavioral therapy for insomnia. Chronobiology International2020;37(2):248-59.">Janku 2020</a>; <a href="./references#CD013244-bbs2-0013" title="KnufinkeM , Fittkau-KochL , MøstEI , KompierMA , NieuwenhuysA . Restricting short-wavelength light in the evening to improve sleep in recreational athletes - A pilot study. European Journal of Sport Science2019;19(6):728‐35. ">Knufinke 2019</a>; <a href="./references#CD013244-bbs2-0016" title="ShechterA , KimEW , St-OngeMP , WestwoodAJ . Blocking nocturnal blue light for insomnia: a randomized controlled trial. Journal of Psychiatric Research2018;96:196‐202. ">Shechter 2018</a>). Together, these studies involved 148 participants with heterogeneous characteristics, and measured subjective sleep quality using a visual analogue scale or Likert scale‐based questionnaire. The recruited study populations included recreational athletes (<a href="./references#CD013244-bbs2-0013" title="KnufinkeM , Fittkau-KochL , MøstEI , KompierMA , NieuwenhuysA . Restricting short-wavelength light in the evening to improve sleep in recreational athletes - A pilot study. European Journal of Sport Science2019;19(6):728‐35. ">Knufinke 2019</a>), participants with sleep difficulty (<a href="./references#CD013244-bbs2-0004" title="BurkhartK , PhelpsJR . Amber lenses to block blue light and improve sleep: a randomized trial. Chronobiology International2009;26(8):1602‐12. ">Burkhart 2009</a>), participants with chronic insomnia symptoms (<a href="./references#CD013244-bbs2-0016" title="ShechterA , KimEW , St-OngeMP , WestwoodAJ . Blocking nocturnal blue light for insomnia: a randomized controlled trial. Journal of Psychiatric Research2018;96:196‐202. ">Shechter 2018</a>), participants with a bipolar disorder diagnosis (<a href="./references#CD013244-bbs2-0008" title="EsakiY , TakeuchiI , TsuboiS , FujitaK , IwataN , KitajimaT . A double-blind, randomized, placebo-controlled trial of adjunctive blue-blocking glasses for the treatment of sleep and circadian rhythm in patients with bipolar disorder. Bipolar Disorders2020;22(7):739-48. ">Esaki 2020</a>), participants with an insomnia diagnosis (<a href="./references#CD013244-bbs2-0109" title="JankuK , SmotekM , FarkovaE , KoprivovaJ . Block the light and sleep well: Evening blue light filtration as a part of cognitive behavioral therapy for insomnia. Chronobiology International2020;37(2):248-59.">Janku 2020</a>), and participants with major depressive disorder and sleep onset insomnia (<a href="./references#CD013244-bbs2-0007" title="EsakiY , KitajimaT , TakeuchiI , TsuboiS , FurukawaO , MoriwakiM , et al. Effect of blue-blocking glasses in major depressive disorder with sleep onset insomnia: a randomized, double-blind, placebo-controlled study. Chronobiology international2017;34(6):753‐61. ">Esaki 2017</a>). Trial follow‐up periods ranged from one week (<a href="./references#CD013244-bbs2-0016" title="ShechterA , KimEW , St-OngeMP , WestwoodAJ . Blocking nocturnal blue light for insomnia: a randomized controlled trial. Journal of Psychiatric Research2018;96:196‐202. ">Shechter 2018</a>) to five weeks (<a href="./references#CD013244-bbs2-0109" title="JankuK , SmotekM , FarkovaE , KoprivovaJ . Block the light and sleep well: Evening blue light filtration as a part of cognitive behavioral therapy for insomnia. Chronobiology International2020;37(2):248-59.">Janku 2020</a>). </p> <p>Three studies provided quantitative data related to sleep quality (<a href="./references#CD013244-bbs2-0007" title="EsakiY , KitajimaT , TakeuchiI , TsuboiS , FurukawaO , MoriwakiM , et al. Effect of blue-blocking glasses in major depressive disorder with sleep onset insomnia: a randomized, double-blind, placebo-controlled study. Chronobiology international2017;34(6):753‐61. ">Esaki 2017</a>; <a href="./references#CD013244-bbs2-0008" title="EsakiY , TakeuchiI , TsuboiS , FujitaK , IwataN , KitajimaT . A double-blind, randomized, placebo-controlled trial of adjunctive blue-blocking glasses for the treatment of sleep and circadian rhythm in patients with bipolar disorder. Bipolar Disorders2020;22(7):739-48. ">Esaki 2020</a>; <a href="./references#CD013244-bbs2-0109" title="JankuK , SmotekM , FarkovaE , KoprivovaJ . Block the light and sleep well: Evening blue light filtration as a part of cognitive behavioral therapy for insomnia. Chronobiology International2020;37(2):248-59.">Janku 2020</a>). We did not perform a meta‐analysis as the study population and follow‐up periods varied between these studies. The key outcomes of the studies that reported subjective sleep quality are as follows. </p> <p> <ul id="CD013244-list-0009"> <li> <p><a href="./references#CD013244-bbs2-0007" title="EsakiY , KitajimaT , TakeuchiI , TsuboiS , FurukawaO , MoriwakiM , et al. Effect of blue-blocking glasses in major depressive disorder with sleep onset insomnia: a randomized, double-blind, placebo-controlled study. Chronobiology international2017;34(6):753‐61. ">Esaki 2017</a>, involving 20 participants with major depressive disorder and sleep onset insomnia, reported no significant difference for the change in subjective sleep quality measured using a visual analogue scale (0 = good sleep to 100 = poor sleep) at two weeks of follow‐up, with blue‐light filtering lenses compared to non‐blue‐light filtering lenses (MD 19.90 units, 95% CI ‐1.86 to 41.66 units; P = 0.07). </p> </li> <li> <p><a href="./references#CD013244-bbs2-0008" title="EsakiY , TakeuchiI , TsuboiS , FujitaK , IwataN , KitajimaT . A double-blind, randomized, placebo-controlled trial of adjunctive blue-blocking glasses for the treatment of sleep and circadian rhythm in patients with bipolar disorder. Bipolar Disorders2020;22(7):739-48. ">Esaki 2020</a>, involving 43 participants with bipolar disorder, measured the change in subjective sleep quality using a visual analogue scale (0 = good sleep to 100 = poor sleep), at two weeks of follow‐up, and reported no significant difference between blue‐light filtering lenses and non‐blue‐light filtering lenses (MD 8.90 units, 95% CI ‐6.13 to 23.93 units; P = 0.25). </p> </li> <li> <p><a href="./references#CD013244-bbs2-0012" title="JankuK , SmotekM , FarkovaE , KoprivovaJ . Block the light and sleep well: Evening blue light filtration as a part of cognitive behavioral therapy for insomnia. Chronobiology International2020;37(2):248-59. JankuK , SmotekM , FarkovaE , MiletínováE , KoprivovaJ . Blue light blocking glasses and CBT-I: effect on subjective and objective sleep quality. Sleep Medicine2019;64(Suppl 1):S174. ">Janku 2020</a>, involving 27 participants with insomnia, measured the change in subjective sleep quality after six weeks of follow‐up, using the Pittsburgh Sleep Quality Index (PSQI). The PSQI ranges from 0 to 21, and a score of six was defined as the cut‐off for significant insomnia symptoms. The study reported no significant difference between blue‐light filtering lenses compared to non‐blue‐light filtering lenses (MD 0.03 units, 95% CI ‐2.53 to 2.59 units; P = 0.98). </p> </li> <li> <p><a href="./references#CD013244-bbs2-0004" title="BurkhartK , PhelpsJR . Amber lenses to block blue light and improve sleep: a randomized trial. Chronobiology International2009;26(8):1602‐12. ">Burkhart 2009</a>, involving 20 participants with sleep difficulty, measured the change in subjective sleep quality using a Likert scale (0 = very poor sleep and 10 = good sleep) and reported a significant improvement in sleep quality with blue‐light filtering lenses compared to non‐blue‐light filtering lenses. This study presented the results in a figure and did not report the numeric data in the main text of the publication. </p> </li> <li> <p><a href="./references#CD013244-bbs2-0013" title="KnufinkeM , Fittkau-KochL , MøstEI , KompierMA , NieuwenhuysA . Restricting short-wavelength light in the evening to improve sleep in recreational athletes - A pilot study. European Journal of Sport Science2019;19(6):728‐35. ">Knufinke 2019</a>, involving 15 participants who were "recreational athletes", reported an improvement in the daily average change in subjective sleep scores measured over nine days with blue‐light filtering lenses compared to non‐blue‐light filtering lenses. This study did not report either the change from baseline or endpoint outcome data. </p> </li> <li> <p><a href="./references#CD013244-bbs2-0016" title="ShechterA , KimEW , St-OngeMP , WestwoodAJ . Blocking nocturnal blue light for insomnia: a randomized controlled trial. Journal of Psychiatric Research2018;96:196‐202. ">Shechter 2018</a>, involving 15 participants with chronic insomnia symptoms, measured the daily average change in subjective sleep scores over one week, and reported an improvement in subjective sleep with blue‐light filtering lenses compared to non‐blue‐light filtering lenses. This study did not report change from baseline or endpoint data. </p> </li> </ul> </p> <p>We judged the GRADE certainty of evidence as very low for this outcome and downgraded by three levels for risk of bias, as in four studies participants and study personnel were not masked, and in three studies outcome assessors were not masked. Two studies had other risks of bias due to significant baseline imbalances between participant groups. Further, the included studies had small sample sizes and reported variable findings. </p> </section> <section id="CD013244-sec-0075"> <h4 class="title">Secondary outcome: overall patient satisfaction with their visual performance</h4> <p>None of the included trials provided information related to patient satisfaction with their visual performance. </p> </section> <section id="CD013244-sec-0076"> <h4 class="title">Adverse outcomes</h4> <p><a href="#CD013244-tbl-0003">Table 2</a> summarises adverse events as reported in the included studies. Five of the nine studies that assessed adverse events did not report any such events (<a href="./references#CD013244-bbs2-0004" title="BurkhartK , PhelpsJR . Amber lenses to block blue light and improve sleep: a randomized trial. Chronobiology International2009;26(8):1602‐12. ">Burkhart 2009</a>; <a href="./references#CD013244-bbs2-0109" title="JankuK , SmotekM , FarkovaE , KoprivovaJ . Block the light and sleep well: Evening blue light filtration as a part of cognitive behavioral therapy for insomnia. Chronobiology International2020;37(2):248-59.">Janku 2020</a>; <a href="./references#CD013244-bbs2-0015" title="Perez AlgortaG , Van MeterA , DubickaB , JonesS , YoungstromE , LobbanF . Blue blocking glasses worn at night in first year higher education students with sleep complaints: a feasibility study. Pilot and Feasibility Studies2018;4:166. ">Perez Algorta 2018</a>; <a href="./references#CD013244-bbs2-0016" title="ShechterA , KimEW , St-OngeMP , WestwoodAJ . Blocking nocturnal blue light for insomnia: a randomized controlled trial. Journal of Psychiatric Research2018;96:196‐202. ">Shechter 2018</a>; <a href="./references#CD013244-bbs2-0017" title="SinghS , DownieLE , AndersonAJ . Do blue-blocking lenses reduce eye strain from extended screen time? A double-masked, randomized controlled trial. American Journal of Ophthalmology2021;226:243–51. [DOI: 10.1016/j.ajo.2021.02.010]">Singh 2021</a>). The reported adverse events in the other included studies were as follows. </p> <p> <ul id="CD013244-list-0010"> <li> <p><a href="./references#CD013244-bbs2-0010" title="HenriksenTE , SkredeS , FasmerOB , SchoeyenH , LeskauskaiteI , Bjørke-BertheussenJ , et al. Blue-blocking glasses as additive treatment for mania: a randomized placebo-controlled trial. Bipolar Disorders2016;18(3):221‐32. ">Henriksen 2016</a> (n = 32) reported increased depressive symptoms (n = 2) and headache (n = 1) in participants assigned to the blue‐light filtering lens group. However, the authors did not explicitly state the proportion of adverse events in the non‐blue‐light filtering lens group. </p> </li> <li> <p><a href="./references#CD013244-bbs2-0007" title="EsakiY , KitajimaT , TakeuchiI , TsuboiS , FurukawaO , MoriwakiM , et al. Effect of blue-blocking glasses in major depressive disorder with sleep onset insomnia: a randomized, double-blind, placebo-controlled study. Chronobiology international2017;34(6):753‐61. ">Esaki 2017</a> (n = 20) reported pain or discomfort from wearing the spectacles across both the blue‐light filtering (n = 4) and non‐blue‐light filtering (n = 4) lens groups. However, the authors mentioned that the provided spectacles were of a single size, and concluded that the discomfort reported could be due to the spectacle frames, rather than the type of lenses, indicating the adverse events may not have been related to the study intervention itself. </p> </li> <li> <p><a href="./references#CD013244-bbs2-0006" title="DanilenkoK , LebedinskaiaMY , GadetskaiaEV , MarkovAA , IvanovaYA , AftanasLI . Six day combined partial wake and light therapy for unipolar depression. European Neuropsychopharmacology2019;29:S410‐11. DanilenkoKV , LebedinskaiaMY , GadetskaiaEV , MarkovAA , IvanovaYA , AftanasLI . A 6-day combined wake and light therapy trial for unipolar depression. Journal of Affective Disorders2019;259:355-61. ">Danilenko 2019</a> (n = 35) reported no adverse events in the blue‐light filtering lens group and that two participants in the non‐blue‐light filtering group were occasionally hyperthymic. </p> </li> <li> <p><a href="./references#CD013244-bbs2-0008" title="EsakiY , TakeuchiI , TsuboiS , FujitaK , IwataN , KitajimaT . A double-blind, randomized, placebo-controlled trial of adjunctive blue-blocking glasses for the treatment of sleep and circadian rhythm in patients with bipolar disorder. Bipolar Disorders2020;22(7):739-48. ">Esaki 2020</a> (n = 43) reported discomfort from wearing the glasses (n = 2), pain from the face contacting part of the glasses (n = 1), and lowered mood (n = 1) in the blue‐light filtering lens group. In the control group, participants reported discomfort from wearing the glasses (n = 3) and pain from the face contacting part of the glasses (n = 4). </p> </li> </ul> </p> <p>We judged the GRADE certainty of evidence for this outcome as low. It was downgraded by one level each for risk of bias and inconsistency, as in four studies participants, study personnel and outcome assessors were not masked, and two studies had an 'other' risk of bias due to baseline imbalance. Further, we noted variability in the reported adverse events across the studies. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD013244-sec-0077" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD013244-sec-0077"></div> <p>Blue‐light filtering spectacle lenses have been widely advertised by some members of the optical industry, with claims that they can reduce visual fatigue from digital device use, protect the macula, and improve sleep quality. The mechanism(s) by which these lenses might impart at least some of these effects remains unclear. Despite this, the prescribing rate of blue‐light filtering lenses among eye care practitioners has increased over the last decade (<a href="./references#CD013244-bbs2-0145" title="SinghS , DownieLE , AndersonAJ . Insights into Australian optometrists’ knowledge and attitude towards prescribing blue light‐blocking ophthalmic devices. Ophthalmic and Physiological Optics2019;39(3):194-204.">Singh 2019</a>). The primary objective of this systematic review was to assess the effects of blue‐light filtering spectacle lenses on eye strain, visual performance, macular health and sleep quality, in adult populations. </p> <section id="CD013244-sec-0078"> <h3 class="title" id="CD013244-sec-0078">Summary of main results</h3> <p>This review identified 17 eligible RCTs in which blue‐light filtering lenses were compared with non‐blue‐light filtering lenses. Individual study sample sizes ranged from five to 156 participants, with follow‐up periods ranging from less than one day to five weeks. The studies were conducted in six countries, and included diverse study populations, ranging from healthy adults through to those with significant health conditions (e.g. bipolar disorder, insomnia). Overall, there was no high‐certainty evidence for any of the prespecified outcome measures (see <a href="./full#CD013244-tbl-0001">summary of findings Table 1</a> for details). For risk of bias assessment, none of the included studies were judged to have 'low' risk of bias across all seven assessment domains. The two domains judged to have the lowest overall risk of bias across the included trials were 'incomplete outcome data' (attrition bias) and 'other potential sources of bias'. </p> <p>We did not perform meta‐analyses for any of the outcome measures due to a lack of available quantitative data in the study reports, heterogenous study populations, and the relatively short follow‐up period in most studies (i.e. less than two weeks) compared to the follow‐up period of interest defined in our protocol (being one month, with an acceptable range of between two weeks and three months). This highlights a research gap with respect to studies evaluating the longer‐term effects of blue‐light filtering spectacles, and led to the presentation of only descriptive syntheses in the present review. </p> <p>Information relating to the efficacy outcome measures were available for: change in visual fatigue scores (three trials), change in CFF (two trials), change in BCVA (one trial), proportion of participants with reduced daytime alertness (two trials), and change in subjective sleep quality (six trials). </p> <p>For the primary outcome measures, all three trials that investigated subjective visual fatigue reported no significant difference in symptoms with blue‐light filtering lenses compared to non‐blue‐light filtering lenses (<a href="./references#CD013244-bbs2-0005" title="DabrowieckiA , VillalobosA , KrupinskiEA . Impact of blue light filtering glasses on computer vision syndrome in radiology residents: a pilot study. Journal of Medical Imaging2020;7(2):022402. ">Dabrowiecki 2020</a>; <a href="./references#CD013244-bbs2-0014" title="LinJB , GerrattBW , BassiCJ , ApteRS . Short-wavelength light-blocking eyeglasses attenuate symptoms of eye fatigue. Investigative Ophthalmology and Visual Science2017;58(1):442‐7. ">Lin 2017</a>; <a href="./references#CD013244-bbs2-0017" title="SinghS , DownieLE , AndersonAJ . Do blue-blocking lenses reduce eye strain from extended screen time? A double-masked, randomized controlled trial. American Journal of Ophthalmology2021;226:243–51. [DOI: 10.1016/j.ajo.2021.02.010]">Singh 2021</a>). Of the two trials that investigated CFF, one double‐masked RCT involving 120 participants with computer vision syndrome, reported no significant difference between blue‐ and non‐blue‐light filtering spectacle interventions (<a href="./references#CD013244-bbs2-0017" title="SinghS , DownieLE , AndersonAJ . Do blue-blocking lenses reduce eye strain from extended screen time? A double-masked, randomized controlled trial. American Journal of Ophthalmology2021;226:243–51. [DOI: 10.1016/j.ajo.2021.02.010]">Singh 2021</a>). Another study did not provide quantitative data but reported a difference between intervention arms, favouring a 'high' blue‐light filtering spectacle lens type (<a href="./references#CD013244-bbs2-0014" title="LinJB , GerrattBW , BassiCJ , ApteRS . Short-wavelength light-blocking eyeglasses attenuate symptoms of eye fatigue. Investigative Ophthalmology and Visual Science2017;58(1):442‐7. ">Lin 2017</a>). However, this study received industry funding, did not register the clinical trial, and did not mask outcome assessors (<a href="./references#CD013244-bbs2-0014" title="LinJB , GerrattBW , BassiCJ , ApteRS . Short-wavelength light-blocking eyeglasses attenuate symptoms of eye fatigue. Investigative Ophthalmology and Visual Science2017;58(1):442‐7. ">Lin 2017</a>). </p> <p>For the secondary outcome measures, the trial that assessed BCVA reported no significant difference between intervention arms (<a href="./references#CD013244-bbs2-0009" title="Hammond, BR. Attenuating photostress and glare disability in pseudophakic patients through the addition of a short-wave absorbing filter. Journal of Ophthalmology2015;2015:Article ID 607635. [DOI: 10.1155/2015/607635]NCT01938989. Effect of blue light filtration on visual performance. clinicaltrials.gov/ct2/show/NCT01938989 (first received 11 September 2013). ">Hammond 2015</a>). The two trials that evaluated daytime alertness using subjective symptom scores reported no significant difference between blue‐light filtering and non‐blue‐light filtering lenses (<a href="./references#CD013244-bbs2-0109" title="JankuK , SmotekM , FarkovaE , KoprivovaJ . Block the light and sleep well: Evening blue light filtration as a part of cognitive behavioral therapy for insomnia. Chronobiology International2020;37(2):248-59.">Janku 2020</a>; <a href="./references#CD013244-bbs2-0013" title="KnufinkeM , Fittkau-KochL , MøstEI , KompierMA , NieuwenhuysA . Restricting short-wavelength light in the evening to improve sleep in recreational athletes - A pilot study. European Journal of Sport Science2019;19(6):728‐35. ">Knufinke 2019</a>). For the subjective sleep outcome, different findings were reported across the studies, which likely relates to the highly divergent participant populations in the six trials. Three trials that provided quantitative data reported no significant difference in subjective sleep quality with blue‐light filtering lenses compared to non‐blue‐light filtering lenses (<a href="./references#CD013244-bbs2-0007" title="EsakiY , KitajimaT , TakeuchiI , TsuboiS , FurukawaO , MoriwakiM , et al. Effect of blue-blocking glasses in major depressive disorder with sleep onset insomnia: a randomized, double-blind, placebo-controlled study. Chronobiology international2017;34(6):753‐61. ">Esaki 2017</a>; <a href="./references#CD013244-bbs2-0008" title="EsakiY , TakeuchiI , TsuboiS , FujitaK , IwataN , KitajimaT . A double-blind, randomized, placebo-controlled trial of adjunctive blue-blocking glasses for the treatment of sleep and circadian rhythm in patients with bipolar disorder. Bipolar Disorders2020;22(7):739-48. ">Esaki 2020</a>; <a href="./references#CD013244-bbs2-0109" title="JankuK , SmotekM , FarkovaE , KoprivovaJ . Block the light and sleep well: Evening blue light filtration as a part of cognitive behavioral therapy for insomnia. Chronobiology International2020;37(2):248-59.">Janku 2020</a>). One trial with a small sample size (n = 20) that did not provide quantitative data reported an improvement in subjective sleep quality with blue‐light filtering lenses compared to non‐blue‐light filtering lenses (<a href="./references#CD013244-bbs2-0004" title="BurkhartK , PhelpsJR . Amber lenses to block blue light and improve sleep: a randomized trial. Chronobiology International2009;26(8):1602‐12. ">Burkhart 2009</a>). This trial had important baseline differences between the participant groups that might have had affected the reported results (<a href="./references#CD013244-bbs2-0004" title="BurkhartK , PhelpsJR . Amber lenses to block blue light and improve sleep: a randomized trial. Chronobiology International2009;26(8):1602‐12. ">Burkhart 2009</a>). Two trials that did not mask participants, personnel or outcome assessors reported an average daily improvement in subjective sleep quality with blue‐light filtering lenses compared to non‐blue‐light filtering lenses (<a href="./references#CD013244-bbs2-0013" title="KnufinkeM , Fittkau-KochL , MøstEI , KompierMA , NieuwenhuysA . Restricting short-wavelength light in the evening to improve sleep in recreational athletes - A pilot study. European Journal of Sport Science2019;19(6):728‐35. ">Knufinke 2019</a>; <a href="./references#CD013244-bbs2-0016" title="ShechterA , KimEW , St-OngeMP , WestwoodAJ . Blocking nocturnal blue light for insomnia: a randomized controlled trial. Journal of Psychiatric Research2018;96:196‐202. ">Shechter 2018</a>). </p> <p>For the safety outcomes, nine studies reported outcomes for adverse events. Of these, participants in four studies experienced adverse events (<a href="./references#CD013244-bbs2-0006" title="DanilenkoK , LebedinskaiaMY , GadetskaiaEV , MarkovAA , IvanovaYA , AftanasLI . Six day combined partial wake and light therapy for unipolar depression. European Neuropsychopharmacology2019;29:S410‐11. DanilenkoKV , LebedinskaiaMY , GadetskaiaEV , MarkovAA , IvanovaYA , AftanasLI . A 6-day combined wake and light therapy trial for unipolar depression. Journal of Affective Disorders2019;259:355-61. ">Danilenko 2019</a>; <a href="./references#CD013244-bbs2-0007" title="EsakiY , KitajimaT , TakeuchiI , TsuboiS , FurukawaO , MoriwakiM , et al. Effect of blue-blocking glasses in major depressive disorder with sleep onset insomnia: a randomized, double-blind, placebo-controlled study. Chronobiology international2017;34(6):753‐61. ">Esaki 2017</a>; <a href="./references#CD013244-bbs2-0008" title="EsakiY , TakeuchiI , TsuboiS , FujitaK , IwataN , KitajimaT . A double-blind, randomized, placebo-controlled trial of adjunctive blue-blocking glasses for the treatment of sleep and circadian rhythm in patients with bipolar disorder. Bipolar Disorders2020;22(7):739-48. ">Esaki 2020</a>; <a href="./references#CD013244-bbs2-0010" title="HenriksenTE , SkredeS , FasmerOB , SchoeyenH , LeskauskaiteI , Bjørke-BertheussenJ , et al. Blue-blocking glasses as additive treatment for mania: a randomized placebo-controlled trial. Bipolar Disorders2016;18(3):221‐32. ">Henriksen 2016</a>), with three describing events that were considered related to the study intervention (<a href="./references#CD013244-bbs2-0006" title="DanilenkoK , LebedinskaiaMY , GadetskaiaEV , MarkovAA , IvanovaYA , AftanasLI . Six day combined partial wake and light therapy for unipolar depression. European Neuropsychopharmacology2019;29:S410‐11. DanilenkoKV , LebedinskaiaMY , GadetskaiaEV , MarkovAA , IvanovaYA , AftanasLI . A 6-day combined wake and light therapy trial for unipolar depression. Journal of Affective Disorders2019;259:355-61. ">Danilenko 2019</a>; <a href="./references#CD013244-bbs2-0008" title="EsakiY , TakeuchiI , TsuboiS , FujitaK , IwataN , KitajimaT . A double-blind, randomized, placebo-controlled trial of adjunctive blue-blocking glasses for the treatment of sleep and circadian rhythm in patients with bipolar disorder. Bipolar Disorders2020;22(7):739-48. ">Esaki 2020</a>; <a href="./references#CD013244-bbs2-0010" title="HenriksenTE , SkredeS , FasmerOB , SchoeyenH , LeskauskaiteI , Bjørke-BertheussenJ , et al. Blue-blocking glasses as additive treatment for mania: a randomized placebo-controlled trial. Bipolar Disorders2016;18(3):221‐32. ">Henriksen 2016</a>). Such events were generally mild, and mainly related to discomfort from wearing the spectacles. We did not perform meta‐analyses as one study had a different participant population (<a href="./references#CD013244-bbs2-0006" title="DanilenkoK , LebedinskaiaMY , GadetskaiaEV , MarkovAA , IvanovaYA , AftanasLI . Six day combined partial wake and light therapy for unipolar depression. European Neuropsychopharmacology2019;29:S410‐11. DanilenkoKV , LebedinskaiaMY , GadetskaiaEV , MarkovAA , IvanovaYA , AftanasLI . A 6-day combined wake and light therapy trial for unipolar depression. Journal of Affective Disorders2019;259:355-61. ">Danilenko 2019</a>), and another study did not report the proportion of adverse events in the non‐blue‐light filtering lens group (<a href="./references#CD013244-bbs2-0010" title="HenriksenTE , SkredeS , FasmerOB , SchoeyenH , LeskauskaiteI , Bjørke-BertheussenJ , et al. Blue-blocking glasses as additive treatment for mania: a randomized placebo-controlled trial. Bipolar Disorders2016;18(3):221‐32. ">Henriksen 2016</a>). </p> <p>We did not identify any RCTs evaluating affects of blue‐light filtering spectacle lenses on contrast sensitivity, discomfort glare, colour discrimination, macular health, or serum melatonin levels. In addition, none of the included studies evaluated overall patient satisfaction with their visual performance. </p> </section> <section id="CD013244-sec-0079"> <h3 class="title" id="CD013244-sec-0079">Overall completeness and applicability of evidence</h3> <p>The majority (94%) of the 17 included RCTs were published after 2010, indicating a growing interest in the area of blue‐light filtering spectacle lenses over the last decade. The inclusion of a diverse group of participants across the included studies (refer to table of <a href="#CD013244-sec-0043">Included studies</a>) limited our ability to perform meta‐analyses, as did the lack of reported quantitative data in the study reports. </p> <p>A notable finding was that 65% of included trials had a follow‐up period of less than two weeks. As such, the longer‐term potential benefits and adverse effects of blue‐light filtering lenses on the prespecified outcomes investigated in this review are not known. On assessing the age group of the participant population across the included trials, 47% of the included trials investigated populations over 40 years of age. However, 88% of these studies specifically targeted populations with mania, depression and insomnia symptoms, with the intent of investigating the utility of blue‐light filtering spectacle lenses for specific purposes (e.g. improving sleep quality). Hence, there was limited information relating to the effects of blue‐light filtering lenses in healthy older adults. Based on the limited availability of data, it is unclear if there might be a difference in the measured outcomes among individuals less than 40 years old versus those over 40 years of age. This consideration is relevant, given that there is a natural reduction in blue light transmission within the eye associated with yellowing of the human crystalline lens; such effects may alter the relative efficacy of a blue‐light filtering spectacle lenses as a function of participant age. </p> <p>The three studies that evaluated subjective visual fatigue reported no significant difference between blue‐light filtering lenses compared to non‐blue‐light filtering lenses (<a href="./references#CD013244-bbs2-0005" title="DabrowieckiA , VillalobosA , KrupinskiEA . Impact of blue light filtering glasses on computer vision syndrome in radiology residents: a pilot study. Journal of Medical Imaging2020;7(2):022402. ">Dabrowiecki 2020</a>; <a href="./references#CD013244-bbs2-0014" title="LinJB , GerrattBW , BassiCJ , ApteRS . Short-wavelength light-blocking eyeglasses attenuate symptoms of eye fatigue. Investigative Ophthalmology and Visual Science2017;58(1):442‐7. ">Lin 2017</a>; <a href="./references#CD013244-bbs2-0017" title="SinghS , DownieLE , AndersonAJ . Do blue-blocking lenses reduce eye strain from extended screen time? A double-masked, randomized controlled trial. American Journal of Ophthalmology2021;226:243–51. [DOI: 10.1016/j.ajo.2021.02.010]">Singh 2021</a>). However, we judged only one trial to have robust methodology based on the risk of bias assessments, as defined by prospective clinical trial registration, allocation concealment, double‐masking, and the development of an a priori data analysis plan before performing the formal data analyses (<a href="./references#CD013244-bbs2-0017" title="SinghS , DownieLE , AndersonAJ . Do blue-blocking lenses reduce eye strain from extended screen time? A double-masked, randomized controlled trial. American Journal of Ophthalmology2021;226:243–51. [DOI: 10.1016/j.ajo.2021.02.010]">Singh 2021</a>). Further, only the <a href="./references#CD013244-bbs2-0017" title="SinghS , DownieLE , AndersonAJ . Do blue-blocking lenses reduce eye strain from extended screen time? A double-masked, randomized controlled trial. American Journal of Ophthalmology2021;226:243–51. [DOI: 10.1016/j.ajo.2021.02.010]">Singh 2021</a> trial recruited symptomatic computer users, who are the primary population that blue‐light filtering lenses are marketed to. The other two trials enrolled computer users without specifying whether they were necessarily symptomatic of eye strain (<a href="./references#CD013244-bbs2-0014" title="LinJB , GerrattBW , BassiCJ , ApteRS . Short-wavelength light-blocking eyeglasses attenuate symptoms of eye fatigue. Investigative Ophthalmology and Visual Science2017;58(1):442‐7. ">Lin 2017</a>), and radiology residents (<a href="./references#CD013244-bbs2-0005" title="DabrowieckiA , VillalobosA , KrupinskiEA . Impact of blue light filtering glasses on computer vision syndrome in radiology residents: a pilot study. Journal of Medical Imaging2020;7(2):022402. ">Dabrowiecki 2020</a>). Overall, the relatively consistent findings reported across the three trials that evaluated this outcome suggest blue‐light filtering lenses may not reduce symptoms of visual fatigue with computer use compared to non‐blue‐light filtering lenses. </p> <p>The two trials that evaluated CFF reported opposite findings (<a href="./references#CD013244-bbs2-0014" title="LinJB , GerrattBW , BassiCJ , ApteRS . Short-wavelength light-blocking eyeglasses attenuate symptoms of eye fatigue. Investigative Ophthalmology and Visual Science2017;58(1):442‐7. ">Lin 2017</a>; <a href="./references#CD013244-bbs2-0017" title="SinghS , DownieLE , AndersonAJ . Do blue-blocking lenses reduce eye strain from extended screen time? A double-masked, randomized controlled trial. American Journal of Ophthalmology2021;226:243–51. [DOI: 10.1016/j.ajo.2021.02.010]">Singh 2021</a>). The industry‐sponsored trial by <a href="./references#CD013244-bbs2-0014" title="LinJB , GerrattBW , BassiCJ , ApteRS . Short-wavelength light-blocking eyeglasses attenuate symptoms of eye fatigue. Investigative Ophthalmology and Visual Science2017;58(1):442‐7. ">Lin 2017</a> reported a significant benefit with a 'high' blue‐light filtering lens product compared to both 'low' blue‐light filtering and non‐blue‐light filtering lenses. However, the double‐masked RCT by <a href="./references#CD013244-bbs2-0017" title="SinghS , DownieLE , AndersonAJ . Do blue-blocking lenses reduce eye strain from extended screen time? A double-masked, randomized controlled trial. American Journal of Ophthalmology2021;226:243–51. [DOI: 10.1016/j.ajo.2021.02.010]">Singh 2021</a> reported no significant difference between blue‐light filtering and non‐blue‐light filtering lenses for this outcome. Visually inspecting the plots in the trial report of <a href="./references#CD013244-bbs2-0014" title="LinJB , GerrattBW , BassiCJ , ApteRS . Short-wavelength light-blocking eyeglasses attenuate symptoms of eye fatigue. Investigative Ophthalmology and Visual Science2017;58(1):442‐7. ">Lin 2017</a>, which did not provide numeric quantitative data, suggests an approximate change of 2 Hz with the 'high' blue‐light filtering lenses; although described as "statistically significant", the clinical significance of this small change remains unclear. Two recent studies that evaluated the association between CFF and visual fatigue, determined via a symptom questionnaire, reported no association between these outcome measures (<a href="./references#CD013244-bbs2-0061" title="AndersonAJ , SinghS , DownieLE . Investigating the relationship between critical flicker fusion frequency and symptoms of eye strain. Investigative Ophthalmology and Visual Science2022;63(7):2249-F0457.">Anderson 2022</a>; <a href="./references#CD013244-bbs2-0164" title="YanK , RosenfieldM . Digital eyestrain and the critical fusion frequency. Optometry and Vision Science2022;99(3):253-8.">Yan 2022</a>). These findings suggest that using CFF as a surrogate objective marker of visual fatigue symptoms, as has been adopted in previous studies, may not be appropriate. </p> <p>Regarding the six studies that investigated subjective sleep quality, aside from one study that recruited recreational athletes (<a href="./references#CD013244-bbs2-0013" title="KnufinkeM , Fittkau-KochL , MøstEI , KompierMA , NieuwenhuysA . Restricting short-wavelength light in the evening to improve sleep in recreational athletes - A pilot study. European Journal of Sport Science2019;19(6):728‐35. ">Knufinke 2019</a>), none included healthy individuals, and instead focused on evaluating whether blue‐light filtering lenses might have benefit in individuals with significant health disorders, including insomnia, manic depression and bipolar disorder. This finding was unexpected given that computer users are a key consumer population targeted by the optical industry with claims that blue‐light filtering lenses can benefit sleep cycles. The overall body of evidence relating to the potential role of blue‐light filtering lenses for promoting subjective sleep quality is inconclusive, given the high degree of variability reported across the included studies. </p> <p>Although the link between blue‐light exposure and age‐related macular degeneration in humans remains unclear, there have been claims by certain members of the optical industry and mainstream media that blue light can cause retinal phototoxicity, and that blue‐light filtering lenses offer protection against such damage (<a href="./references#CD013244-bbs2-0145" title="SinghS , DownieLE , AndersonAJ . Insights into Australian optometrists’ knowledge and attitude towards prescribing blue light‐blocking ophthalmic devices. Ophthalmic and Physiological Optics2019;39(3):194-204.">Singh 2019</a>). None of the 17 studies included in this review evaluated the role of blue‐light filtering lenses for protecting the macula. As such, we were unable to identify any RCT evidence to support the application of blue‐light filtering lenses, in preference to non‐blue‐light filtering lenses, for providing macular protection. Such studies have a range of practical challenges with their execution, including the need to evaluate large groups of individuals over protracted periods of time in order to detect potential intergroup differences in the outcome of interest. Nevertheless, it is important that consumers and practitioners are aware of the lack of current clinical studies evaluating whether blue‐light filtering lenses have any utility in this potential application. </p> <p>Despite the establishment of the International Medical Device Regulators Forum (IMDRF) in 2011, adverse events were not consistently assessed or reported in the included trials. Three of the nine studies that assessed adverse events reported side effects that were deemed to be associated with the study intervention (<a href="./references#CD013244-bbs2-0006" title="DanilenkoK , LebedinskaiaMY , GadetskaiaEV , MarkovAA , IvanovaYA , AftanasLI . Six day combined partial wake and light therapy for unipolar depression. European Neuropsychopharmacology2019;29:S410‐11. DanilenkoKV , LebedinskaiaMY , GadetskaiaEV , MarkovAA , IvanovaYA , AftanasLI . A 6-day combined wake and light therapy trial for unipolar depression. Journal of Affective Disorders2019;259:355-61. ">Danilenko 2019</a>; <a href="./references#CD013244-bbs2-0008" title="EsakiY , TakeuchiI , TsuboiS , FujitaK , IwataN , KitajimaT . A double-blind, randomized, placebo-controlled trial of adjunctive blue-blocking glasses for the treatment of sleep and circadian rhythm in patients with bipolar disorder. Bipolar Disorders2020;22(7):739-48. ">Esaki 2020</a>; <a href="./references#CD013244-bbs2-0010" title="HenriksenTE , SkredeS , FasmerOB , SchoeyenH , LeskauskaiteI , Bjørke-BertheussenJ , et al. Blue-blocking glasses as additive treatment for mania: a randomized placebo-controlled trial. Bipolar Disorders2016;18(3):221‐32. ">Henriksen 2016</a>). All the adverse events were relatively mild, with studies reporting increased depressive symptoms, headache, and discomfort from wearing the glasses. Similar symptoms of discomfort from wearing glasses were reported, along with occasional hyperthymia, in participants assigned to non‐blue‐light filtering lenses. It should be noted that these three studies involved participants with bipolar or depressive disorders. The rate of adverse events with blue‐light filtering lenses compared to non‐blue‐light filtering in healthy individuals thus remains uncertain. As this is the population that typically presents for routine eye care and is prescribed these lenses, there is a need to ensure that future trials fully report adverse events, in order to obtain a more comprehensive (and generalisable) understanding of any potential side effects. </p> <p>Another important consideration with interpreting the presented findings is that the included studies used a wide range of blue‐light filtering spectacle lens products that filter blue light by different amounts (see <a href="#CD013244-tbl-0002">Table 1</a> for details). Given a lack of suitable available data, subgroup analyses could not be performed to assess whether there was any difference between blue‐light filtering lenses that attenuate different amounts of blue light for the prespecified study outcome measures. This is another relevant question that might be addressed with the availability of data from future studies. </p> <p>Overall, as only one study evaluated the potential change in BCVA with the use of blue‐light filtering lenses compared to non‐blue‐light filtering lenses, current evidence for effect(s) on this outcome suggests little or no effect. There is also currently no RCT evidence to draw conclusions on whether blue‐light filtering lenses modify aspects of visual performance (i.e. discomfort glare, contrast sensitivity and colour discrimination), serum melatonin levels, or their potential effect(s) on patient visual satisfaction, compared with non‐blue‐light filtering lenses. </p> </section> <section id="CD013244-sec-0080"> <h3 class="title" id="CD013244-sec-0080">Quality of the evidence</h3> <p>Overall, we graded the certainty of the body of evidence for all prespecified outcomes as moderate, low or very low, using the GRADE approach (see <a href="./full#CD013244-tbl-0001">summary of findings Table 1</a> for details). </p> <p>We judged the certainty of the evidence for both the primary outcomes (subjective visual fatigue score and CFF) to be low. For subjective symptom scores, we downgraded the evidence due to a high risk of bias detected across domains relating to performance bias and detection bias, and due to imprecision (wide confidence intervals). For the CFF outcome, we downgraded evidence certainty due to a high risk of performance bias and due to inconsistent findings between studies (with one study reporting positive effects with blue‐light filtering lenses and another study reporting no significant difference between the study groups). </p> <p>For BCVA, we downgraded the certainty of evidence to moderate due to a high risk of detection bias. We downgraded the certainty of evidence for the subjective sleep score outcome to very low, due to studies having small sample sizes and reporting variable findings, and high risks detected across the domains of performance bias, detection bias, and other bias (studies reporting significant baseline imbalance). </p> <p>We downgraded the certainty of evidence for adverse events to low, due to inconsistency in the reported study findings and our evaluation of high risks of bias for selection bias, performance bias, detection bias, and other risk of bias (studies reporting significant baseline imbalance between the participant groups). </p> </section> <section id="CD013244-sec-0081"> <h3 class="title" id="CD013244-sec-0081">Potential biases in the review process</h3> <p>We followed the standard methodological procedures recommended by Cochrane to minimise any potential bias in the conduct of this systematic review. Two of the review authors (SS and LED) were first‐ (SS) and senior‐authors (LED), respectively, on one of the studies included in this review (<a href="./references#CD013244-bbs2-0017" title="SinghS , DownieLE , AndersonAJ . Do blue-blocking lenses reduce eye strain from extended screen time? A double-masked, randomized controlled trial. American Journal of Ophthalmology2021;226:243–51. [DOI: 10.1016/j.ajo.2021.02.010]">Singh 2021</a>). For this study, two independent review authors (JL and CH) performed the risk of bias assessment and consensus. Overall, we consider this process to have mitigated this potential bias. </p> </section> <section id="CD013244-sec-0082"> <h3 class="title" id="CD013244-sec-0082">Agreements and disagreements with other studies or reviews</h3> <p>A previous systematic review investigated the potential benefits and harms of blue‐light filtering lenses on visual performance, macular health and the sleep‐wake cycle (<a href="./references#CD013244-bbs2-0119" title="LawrensonJG , HullCH , DownieLE . The effect of blue-light blocking spectacle lenses on visual performance, macular health and the sleep-wake cycle: a systematic review of the literature. Ophthalmic and Physiological Optics2017;37(6):644-54.">Lawrenson 2017</a>). The review included both randomised and pseudo‐randomised controlled trials, and three studies met the authors' eligibility criteria. All three studies were reported to have an unclear or high risk of selection bias. Overall, the review found a lack of high‐quality evidence to support the use of blue‐light blocking lenses by the general population to improve ocular health, sleep patterns or eye strain, compared to non‐blue‐light filtering lenses. The findings reported in the systematic review by <a href="./references#CD013244-bbs2-0119" title="LawrensonJG , HullCH , DownieLE . The effect of blue-light blocking spectacle lenses on visual performance, macular health and the sleep-wake cycle: a systematic review of the literature. Ophthalmic and Physiological Optics2017;37(6):644-54.">Lawrenson 2017</a> broadly align with the findings in the current review. </p> <p>One recently published systematic review evaluated the benefits and harms of interventions available for the treatment of computer vision syndrome (<a href="./references#CD013244-bbs2-0146" title="SinghS , McGuinnessMB , AndersonAJ , DownieLE . Interventions for the management of computer vision syndrome: a systematic review and meta-analysis. Ophthalmology2022;129(10):1192–1215. [DOI: 10.1016/j.ophtha.2022.05.009]">Singh 2022</a>). This review included only RCTs and considered outcomes related to visual fatigue symptoms, CFF, quality of life, dry eye symptoms, amplitude of accommodation, near point of convergence, blink rate, overall patient satisfaction, and adverse events. This review investigated a diverse range of interventions, including a comparison between blue‐light filtering versus non‐blue‐light filtering spectacle lenses. The review included three RCTs that had evaluated visual fatigue symptoms, and two studies that had quantified CFF; these studies mirror those included in the current review. <a href="./references#CD013244-bbs2-0146" title="SinghS , McGuinnessMB , AndersonAJ , DownieLE . Interventions for the management of computer vision syndrome: a systematic review and meta-analysis. Ophthalmology2022;129(10):1192–1215. [DOI: 10.1016/j.ophtha.2022.05.009]">Singh 2022</a> reported there may be no overall effect on visual fatigue, and little to no effect on CFF, with blue‐light filtering lenses compared to non‐blue‐light filtering lenses. These findings are similar to the appraisal of the evidence in the current review. </p> <p>Another recent systematic review investigated the effect of blue‐light filtering lenses (both spectacles and IOLs) on the progression of age‐related macular degeneration, visual fatigue symptoms, and sleep quality (<a href="./references#CD013244-bbs2-0155" title="VaggeA , FerroDL , Del NoceC , Di MolaI , SindacoD , TraversoCE . Blue light filtering ophthalmic lenses: A systematic review. Seminars in Ophthalmology2021;36(7):541-8.">Vagge 2021</a>). The review reported individual study findings to be inconsistent in relation to the potential application of blue‐light blocking devices for protecting macular health, reducing visual fatigue, or promoting sleep quality. Although these findings are broadly consistent with the current review, it should be noted that this review by <a href="./references#CD013244-bbs2-0155" title="VaggeA , FerroDL , Del NoceC , Di MolaI , SindacoD , TraversoCE . Blue light filtering ophthalmic lenses: A systematic review. Seminars in Ophthalmology2021;36(7):541-8.">Vagge 2021</a> was not prospectively registered on a public systematic review registry, did not perform risk of bias assessments on the included studies, and did not evaluate the overall evidence certainty using an approach such as GRADE. </p> <p>Two other systematic reviews have evaluated the effects of blue‐light filtering spectacle lenses on sleep‐related outcomes (<a href="./references#CD013244-bbs2-0104" title="HesterL , DangD , BarkerCJ , HeathM , MesiyaS , TienabesoT , et al. Evening wear of blue-blocking glasses for sleep and mood disorders: a systematic review. Chronobiology International2021;38(10):1375-83.">Hester 2021</a>; <a href="./references#CD013244-bbs2-0143" title="ShechterA , QuispeKA , MizhquiriBJ , SlaterC , FalzonL . Interventions to reduce short-wavelength (“blue”) light exposure at night and their effects on sleep: a systematic review and meta-analysis. Sleep Advances2020;1(1):zpaa002.">Shechter 2020</a>). <a href="./references#CD013244-bbs2-0143" title="ShechterA , QuispeKA , MizhquiriBJ , SlaterC , FalzonL . Interventions to reduce short-wavelength (“blue”) light exposure at night and their effects on sleep: a systematic review and meta-analysis. Sleep Advances2020;1(1):zpaa002.">Shechter 2020</a> included 12 studies with study populations comprising both healthy individuals and people with pathological conditions (i.e. medical, psychiatric, sleep, or circadian rhythms disorders). <a href="./references#CD013244-bbs2-0143" title="ShechterA , QuispeKA , MizhquiriBJ , SlaterC , FalzonL . Interventions to reduce short-wavelength (“blue”) light exposure at night and their effects on sleep: a systematic review and meta-analysis. Sleep Advances2020;1(1):zpaa002.">Shechter 2020</a> concluded there to be some evidence that the use of blue‐light filtering lenses can improve sleep in people with certain pathological conditions. The other systematic review included 29 studies with heterogeneous study designs (<a href="./references#CD013244-bbs2-0104" title="HesterL , DangD , BarkerCJ , HeathM , MesiyaS , TienabesoT , et al. Evening wear of blue-blocking glasses for sleep and mood disorders: a systematic review. Chronobiology International2021;38(10):1375-83.">Hester 2021</a>). This review focused on clinical populations with sleep and mood disorders, and concluded that blue‐light filtering lenses could improve sleep in people reporting insomnia or a delayed sleep phase. However, the review by <a href="./references#CD013244-bbs2-0104" title="HesterL , DangD , BarkerCJ , HeathM , MesiyaS , TienabesoT , et al. Evening wear of blue-blocking glasses for sleep and mood disorders: a systematic review. Chronobiology International2021;38(10):1375-83.">Hester 2021</a> was not prospectively registered and risk of bias assessments were not undertaken. The findings reported in the systematic reviews by <a href="./references#CD013244-bbs2-0104" title="HesterL , DangD , BarkerCJ , HeathM , MesiyaS , TienabesoT , et al. Evening wear of blue-blocking glasses for sleep and mood disorders: a systematic review. Chronobiology International2021;38(10):1375-83.">Hester 2021</a> and somewhat contrast with those reported in the current review. A likely reason is that the current review included only RCTs, whereas <a href="./references#CD013244-bbs2-0143" title="ShechterA , QuispeKA , MizhquiriBJ , SlaterC , FalzonL . Interventions to reduce short-wavelength (“blue”) light exposure at night and their effects on sleep: a systematic review and meta-analysis. Sleep Advances2020;1(1):zpaa002.">Shechter 2020</a> included RCTs, single‐arm trials and pre‐/post‐intervention designs, and <a href="./references#CD013244-bbs2-0104" title="HesterL , DangD , BarkerCJ , HeathM , MesiyaS , TienabesoT , et al. Evening wear of blue-blocking glasses for sleep and mood disorders: a systematic review. Chronobiology International2021;38(10):1375-83.">Hester 2021</a> included RCTs, uncontrolled trials, a case series and a case study. The inclusion of study designs with the potential for more bias reduces the certainty of the conclusions in these earlier reviews, and thus their findings should be interpreted with caution. </p> <p>A prior Cochrane Review and meta‐analysis by <a href="./references#CD013244-bbs2-0090" title="DownieLE , BusijaL , KellerPR . Blue-light filtering intraocular lenses (IOLs) for protecting macular health. Cochrane Database of Systematic Reviews2018, Issue 5. Art. No: CD011977. [DOI: 10.1002/14651858.CD011977.pub2]">Downie 2018</a> examined the potential benefits and adverse effects of blue‐light blocking IOLs, compared to non‐blue‐light blocking IOLs, for protecting macular health, and modulating visual function (i.e. BCVA, colour discrimination and contrast sensitivity). Based on analysing data from 51 eligible RCTs, the authors concluded that there was a lack of clinical evidence to support the use of blue‐light blocking IOLs for protecting macular health, or altering the risks associated with the development and progression of AMD (<a href="./references#CD013244-bbs2-0091" title="DownieLE , WormaldR , EvansJ , VirgiliG , KellerPR , LawrensonJG , et al. Analysis of a systematic review about blue light–filtering intraocular lenses for retinal protection: Understanding the limitations of the evidence. JAMA Ophthalmology2019;137(6):694-7.">Downie 2019</a>). The authors found no significant difference in short‐term BCVA between blue‐light blocking IOLs and non‐blue‐light blocking IOLs. Furthermore, there were no relevant combinable data to ascertain the potential effects of blue‐light blocking IOLs on contrast sensitivity or colour discrimination. The findings related to visual function, and macular health outcomes were similar to the findings reported in the current review that investigated blue‐light filtering spectacle lenses. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD013244-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013244.pub2/media/CDSR/CD013244/urn:x-wiley:14651858:media:CD013244:CD013244-FIG-01" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram" data-id="CD013244-fig-0001" src="/cdsr/doi/10.1002/14651858.CD013244.pub2/media/CDSR/CD013244/image_n/nCD013244-FIG-01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013244.pub2/media/CDSR/CD013244/image_t/tCD013244-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013244.pub2/full#CD013244-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013244.pub2/media/CDSR/CD013244/image_n/nCD013244-FIG-01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013244-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013244.pub2/media/CDSR/CD013244/urn:x-wiley:14651858:media:CD013244:CD013244-FIG-02" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study" data-id="CD013244-fig-0002" src="/cdsr/doi/10.1002/14651858.CD013244.pub2/media/CDSR/CD013244/image_n/nCD013244-FIG-02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013244.pub2/media/CDSR/CD013244/image_t/tCD013244-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013244.pub2/full#CD013244-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013244.pub2/media/CDSR/CD013244/image_n/nCD013244-FIG-02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013244-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013244.pub2/media/CDSR/CD013244/urn:x-wiley:14651858:media:CD013244:CD013244-FIG-03" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies" data-id="CD013244-fig-0003" src="/cdsr/doi/10.1002/14651858.CD013244.pub2/media/CDSR/CD013244/image_n/nCD013244-FIG-03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013244.pub2/media/CDSR/CD013244/image_t/tCD013244-FIG-03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013244.pub2/full#CD013244-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013244.pub2/media/CDSR/CD013244/image_n/nCD013244-FIG-03.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD013244-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Summary of findings 1: blue‐light filtering lenses compared to non‐blue‐light filtering lenses</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>Blue‐light filtering lenses compared with non‐blue‐light filtering lenses</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population</b>: adults </p> <p><b>Setting</b>: any setting </p> <p><b>Intervention</b>: blue‐light filtering lenses </p> <p><b>Comparison</b>: non‐blue‐light filtering lenses </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Outcome</b> </p> </th> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Relative effect (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Number of participants</b> </p> <p><b>(Number of studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Certainty of</b> </p> <p><b>the evidence</b> </p> <p><b>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with non‐blue light‐filtering lenses</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with blue‐light filtering lenses</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Visual fatigue score, measured using a Likert scale or VAS, with follow‐up ranging from &lt; 1 to 5 days (higher values indicate a poorer outcome) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in visual fatigue score in the non‐blue‐light filtering lens group was on average 86.92 units higher (55.42 higher to 118.4 higher). </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in visual fatigue score in the blue‐light filtering lens group was on average 96.68 units higher (65.07 higher to 128.3 higher) (<a href="./references#CD013244-bbs2-0017" title="SinghS , DownieLE , AndersonAJ . Do blue-blocking lenses reduce eye strain from extended screen time? A double-masked, randomized controlled trial. American Journal of Ophthalmology2021;226:243–51. [DOI: 10.1016/j.ajo.2021.02.010]">Singh 2021</a>). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9.76 units higher (33.95 lower to 53.47 higher)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>120 (1 RCT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<sup>a</sup> </p> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quantitative data reported for this outcome derive from <a href="./references#CD013244-bbs2-0017" title="SinghS , DownieLE , AndersonAJ . Do blue-blocking lenses reduce eye strain from extended screen time? A double-masked, randomized controlled trial. American Journal of Ophthalmology2021;226:243–51. [DOI: 10.1016/j.ajo.2021.02.010]">Singh 2021</a> (120 participants). </p> <p>Symptom scores were reported only as P values or in a non‐numeric form in 1 study (<a href="./references#CD013244-bbs2-0014" title="LinJB , GerrattBW , BassiCJ , ApteRS . Short-wavelength light-blocking eyeglasses attenuate symptoms of eye fatigue. Investigative Ophthalmology and Visual Science2017;58(1):442‐7. ">Lin 2017</a>), and another study presented data as the average daily change over a 5‐day period, rather than as the change from baseline or endpoint data value (<a href="./references#CD013244-bbs2-0005" title="DabrowieckiA , VillalobosA , KrupinskiEA . Impact of blue light filtering glasses on computer vision syndrome in radiology residents: a pilot study. Journal of Medical Imaging2020;7(2):022402. ">Dabrowiecki 2020</a>). </p> <p>2 trials reported no significant difference between intervention arms (<a href="./references#CD013244-bbs2-0005" title="DabrowieckiA , VillalobosA , KrupinskiEA . Impact of blue light filtering glasses on computer vision syndrome in radiology residents: a pilot study. Journal of Medical Imaging2020;7(2):022402. ">Dabrowiecki 2020</a>; <a href="./references#CD013244-bbs2-0014" title="LinJB , GerrattBW , BassiCJ , ApteRS . Short-wavelength light-blocking eyeglasses attenuate symptoms of eye fatigue. Investigative Ophthalmology and Visual Science2017;58(1):442‐7. ">Lin 2017</a>). </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CFF, measured in Hz, with a follow‐up of 2 hours (lower values indicate a poorer outcome)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in CFF in the non‐blue‐light filtering lens group was on average 0.12 Hz lower (1.47 lower to 1.24 higher) (<a href="./references#CD013244-bbs2-0017" title="SinghS , DownieLE , AndersonAJ . Do blue-blocking lenses reduce eye strain from extended screen time? A double-masked, randomized controlled trial. American Journal of Ophthalmology2021;226:243–51. [DOI: 10.1016/j.ajo.2021.02.010]">Singh 2021</a>). </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in CFF in the blue‐light filtering lens group was on average 1.25 Hz lower (2.60 lower to 0.09 higher) (<a href="./references#CD013244-bbs2-0017" title="SinghS , DownieLE , AndersonAJ . Do blue-blocking lenses reduce eye strain from extended screen time? A double-masked, randomized controlled trial. American Journal of Ophthalmology2021;226:243–51. [DOI: 10.1016/j.ajo.2021.02.010]">Singh 2021</a>). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.13 Hz lower (3.00 lower to 0.74 higher)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>120 (1 RCT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<sup>b</sup> </p> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quantitative data reported for this outcome derive from <a href="./references#CD013244-bbs2-0017" title="SinghS , DownieLE , AndersonAJ . Do blue-blocking lenses reduce eye strain from extended screen time? A double-masked, randomized controlled trial. American Journal of Ophthalmology2021;226:243–51. [DOI: 10.1016/j.ajo.2021.02.010]">Singh 2021</a> (120 participants). </p> <p>CFF data were reported only as P values or in a non‐numeric form in one study (<a href="./references#CD013244-bbs2-0014" title="LinJB , GerrattBW , BassiCJ , ApteRS . Short-wavelength light-blocking eyeglasses attenuate symptoms of eye fatigue. Investigative Ophthalmology and Visual Science2017;58(1):442‐7. ">Lin 2017</a>). <a href="./references#CD013244-bbs2-0014" title="LinJB , GerrattBW , BassiCJ , ApteRS . Short-wavelength light-blocking eyeglasses attenuate symptoms of eye fatigue. Investigative Ophthalmology and Visual Science2017;58(1):442‐7. ">Lin 2017</a> reported a significantly less negative change in CFF (i.e. less visual fatigue) with high blue‐light filtering lenses compared to low blue‐light filtering and non‐blue‐light filtering lenses. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>BCVA, measured in log units, with follow‐up of less than 1 day (higher values indicate a poorer outcome) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean BCVA in the non‐blue‐light filtering lens group was on average 0.049 units.</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean BCVA in the blue‐light filtering lens group was on average 0.051 units.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.00 log units (0.02 lower to 0.02 higher)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>156 (1 RCT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<sup>c</sup> </p> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quantitative data reported for this outcome derive from <a href="./references#CD013244-bbs2-0009" title="Hammond, BR. Attenuating photostress and glare disability in pseudophakic patients through the addition of a short-wave absorbing filter. Journal of Ophthalmology2015;2015:Article ID 607635. [DOI: 10.1155/2015/607635]NCT01938989. Effect of blue light filtration on visual performance. clinicaltrials.gov/ct2/show/NCT01938989 (first received 11 September 2013). ">Hammond 2015</a>. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Proportion of eyes or individuals that developed macular structural changes</p> </td> <td align="center" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No relevant data were available for this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Colour discrimination, measured using the FM‐100 hue test</p> </td> <td align="center" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No relevant data were available for this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Subjective sleep scores, measured using a VAS or Likert scale, with follow‐up ranging from 4 days to 5 weeks (higher values indicate a poorer outcome) </p> </td> <td align="" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>6 studies reported subjective sleep scores (<a href="./references#CD013244-bbs2-0004" title="BurkhartK , PhelpsJR . Amber lenses to block blue light and improve sleep: a randomized trial. Chronobiology International2009;26(8):1602‐12. ">Burkhart 2009</a>; <a href="./references#CD013244-bbs2-0007" title="EsakiY , KitajimaT , TakeuchiI , TsuboiS , FurukawaO , MoriwakiM , et al. Effect of blue-blocking glasses in major depressive disorder with sleep onset insomnia: a randomized, double-blind, placebo-controlled study. Chronobiology international2017;34(6):753‐61. ">Esaki 2017</a>; <a href="./references#CD013244-bbs2-0008" title="EsakiY , TakeuchiI , TsuboiS , FujitaK , IwataN , KitajimaT . A double-blind, randomized, placebo-controlled trial of adjunctive blue-blocking glasses for the treatment of sleep and circadian rhythm in patients with bipolar disorder. Bipolar Disorders2020;22(7):739-48. ">Esaki 2020</a>; <a href="./references#CD013244-bbs2-0012" title="JankuK , SmotekM , FarkovaE , KoprivovaJ . Block the light and sleep well: Evening blue light filtration as a part of cognitive behavioral therapy for insomnia. Chronobiology International2020;37(2):248-59. JankuK , SmotekM , FarkovaE , MiletínováE , KoprivovaJ . Blue light blocking glasses and CBT-I: effect on subjective and objective sleep quality. Sleep Medicine2019;64(Suppl 1):S174. ">Janku 2020</a>; <a href="./references#CD013244-bbs2-0013" title="KnufinkeM , Fittkau-KochL , MøstEI , KompierMA , NieuwenhuysA . Restricting short-wavelength light in the evening to improve sleep in recreational athletes - A pilot study. European Journal of Sport Science2019;19(6):728‐35. ">Knufinke 2019</a>; <a href="./references#CD013244-bbs2-0016" title="ShechterA , KimEW , St-OngeMP , WestwoodAJ . Blocking nocturnal blue light for insomnia: a randomized controlled trial. Journal of Psychiatric Research2018;96:196‐202. ">Shechter 2018</a>). Of these, 3 studies reported a significant improvement in sleep scores with blue‐light filtering lenses compared to non‐blue‐light filtering lenses (<a href="./references#CD013244-bbs2-0004" title="BurkhartK , PhelpsJR . Amber lenses to block blue light and improve sleep: a randomized trial. Chronobiology International2009;26(8):1602‐12. ">Burkhart 2009</a>; <a href="./references#CD013244-bbs2-0013" title="KnufinkeM , Fittkau-KochL , MøstEI , KompierMA , NieuwenhuysA . Restricting short-wavelength light in the evening to improve sleep in recreational athletes - A pilot study. European Journal of Sport Science2019;19(6):728‐35. ">Knufinke 2019</a>; <a href="./references#CD013244-bbs2-0016" title="ShechterA , KimEW , St-OngeMP , WestwoodAJ . Blocking nocturnal blue light for insomnia: a randomized controlled trial. Journal of Psychiatric Research2018;96:196‐202. ">Shechter 2018</a>); however, the magnitude of the difference between intervention arms could not be calculated, due to a lack of complete data reporting. </p> <p>The other 3 studies reported no significant difference in subjective sleep scores between intervention arms (<a href="./references#CD013244-bbs2-0007" title="EsakiY , KitajimaT , TakeuchiI , TsuboiS , FurukawaO , MoriwakiM , et al. Effect of blue-blocking glasses in major depressive disorder with sleep onset insomnia: a randomized, double-blind, placebo-controlled study. Chronobiology international2017;34(6):753‐61. ">Esaki 2017</a>; <a href="./references#CD013244-bbs2-0008" title="EsakiY , TakeuchiI , TsuboiS , FujitaK , IwataN , KitajimaT . A double-blind, randomized, placebo-controlled trial of adjunctive blue-blocking glasses for the treatment of sleep and circadian rhythm in patients with bipolar disorder. Bipolar Disorders2020;22(7):739-48. ">Esaki 2020</a>; <a href="./references#CD013244-bbs2-0012" title="JankuK , SmotekM , FarkovaE , KoprivovaJ . Block the light and sleep well: Evening blue light filtration as a part of cognitive behavioral therapy for insomnia. Chronobiology International2020;37(2):248-59. JankuK , SmotekM , FarkovaE , MiletínováE , KoprivovaJ . Blue light blocking glasses and CBT-I: effect on subjective and objective sleep quality. Sleep Medicine2019;64(Suppl 1):S174. ">Janku 2020</a>). For these 3 studies, the difference between intervention arms ranged from 19.90 units higher (indicating poor sleep) (1.86 lower to 41.66 higher, 20 participants) to 0.03 units higher (2.53 lower to 2.59 higher, 27 participants). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>148 (6 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<sup>d</sup> </p> <p>Very low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Subjective sleep scores were reported only as P values or in a non‐numeric form in 1 study (<a href="./references#CD013244-bbs2-0004" title="BurkhartK , PhelpsJR . Amber lenses to block blue light and improve sleep: a randomized trial. Chronobiology International2009;26(8):1602‐12. ">Burkhart 2009</a>). Data were presented as the average daily change, rather than the change from baseline or endpoint data in 1 study (<a href="./references#CD013244-bbs2-0016" title="ShechterA , KimEW , St-OngeMP , WestwoodAJ . Blocking nocturnal blue light for insomnia: a randomized controlled trial. Journal of Psychiatric Research2018;96:196‐202. ">Shechter 2018</a>). </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Proportion of participants with adverse events with a probable causal linked with the study intervention </p> </td> <td align="" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>4 studies reported adverse events, consisting of increased depressive symptoms, headache, lower mood, and pain or discomfort from wearing the spectacles across the study intervention arms. In the control arms, reported adverse events were hyperthermia and discomfort from wearing the spectacles. </p> <p>1 study reported adverse events in only the active intervention (blue‐light filtering lens) group (n = 3/13 participants) (<a href="./references#CD013244-bbs2-0010" title="HenriksenTE , SkredeS , FasmerOB , SchoeyenH , LeskauskaiteI , Bjørke-BertheussenJ , et al. Blue-blocking glasses as additive treatment for mania: a randomized placebo-controlled trial. Bipolar Disorders2016;18(3):221‐32. ">Henriksen 2016</a>). </p> <p>1 study reported an identical number of adverse events across both the active intervention and control arms (n = 4/10 versus n = 4/10) (<a href="./references#CD013244-bbs2-0007" title="EsakiY , KitajimaT , TakeuchiI , TsuboiS , FurukawaO , MoriwakiM , et al. Effect of blue-blocking glasses in major depressive disorder with sleep onset insomnia: a randomized, double-blind, placebo-controlled study. Chronobiology international2017;34(6):753‐61. ">Esaki 2017</a>). </p> <p>2 studies reported more adverse events in the control arm than with the active intervention (n = 0/19 versus n = 2/16, and n = 4/44 versus n = 7/44 participants) (<a href="./references#CD013244-bbs2-0006" title="DanilenkoK , LebedinskaiaMY , GadetskaiaEV , MarkovAA , IvanovaYA , AftanasLI . Six day combined partial wake and light therapy for unipolar depression. European Neuropsychopharmacology2019;29:S410‐11. DanilenkoKV , LebedinskaiaMY , GadetskaiaEV , MarkovAA , IvanovaYA , AftanasLI . A 6-day combined wake and light therapy trial for unipolar depression. Journal of Affective Disorders2019;259:355-61. ">Danilenko 2019</a>; <a href="./references#CD013244-bbs2-0008" title="EsakiY , TakeuchiI , TsuboiS , FujitaK , IwataN , KitajimaT . A double-blind, randomized, placebo-controlled trial of adjunctive blue-blocking glasses for the treatment of sleep and circadian rhythm in patients with bipolar disorder. Bipolar Disorders2020;22(7):739-48. ">Esaki 2020</a>). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>333 (9 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<sup>e</sup> </p> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There were no adverse events reported across both intervention and control groups in 5 studies (<a href="./references#CD013244-bbs2-0004" title="BurkhartK , PhelpsJR . Amber lenses to block blue light and improve sleep: a randomized trial. Chronobiology International2009;26(8):1602‐12. ">Burkhart 2009</a>; <a href="./references#CD013244-bbs2-0012" title="JankuK , SmotekM , FarkovaE , KoprivovaJ . Block the light and sleep well: Evening blue light filtration as a part of cognitive behavioral therapy for insomnia. Chronobiology International2020;37(2):248-59. JankuK , SmotekM , FarkovaE , MiletínováE , KoprivovaJ . Blue light blocking glasses and CBT-I: effect on subjective and objective sleep quality. Sleep Medicine2019;64(Suppl 1):S174. ">Janku 2020</a>; <a href="./references#CD013244-bbs2-0015" title="Perez AlgortaG , Van MeterA , DubickaB , JonesS , YoungstromE , LobbanF . Blue blocking glasses worn at night in first year higher education students with sleep complaints: a feasibility study. Pilot and Feasibility Studies2018;4:166. ">Perez Algorta 2018</a>; <a href="./references#CD013244-bbs2-0016" title="ShechterA , KimEW , St-OngeMP , WestwoodAJ . Blocking nocturnal blue light for insomnia: a randomized controlled trial. Journal of Psychiatric Research2018;96:196‐202. ">Shechter 2018</a>; <a href="./references#CD013244-bbs2-0017" title="SinghS , DownieLE , AndersonAJ . Do blue-blocking lenses reduce eye strain from extended screen time? A double-masked, randomized controlled trial. American Journal of Ophthalmology2021;226:243–51. [DOI: 10.1016/j.ajo.2021.02.010]">Singh 2021</a>). </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI). </p> <p>BCVA: best‐corrected visual acuity; CI: confidence interval; MD: mean difference; CFF: critical flicker‐fusion frequency; Hz: hertz; VAS: visual analogue scale; FM: Farnsworth Munsell.; RCT: randomised controlled trial. </p> <p><b>GRADE Working Group grades of evidence.</b> </p> <p><b>High quality</b>: further research is very unlikely to change our confidence in the estimate of effect. </p> <p><b>Moderate quality</b>: further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. </p> <p><b>Low quality</b>: further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. </p> <p><b>Very low quality</b>: we are very uncertain about the estimate. </p> <p><sup>a</sup>Downgraded two levels for risk of bias and imprecision, because outcome assessors were not masked in one study (<a href="./references#CD013244-bbs2-0005" title="DabrowieckiA , VillalobosA , KrupinskiEA . Impact of blue light filtering glasses on computer vision syndrome in radiology residents: a pilot study. Journal of Medical Imaging2020;7(2):022402. ">Dabrowiecki 2020</a>), one study did not mask participants and study personnel (<a href="./references#CD013244-bbs2-0014" title="LinJB , GerrattBW , BassiCJ , ApteRS . Short-wavelength light-blocking eyeglasses attenuate symptoms of eye fatigue. Investigative Ophthalmology and Visual Science2017;58(1):442‐7. ">Lin 2017</a>), and one study had wide confidence intervals (<a href="./references#CD013244-bbs2-0017" title="SinghS , DownieLE , AndersonAJ . Do blue-blocking lenses reduce eye strain from extended screen time? A double-masked, randomized controlled trial. American Journal of Ophthalmology2021;226:243–51. [DOI: 10.1016/j.ajo.2021.02.010]">Singh 2021</a>).<br/><sup>b</sup>Downgraded one level each for risk of bias and inconsistency, because one study did not mask participants and study personnel (<a href="./references#CD013244-bbs2-0014" title="LinJB , GerrattBW , BassiCJ , ApteRS . Short-wavelength light-blocking eyeglasses attenuate symptoms of eye fatigue. Investigative Ophthalmology and Visual Science2017;58(1):442‐7. ">Lin 2017</a>), and one study showed no intergroup differences (<a href="./references#CD013244-bbs2-0017" title="SinghS , DownieLE , AndersonAJ . Do blue-blocking lenses reduce eye strain from extended screen time? A double-masked, randomized controlled trial. American Journal of Ophthalmology2021;226:243–51. [DOI: 10.1016/j.ajo.2021.02.010]">Singh 2021</a>) while the other reported a positive effect with the blue‐light filtering intervention (<a href="./references#CD013244-bbs2-0014" title="LinJB , GerrattBW , BassiCJ , ApteRS . Short-wavelength light-blocking eyeglasses attenuate symptoms of eye fatigue. Investigative Ophthalmology and Visual Science2017;58(1):442‐7. ">Lin 2017</a>).<br/><sup>c</sup>Downgraded one level for risk of bias, because data derived from one study, in which the outcome assessor was not masked (<a href="./references#CD013244-bbs2-0009" title="Hammond, BR. Attenuating photostress and glare disability in pseudophakic patients through the addition of a short-wave absorbing filter. Journal of Ophthalmology2015;2015:Article ID 607635. [DOI: 10.1155/2015/607635]NCT01938989. Effect of blue light filtration on visual performance. clinicaltrials.gov/ct2/show/NCT01938989 (first received 11 September 2013). ">Hammond 2015</a>).<br/><sup>d</sup>Downgraded three levels for risk of bias, imprecision and inconsistency. In four studies, participants or study personnel, or both, were not masked (<a href="./references#CD013244-bbs2-0004" title="BurkhartK , PhelpsJR . Amber lenses to block blue light and improve sleep: a randomized trial. Chronobiology International2009;26(8):1602‐12. ">Burkhart 2009</a>; <a href="./references#CD013244-bbs2-0012" title="JankuK , SmotekM , FarkovaE , KoprivovaJ . Block the light and sleep well: Evening blue light filtration as a part of cognitive behavioral therapy for insomnia. Chronobiology International2020;37(2):248-59. JankuK , SmotekM , FarkovaE , MiletínováE , KoprivovaJ . Blue light blocking glasses and CBT-I: effect on subjective and objective sleep quality. Sleep Medicine2019;64(Suppl 1):S174. ">Janku 2020</a>; <a href="./references#CD013244-bbs2-0013" title="KnufinkeM , Fittkau-KochL , MøstEI , KompierMA , NieuwenhuysA . Restricting short-wavelength light in the evening to improve sleep in recreational athletes - A pilot study. European Journal of Sport Science2019;19(6):728‐35. ">Knufinke 2019</a>; <a href="./references#CD013244-bbs2-0016" title="ShechterA , KimEW , St-OngeMP , WestwoodAJ . Blocking nocturnal blue light for insomnia: a randomized controlled trial. Journal of Psychiatric Research2018;96:196‐202. ">Shechter 2018</a>), and in three studies outcome assessors were not masked (<a href="./references#CD013244-bbs2-0004" title="BurkhartK , PhelpsJR . Amber lenses to block blue light and improve sleep: a randomized trial. Chronobiology International2009;26(8):1602‐12. ">Burkhart 2009</a>; <a href="./references#CD013244-bbs2-0013" title="KnufinkeM , Fittkau-KochL , MøstEI , KompierMA , NieuwenhuysA . Restricting short-wavelength light in the evening to improve sleep in recreational athletes - A pilot study. European Journal of Sport Science2019;19(6):728‐35. ">Knufinke 2019</a>; <a href="./references#CD013244-bbs2-0016" title="ShechterA , KimEW , St-OngeMP , WestwoodAJ . Blocking nocturnal blue light for insomnia: a randomized controlled trial. Journal of Psychiatric Research2018;96:196‐202. ">Shechter 2018</a>). Two studies were at high risk of other bias due to significant baseline imbalance (<a href="./references#CD013244-bbs2-0004" title="BurkhartK , PhelpsJR . Amber lenses to block blue light and improve sleep: a randomized trial. Chronobiology International2009;26(8):1602‐12. ">Burkhart 2009</a>; <a href="./references#CD013244-bbs2-0007" title="EsakiY , KitajimaT , TakeuchiI , TsuboiS , FurukawaO , MoriwakiM , et al. Effect of blue-blocking glasses in major depressive disorder with sleep onset insomnia: a randomized, double-blind, placebo-controlled study. Chronobiology international2017;34(6):753‐61. ">Esaki 2017</a>). Further, the included studies had small sample sizes and reported variable findings.<br/><sup>e</sup>Downgraded two levels for risk of bias and inconsistency. In four studies, participants and study personnel were not masked (<a href="./references#CD013244-bbs2-0004" title="BurkhartK , PhelpsJR . Amber lenses to block blue light and improve sleep: a randomized trial. Chronobiology International2009;26(8):1602‐12. ">Burkhart 2009</a>; <a href="./references#CD013244-bbs2-0012" title="JankuK , SmotekM , FarkovaE , KoprivovaJ . Block the light and sleep well: Evening blue light filtration as a part of cognitive behavioral therapy for insomnia. Chronobiology International2020;37(2):248-59. JankuK , SmotekM , FarkovaE , MiletínováE , KoprivovaJ . Blue light blocking glasses and CBT-I: effect on subjective and objective sleep quality. Sleep Medicine2019;64(Suppl 1):S174. ">Janku 2020</a>; <a href="./references#CD013244-bbs2-0015" title="Perez AlgortaG , Van MeterA , DubickaB , JonesS , YoungstromE , LobbanF . Blue blocking glasses worn at night in first year higher education students with sleep complaints: a feasibility study. Pilot and Feasibility Studies2018;4:166. ">Perez Algorta 2018</a>; <a href="./references#CD013244-bbs2-0016" title="ShechterA , KimEW , St-OngeMP , WestwoodAJ . Blocking nocturnal blue light for insomnia: a randomized controlled trial. Journal of Psychiatric Research2018;96:196‐202. ">Shechter 2018</a>), and in four studies outcome assessors were not masked (<a href="./references#CD013244-bbs2-0004" title="BurkhartK , PhelpsJR . Amber lenses to block blue light and improve sleep: a randomized trial. Chronobiology International2009;26(8):1602‐12. ">Burkhart 2009</a>; <a href="./references#CD013244-bbs2-0010" title="HenriksenTE , SkredeS , FasmerOB , SchoeyenH , LeskauskaiteI , Bjørke-BertheussenJ , et al. Blue-blocking glasses as additive treatment for mania: a randomized placebo-controlled trial. Bipolar Disorders2016;18(3):221‐32. ">Henriksen 2016</a>; <a href="./references#CD013244-bbs2-0015" title="Perez AlgortaG , Van MeterA , DubickaB , JonesS , YoungstromE , LobbanF . Blue blocking glasses worn at night in first year higher education students with sleep complaints: a feasibility study. Pilot and Feasibility Studies2018;4:166. ">Perez Algorta 2018</a>; <a href="./references#CD013244-bbs2-0016" title="ShechterA , KimEW , St-OngeMP , WestwoodAJ . Blocking nocturnal blue light for insomnia: a randomized controlled trial. Journal of Psychiatric Research2018;96:196‐202. ">Shechter 2018</a>). Two studies were at high risk of other bias due to significant baseline imbalance (<a href="./references#CD013244-bbs2-0004" title="BurkhartK , PhelpsJR . Amber lenses to block blue light and improve sleep: a randomized trial. Chronobiology International2009;26(8):1602‐12. ">Burkhart 2009</a>; <a href="./references#CD013244-bbs2-0007" title="EsakiY , KitajimaT , TakeuchiI , TsuboiS , FurukawaO , MoriwakiM , et al. Effect of blue-blocking glasses in major depressive disorder with sleep onset insomnia: a randomized, double-blind, placebo-controlled study. Chronobiology international2017;34(6):753‐61. ">Esaki 2017</a>). Further, the reported adverse events were observed to vary across the studies. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Summary of findings 1: blue‐light filtering lenses compared to non‐blue‐light filtering lenses</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013244.pub2/full#CD013244-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD013244-tbl-0002"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Summary of study design, participants, interventions, and follow‐up periods for the included studies</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study design</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Recruited sample size</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Participant population</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Blue‐light filtering lens name(s) (manufacturer)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Non‐blue‐light filtering lens name(s) (manufacturer)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Intervention follow‐up duration</b> </p> </th> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013244-bbs2-0002" title="AlzahranHS , RoyM , HonsonV , KhuuSK . Effect of blue-blocking lenses on colour contrast sensitivity. Clinical and Experimental Optometry2021;104(2):207-14. ">Alzahrani 2021</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Randomised,</p> <p>cross‐over, controlled</p> <p>trial</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Healthy volunteers</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Crizal Prevencia (Essilor), Blue Guardian (Opticare), and Blu‐OLP (GenOp) lenses.</p> <p>Spectral transmittance data presented in figure 1 of the publication.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> <p>Spectral transmittance data presented in figure 1 of the publication.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013244-bbs2-0001" title="AlzahraniHS , KhuuSK , AliA , RoyM . The effect of blue-blocking lenses on photostress recovery times. Optometry and Vision Science2020;97(11):995-1004. ">Alzahrani 2020</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Randomised,</p> <p>cross‐over, controlled</p> <p>trial</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Individuals with no history of ocular disease or abnormal vision</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>UV++Blue Control (JuzVision, Bulli, NSW, Australia), Crizal Prevencia (Essilor, Silverwater, NSW, Australia), BlueGuardian (Opticare, Sydney, NSW, Australia), and Blu‐OLP (GenOp, Rosebery, NSW, Australia) lenses </p> <p>Spectral transmittance data presented in figure 1 of the publication.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> <p>Spectral transmittance data presented in figure 1 of the publication.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013244-bbs2-0003" title="BigalkeJA , GreenlundIM , NicevskiJR , CarterJR . Effect of evening blue light blocking glasses on subjective and objective sleep in healthy adults: a randomized control trial. Sleep Health2021;7(4):485–90. ">Bigalke 2021</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Randomised,</p> <p>cross‐over, controlled</p> <p>trial</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Healthy volunteers</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported (LowBlueLights. com, University Heights, OH, USA)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported (Ultra‐Spec 2001 OTG, Uvex, Honeywell Safety, USA)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 week</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013244-bbs2-0004" title="BurkhartK , PhelpsJR . Amber lenses to block blue light and improve sleep: a randomized trial. Chronobiology International2009;26(8):1602‐12. ">Burkhart 2009</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Randomised,</p> <p>parallel‐group,</p> <p>controlled trial</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sleep difficulty</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported (NoIR Polycarbonate Eyewear)</p> <p>“blocked wavelengths &lt; 550nm (blue‐green or longer wavelengths being transmitted)”</p> <p>Spectral transmittance data presented in figure 1 of the publication.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported (NoIR Polycarbonate Eyewear)</p> <p>Spectral transmittance data presented in figure 1 of the publication.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 weeks</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013244-bbs2-0005" title="DabrowieckiA , VillalobosA , KrupinskiEA . Impact of blue light filtering glasses on computer vision syndrome in radiology residents: a pilot study. Journal of Medical Imaging2020;7(2):022402. ">Dabrowiecki 2020</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Randomised,</p> <p>cross‐over, controlled</p> <p>trial</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Radiology residents</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported (Felix Gray, Inc., NewYork, New York)</p> <p>“The BLFL filter 50% of 380‐ to 500‐nm blue light, nearly 90% of 400‐ to 440‐nm blue light, and reduced glare by 99%” </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported (Felix Gray, Inc., NewYork, New York)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 days</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013244-bbs2-0006" title="DanilenkoK , LebedinskaiaMY , GadetskaiaEV , MarkovAA , IvanovaYA , AftanasLI . Six day combined partial wake and light therapy for unipolar depression. European Neuropsychopharmacology2019;29:S410‐11. DanilenkoKV , LebedinskaiaMY , GadetskaiaEV , MarkovAA , IvanovaYA , AftanasLI . A 6-day combined wake and light therapy trial for unipolar depression. Journal of Affective Disorders2019;259:355-61. ">Danilenko 2019</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Randomised,</p> <p>parallel‐group,</p> <p>controlled trial</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>35</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Major depressive disorder or persistent depressive disorder (dysthymia)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported (Chron‐optic, Québec, Canada)</p> <p>"Orange glasses completely cut the wavelengths below 540 nm (Sasseville et al., 2015; Fig. 1S) and diminished the light intensity by ∼70%” </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported (Chron‐optic, Québec, Canada)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 days</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013244-bbs2-0008" title="EsakiY , TakeuchiI , TsuboiS , FujitaK , IwataN , KitajimaT . A double-blind, randomized, placebo-controlled trial of adjunctive blue-blocking glasses for the treatment of sleep and circadian rhythm in patients with bipolar disorder. Bipolar Disorders2020;22(7):739-48. ">Esaki 2020</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Randomised,</p> <p>parallel‐group,</p> <p>controlled trial</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>43</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bipolar disorder</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported (Yamamoto Kogaku, No. 360S UV Orange, Osaka, Japan)</p> <p>Spectral transmittance data presented in supplementary figure 1 of the publication.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported (Yamamoto Kogaku, No. 331, Osaka, Japan)</p> <p>Spectral transmittance data presented in supplementary figure 1 of the publication.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 weeks</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013244-bbs2-0007" title="EsakiY , KitajimaT , TakeuchiI , TsuboiS , FurukawaO , MoriwakiM , et al. Effect of blue-blocking glasses in major depressive disorder with sleep onset insomnia: a randomized, double-blind, placebo-controlled study. Chronobiology international2017;34(6):753‐61. ">Esaki 2017</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Randomised,</p> <p>parallel‐group,</p> <p>controlled trial</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Major depressive disorder with sleep onset insomnia</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported (Yamamoto Kogaku, No. 360S UV Orange, Osaka, Japan)</p> <p>Spectral transmittance data presented in figure 1 of the publication.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported (Yamamoto Kogaku, No. 331, Osaka, Japan)</p> <p>Spectral transmittance data presented in figure 1 of the publication.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 weeks</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013244-bbs2-0009" title="Hammond, BR. Attenuating photostress and glare disability in pseudophakic patients through the addition of a short-wave absorbing filter. Journal of Ophthalmology2015;2015:Article ID 607635. [DOI: 10.1155/2015/607635]NCT01938989. Effect of blue light filtration on visual performance. clinicaltrials.gov/ct2/show/NCT01938989 (first received 11 September 2013). ">Hammond 2015</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Randomised,</p> <p>cross‐over, controlled</p> <p>trial</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>156</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bilateral pseudophakia</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013244-bbs2-0011" title="HenriksenTEG , GrønliJ , AssmusJ , FasmerOB , SchoeyenH , LeskauskaiteI , et al. Blue-blocking glasses as additive treatment for mania: Effects on actigraphy-derived sleep parameters. Journal of Sleep Research2020;29(5):e12984. [DOI: 10.1111/jsr.12984]">Henriksen 2020</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Randomised,</p> <p>parallel‐group,</p> <p>controlled trial</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bipolar disorder</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported (LowBlueLights.com, University Heights, OH, USA)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported (Uvex, Furth, Germany, and 3M, Austin, TX, USA)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7 days</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013244-bbs2-0010" title="HenriksenTE , SkredeS , FasmerOB , SchoeyenH , LeskauskaiteI , Bjørke-BertheussenJ , et al. Blue-blocking glasses as additive treatment for mania: a randomized placebo-controlled trial. Bipolar Disorders2016;18(3):221‐32. ">Henriksen 2016</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Randomised,</p> <p>parallel‐group,</p> <p>controlled trial</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bipolar disorder</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported (LowBlueLights.com, University Heights, OH,USA)</p> <p>Spectral transmittance data presented in supplementary figure 1 of the publication.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported (Uvex, Furth, Germany and 3M, Austin,TX, USA)</p> <p>Spectral transmittance data presented in supplementary figure 1 of the publication.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7 days</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013244-bbs2-0012" title="JankuK , SmotekM , FarkovaE , KoprivovaJ . Block the light and sleep well: Evening blue light filtration as a part of cognitive behavioral therapy for insomnia. Chronobiology International2020;37(2):248-59. JankuK , SmotekM , FarkovaE , MiletínováE , KoprivovaJ . Blue light blocking glasses and CBT-I: effect on subjective and objective sleep quality. Sleep Medicine2019;64(Suppl 1):S174. ">Janku 2020</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Randomised,</p> <p>parallel‐group,</p> <p>controlled trial</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>35</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Insomnia</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>UVEX S1933X (not reported)</p> <p>“Based on the used spectrum control technology they were supposed to reduce up to 98% of the lights of blue wavelength.” </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>UVEX S1900 (not reported)</p> <p>“clear glasses with no ability to filtrate blue light were used.”</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 weeks</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013244-bbs2-0013" title="KnufinkeM , Fittkau-KochL , MøstEI , KompierMA , NieuwenhuysA . Restricting short-wavelength light in the evening to improve sleep in recreational athletes - A pilot study. European Journal of Sport Science2019;19(6):728‐35. ">Knufinke 2019</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Randomised,</p> <p>cross‐over, controlled</p> <p>trial</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Recreational athletes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported (Eye shield soft red Safety Glasses, Königswinter, Germany)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported (Oramics)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9 nights</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013244-bbs2-0014" title="LinJB , GerrattBW , BassiCJ , ApteRS . Short-wavelength light-blocking eyeglasses attenuate symptoms of eye fatigue. Investigative Ophthalmology and Visual Science2017;58(1):442‐7. ">Lin 2017</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Randomised,</p> <p>parallel‐group,</p> <p>controlled trial</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>36</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Healthy volunteers</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD013244-list-0006"> <li> <p>High blue light blocking lenses (JINS CO., LTD)</p> </li> <li> <p>Low blue light blocking lenses (JINS CO., LTD)</p> </li> </ul> </p> <p>Spectral transmittance data presented in figure 1 of the publication.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported (JINS CO., LTD)</p> <p>Spectral transmittance data presented in figure 1 of the publication.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 hours</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013244-bbs2-0015" title="Perez AlgortaG , Van MeterA , DubickaB , JonesS , YoungstromE , LobbanF . Blue blocking glasses worn at night in first year higher education students with sleep complaints: a feasibility study. Pilot and Feasibility Studies2018;4:166. ">Perez Algorta 2018</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Randomised,</p> <p>cross‐over, controlled</p> <p>trial</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sleep complaints/disorders</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Uvex S1933X (not reported)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Uvex S1932X (not reported)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 days</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013244-bbs2-0016" title="ShechterA , KimEW , St-OngeMP , WestwoodAJ . Blocking nocturnal blue light for insomnia: a randomized controlled trial. Journal of Psychiatric Research2018;96:196‐202. ">Shechter 2018</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Randomised,</p> <p>cross‐over, controlled</p> <p>trial</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Chronic insomnia</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported (Bandit style frames, Uvex, Honeywell Safety, Smithfield, USA)</p> <p>“The amber lenses filter out blue‐wavelength light, while allowing the other visible spectrum light to pass, resulting in a blue‐light absorption (BLA) of 65% and a visible light transmission (VLT) of 90%” </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> <p>“The clear lenses have a VLT of 92%, while allowing for the almost complete transmission of blue‐wavelength light (∼90%) based on manufacturer specifications” </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 week</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013244-bbs2-0017" title="SinghS , DownieLE , AndersonAJ . Do blue-blocking lenses reduce eye strain from extended screen time? A double-masked, randomized controlled trial. American Journal of Ophthalmology2021;226:243–51. [DOI: 10.1016/j.ajo.2021.02.010]">Singh 2021</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Randomised,</p> <p>parallel‐group,</p> <p>controlled trial</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>120</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Symptomatic computer users</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prevencia (Essilor, Dallas, Texas, USA)</p> <p>"The “active” intervention group received blue‐blocking lenses (Prevencia; Essilor, Dallas, Texas, USA) that filtered blue light by front surface coating between 10% and 30% in the range of 400‐500 nm. These lenses almost completely blocked transmission below 400 nm and had approximately 95% transmission between 500 and 700 nm.” </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Crizal UV coated lenses (Essilor)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 hours</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>Abbreviations: BLFL, blue light filtering lens; nm, nanometres</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Summary of study design, participants, interventions, and follow‐up periods for the included studies</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013244.pub2/full#CD013244-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD013244-tbl-0003"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Table 2. Summary of adverse effects reported in included trials</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study ID</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Number of participants and study population</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Adverse event(s)</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013244-bbs2-0004" title="BurkhartK , PhelpsJR . Amber lenses to block blue light and improve sleep: a randomized trial. Chronobiology International2009;26(8):1602‐12. ">Burkhart 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20 participants with sleep difficulty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013244-bbs2-0006" title="DanilenkoK , LebedinskaiaMY , GadetskaiaEV , MarkovAA , IvanovaYA , AftanasLI . Six day combined partial wake and light therapy for unipolar depression. European Neuropsychopharmacology2019;29:S410‐11. DanilenkoKV , LebedinskaiaMY , GadetskaiaEV , MarkovAA , IvanovaYA , AftanasLI . A 6-day combined wake and light therapy trial for unipolar depression. Journal of Affective Disorders2019;259:355-61. ">Danilenko 2019</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>35 participants with major depressive disorder or persistent depressive disorder (dysthymia)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>“No eye‐related adverse events were reported. All patients successfully resisted sleep during daytime, verified by actimetric data. Two patients – both from the white light group – were occasionally hyperthymic following treatment (not reaching hypomania as documented by both patient‐reported questionnaire and psychiatrist).” </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013244-bbs2-0008" title="EsakiY , TakeuchiI , TsuboiS , FujitaK , IwataN , KitajimaT . A double-blind, randomized, placebo-controlled trial of adjunctive blue-blocking glasses for the treatment of sleep and circadian rhythm in patients with bipolar disorder. Bipolar Disorders2020;22(7):739-48. ">Esaki 2020</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>43 participants with bipolar disorder</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events in general involved discomfort from wearing the glasses (BB group, 2; placebo group, 3) and pain from the contacting part of the glasses (BB group, 1; placebo group, 4), as well as lowered mood (BB group, 1). All participants reported that the discomfort or pain improved after removing the glasses. One participant in the BB group reported lowered mood after intervention week 1.” </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013244-bbs2-0007" title="EsakiY , KitajimaT , TakeuchiI , TsuboiS , FurukawaO , MoriwakiM , et al. Effect of blue-blocking glasses in major depressive disorder with sleep onset insomnia: a randomized, double-blind, placebo-controlled study. Chronobiology international2017;34(6):753‐61. ">Esaki 2017</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20 participants with major depressive disorder with sleep onset insomnia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>“Adverse events involved discomfort from wearing the glasses (BB group n = 1) or pain from the contacting part of the glasses (BB group n = 3, placebo group n = 4).” </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013244-bbs2-0010" title="HenriksenTE , SkredeS , FasmerOB , SchoeyenH , LeskauskaiteI , Bjørke-BertheussenJ , et al. Blue-blocking glasses as additive treatment for mania: a randomized placebo-controlled trial. Bipolar Disorders2016;18(3):221‐32. ">Henriksen 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32 participants with bipolar disorder</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>“With regard to side effects, two patients in the BB group reported emerging depressive symptoms on days 6 and 7, respectively.” </p> <p>“One patient, with comorbid migraine, reported headache associated with the use of BB glasses, causing dropout on the second night of the intervention.” </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013244-bbs2-0012" title="JankuK , SmotekM , FarkovaE , KoprivovaJ . Block the light and sleep well: Evening blue light filtration as a part of cognitive behavioral therapy for insomnia. Chronobiology International2020;37(2):248-59. JankuK , SmotekM , FarkovaE , MiletínováE , KoprivovaJ . Blue light blocking glasses and CBT-I: effect on subjective and objective sleep quality. Sleep Medicine2019;64(Suppl 1):S174. ">Janku 2020</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>35 participants with insomnia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013244-bbs2-0015" title="Perez AlgortaG , Van MeterA , DubickaB , JonesS , YoungstromE , LobbanF . Blue blocking glasses worn at night in first year higher education students with sleep complaints: a feasibility study. Pilot and Feasibility Studies2018;4:166. ">Perez Algorta 2018</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13 participants with with sleep complaints/disorders</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013244-bbs2-0016" title="ShechterA , KimEW , St-OngeMP , WestwoodAJ . Blocking nocturnal blue light for insomnia: a randomized controlled trial. Journal of Psychiatric Research2018;96:196‐202. ">Shechter 2018</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15 participants with chronic insomnia symptoms</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013244-bbs2-0017" title="SinghS , DownieLE , AndersonAJ . Do blue-blocking lenses reduce eye strain from extended screen time? A double-masked, randomized controlled trial. American Journal of Ophthalmology2021;226:243–51. [DOI: 10.1016/j.ajo.2021.02.010]">Singh 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>120 symptomatic computer users</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="3"> <div class="table-footnote"> <p>Abbreviations: BB, blue block.</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Table 2. Summary of adverse effects reported in included trials</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013244.pub2/full#CD013244-tbl-0003">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD013244.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD013244-note-0007">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD013244-note-0014">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD013244-note-0019">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD013244-note-0013">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD013244-note-0012">Hrvatski</a> </li> <li class="section-language"> <a class="" href="id#CD013244-note-0020">Bahasa Indonesia</a> </li> <li class="section-language"> <a class="" href="ja#CD013244-note-0018">日本語</a> </li> <li class="section-language"> <a class="" href="ko#CD013244-note-0009">한국어</a> </li> <li class="section-language"> <a class="" href="ms#CD013244-note-0011">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD013244-note-0021">Polski</a> </li> <li class="section-language"> <a class="" href="pt#CD013244-note-0010">Português</a> </li> <li class="section-language"> <a class="" href="ru#CD013244-note-0008">Русский</a> </li> <li class="section-language"> <a class="" href="th#CD013244-note-0017">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD013244-note-0015">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD013244-note-0016">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738735355000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738735355000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013244\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013244\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013244\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013244\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013244\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013244\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013244\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013244\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013244\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013244\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013244\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013244\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013244\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013244\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013244\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013244\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013244\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013244\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=jU9oKp1Y&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013244.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD013244.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD013244.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD013244.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013244.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"/> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740714490938"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD013244.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"/> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740714490942"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD013244.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918d6ff74a7b9377',t:'MTc0MDcxNDQ5MS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 